Anterior cutaneous nerve entrapment syndrome : epidemiology and surgical management by van Assen, T.
  
 
Anterior cutaneous nerve entrapment syndrome :
epidemiology and surgical management
Citation for published version (APA):
van Assen, T. (2015). Anterior cutaneous nerve entrapment syndrome : epidemiology and surgical
management. Maastricht: Maastricht University.
Document status and date:
Published: 01/01/2015
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
3Anterior Cutaneous 
Nerve Entrapment Syndrome
Epidemiology and surgical  
management
Tijmen van Assen 
2
4 5
Colofon
Author:   T. van Assen
Cover design en lay-out:  Miranda Dood, Mirakels Ontwerp
Original cover photo:   Arno Lataster, Dept. of Anatomy and Embryology
    Maastricht University
Printing:   Gildeprint - The Netherlands
ISBN:   978-90-9029031-7
Printing of this thesis was financially supported by institutions of the Máxima Medi-
cal Center; department of surgery – the MMC Academy – SolviMáx, Center of Excel-
lence for Abdominal Wall and Groin Pain – SMC SportMáx Zuidoost Brabant, and 
Rabobank Eindhoven-Veldhoven, Medicidesk.
© T. van Assen, Eindhoven, The Netherlands, 2015.
All rights reserved. No part of this publication may be reproduced or transmitted
in any form by any means, without permission of the author.
Anterior Cutaneous 
Nerve Entrapment Syndrome
Epidemiology and surgical 
management
Een wetenschappelijke proeve op het gebied 
van de Medische Wetenschappen
Proefschrift
ter verkrijging van de graad van doctor
aan de Universiteit Maastricht 
op gezag van Rector Magnificus prof. dr. L.L.G. Soete,
volgens besluit van het College van Decanen,
in het openbaar te verdedigen
 op donderdag 11 juni 2015 om 10.00 uur
door
Tijmen van Assen 
Geboren op 3 maart 1986
te Epe
... finger on the sore spot ...
CENTER OF EXCELLENCE
6 7
Promotores  
Prof. dr. G.L. Beets, Maastricht UMC+
Prof. dr. M. van Kleef, Maastricht UMC+
 
Co-promotores 
Dr. R.M.H. Roumen, MMC Eindhoven / Veldhoven
Dr. M.R.M. Scheltinga, MMC Eindhoven / Veldhoven
Manuscriptcommissie
Prof. dr. N.D. Bouvy, Maastricht UMC+ (voorzitter)
Prof. dr. F.J.P.M. Huygen, Erasmus MC Rotterdam
Prof. dr. J.F.M. Metsemakers, Maastricht University
Prof. dr. J.J. van Overbeeke, Maastricht UMC+
Prof. dr. A.J.P.M. Smout, AMC Amsterdam
Anterior Cutaneous Nerve Entrapment Syndrome
8
Table of contents
9
Table of contents
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Introduction, aims and outline of the thesis
Construction and validation of a questionnaire distinguishing 
a chronic abdominal wall pain syndrome from irritable bowel 
syndrome. Frontline Gastroenterology 2012; 3: 288-294
Chronic abdominal wall pain misdiagnosed as functional abdominal 
pain. Journal of the American Board of Family Medicine 2013; 26: 
738-744
Incidence of abdominal pain due to the anterior cutaneous nerve 
entrapment syndrome in an emergency department. Scandinavian 
Journal of Trauma, Resuscitation and Emergency Medicine; 2015;  
23: 19
Anterior cutaneous nerve entrapment syndrome and the avoidable 
economic burden. (submitted)
A double-blind, randomized, controlled trial on surgery for chronic 
abdominal pain due to anterior cutaneous nerve entrapment 
syndrome. Annals of Surgery. 2013; 257(5): 845-9
Long-term success rates after an anterior neurectomy in patients 
with an abdominal cutaneous nerve entrapment syndrome. Surgery. 
2015; 157(1): 137-43
p.10
p.22
p.40
p.56
p.70
p.92
p.110
Chapter 8
Chapter 9
Chapter 10
Chapter 11
Surgical options after a failed neurectomy in anterior cutaneous 
nerve entrapment syndrome. World Journal of Surgery. 2014; 38(12): 
3105-11
Summarizing discussion, conclusions and future perspectives
Valorisation
Samenvatting (Dutch summary)
Dankwoord
List of publicatons
Curriculum vitae
p.128
p.144
p.158
p.166
p.184
p.189
p.191
1
Chapter 1
Introduction, aims and outline
of the thesis   
1
Introduction, aims and outline of the thesis
13
1
12
Anterior Cutaneous Nerve Entrapment Syndrome / Epidemiology and surgical management
Introduction
“Neuralgia of the nerves which supply the abdominal wall is a subject which has 
never received merited recognition in medical literature. It is an exceedingly common 
affection and failure to recognize its presence inevitably leads to erroneous diagnoses and 
results often in futile operations.” John B. Carnett, an American Surgeon, started his 1926 
article “Intercostal Neuralgia as a Cause of Abdominal Pain and Tenderness” with this 
statement1. Since then, only a limited number of publications attracted attention to this 
pain entity2-6. Due to a lack of widespread knowledge concerning the abdominal wall, the 
anterior cutaneous nerve entrapment syndrome (ACNES), a characteristic abdominal 
wall pain syndrome, is frequently overlooked as the cause. The physicians ‘preoccupation’ 
with intra-abdominal visceral disorders is another cause for the ongoing neglect of 
chronic abdominal wall pain (CAWP) syndromes7. This ignorance leads to unnecessary 
and costly consultations, multiple testing and negative abdominal surgery and may also 
result in frustrated patients, discouraged doctors and unhappy insurance companies4, 7. 
Some studies point towards a high health consumption in ACNES. However, these 
investigations were performed in previous eras in countries that differ from the Dutch 
health care system. One Canadian study reported that 418 diagnostic procedures were 
executed in 100 CAWP patients3. In two other studies on diagnostic testing and hospital 
charges before arriving at the correct diagnosis, direct medical costs were calculated 
to range from 680 US$ up to a staggering 6727 US$ per chronic abdominal wall pain 
(CAWP) patient8, 9.
Older studies concerning ACNES mainly focused on clinical signs and treatment 
using pain point injections with anaesthetics4, 5, 7, 10-17. However, most patients do not 
benefit on the long term from local anesthetics only. Some studies suggested surgical 
resection of end twigs of intercostal nerves, based on similar techniques performed in 
patients with neuropathic groin pain syndromes2, 4. But until recent years, most studies in 
ACNES did not focus on surgical treatment.
Apart from a lack of a complete and easy to implement diagnostic and treatment 
protocol, there is also a lack of reliable numbers on incidence and prevalence. In daily 
practice, physicians continuously have to interpret a patient history and physician’s 
examination, and combine these with estimations of the likelihood of possible causes 
(‘differential diagnosis’). In specific situations, researchers were able to forward ‘educated 
guesses’ on ACNES incidence. For instance, approximately 1% of referrals to general 
surgeons were related to abdominal wall pain syndromes16. Furthermore, abdominal wall 
pain was diagnosed in approximately 15% of referrals for nonspecific abdominal pain in 
one outpatient pain clinic18. Carnett claimed to have seen three patients per week with this 
diagnosis, and Applegate evaluated 1-2 patients with this diagnosis in every 150 patients 
in his family practice1, 7. These subjective observations suggest a substantial incidence. 
However, such estimations are outdated and most were level five evidence rather than 
structurally studied incidence calculations. 
There is still a lot to learn in the world of ACNES. 
Anatomy
The thoraco-abdominal nerves which end up as cutaneous nerves are anchored at 5 
points (Figure 1): 1) the spinal cord; 2) the point at which the posterior branch originates; 
3) the point at which the lateral branch originates; 4) the point at which the anterior 
branch makes a nearly 90° turn to enter the rectus channel; 5) and skin.
Figure 1 Course and distribution of an intercostal nerve at the abdominal level in a 
 transverse section
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The intercostal nerves pass infero-anteriorly from the intercostal spaces and run 
in the neurovascular plane between the internal oblique and the transverse abdominal 
muscles to supply the abdominal skin and muscles. The lateral cutaneous branches 
emerge from the musculature of the anterolateral wall to enter the subcutaneous tissue 
along the anterior axillary line, whereas the anterior abdominal cutaneous branches 
pierce the rectus sheath to enter the subcutaneous tissue a short distance from the median 
plane. Skin and muscles of the anterolateral wall are mainly supplied by the following 
anterolateral branches of thoraco-abdominal nerve(s) (figure 2):
• T7 - T9 supply the skin superior to the umbilicus.
• T10 innervates the skin around the umbilicus.
• T11, plus the cutaneous branches of the subcostal (T12), iliohypogastric, and 
ilioinguinal (L1), supply the skin inferior to the umbilicus.
During their course through the abdominal wall, the thoraco-abdominal, subcostal, and 
iliohypogastric nerves inter-communicate extensively19.
Pathophysiology & Etiology
Peripheral nerve entrapment may occur at anatomic sites where the nerve changes 
direction to enter a fibrous or osseofibrous tunnel, or where the nerve passes over a fibrous 
or muscular band7. At the point where an intercostal nerve penetrates through the rectus 
muscle (nr. 4, figure 1), a fibrous ring provides a smooth surface through which this 
bundle can slide. Just anterior to this ring, a hiatus in the rectus aponeurosis facilitates 
the passage of the anterior branch of the intercostal nerve. Localized compression at 
the level of this ring and subsequently nerve ischemia is hypothesized to cause a typical 
ACNES pain. It is thought that too much pressure from deep tissues or pulling forces 
from superficial structures cause the neurovascular bundle to be pushed against the ring 
leading to irritation and swelling of the bundle and herniation thereafter7.
Several situations can trigger the onset of ACNES or may exacerbate a current 
situation. Increased abdominal pressure due to ‘acute’ moments (coughing, sneezing, 
squeezing) or an abdomen diameter increase due to any cause (pregnancy 9%) will put 
the nerves under greater tension. Scar tissue or sutures can directly compress the nerve 
or place it under traction20, 21. Pulling the abdominal wall during surgery can also disturb 
anatomical structures (20%). Furthermore, increased abdominal muscle use due to 
sports (7%), heavy lifting or sudden movements can elicit the pain (3%). Hypothetically, 
increased muscle tensing is an important underlying cause in ACNES patients who do 
not remember a triggering event (54%)22. On the other hand, little is known about the 
segmental background of this type of pain syndrome23.
Clinical presentation, diagnosis and management
In patients suffering from ACNES, pain is dominant. Pain is mostly severe (VAS 7-8 on a 
0-10 scale) and is characterized as sharp or burning22, 24. Maximal abdominal tenderness 
is usually located on a patient-characteristic spot within lateral boundaries of the rectus 
abdominis muscle. Onset of pain is often acute and usually worsens over time. In most 
patients, the pain is continuous with exacerbations. Provoking factors are certain poses 
(sitting, bending, laying on affected side), and activity in general. Some patients report so-
called ‘pseudo-visceral’ complaints. Abdominal swelling, nausea, bloating and alterations 
in stool or increased ructus may be experienced. These nonspecific complaints may be 
misleading for consulting doctors, and an abdominal wall pain diagnosis is therefore 
easily missed.
Figure 2 Course of thoracic intercostal nerves and their distribution over the abdominal  
 and inguinal region, anterior view
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As ACNES is generally considered a typical clinical syndrome, physical examination 
is a most crucial step in the diagnosis. However, a diagnostic gold standard is currently 
lacking. The diagnosis is established by a set of common signs and symptoms. A constant 
site of abdominal tenderness with a small (<2 cm2, ‘finger tip’) area of maximal intensity 
situated is located at the level of the rectus abdominis muscle. Tenderness increases 
when these abdominal muscles are tensed while the patient lifts the head (Carnett’s test). 
Local sensory disturbances of the skin are frequently present (80-90%). By squeezing an 
overlying skin fold containing the patient’s skin and subcutaneous fat between thumb 
and index finger, the area of interest very much hurts compared to the contralateral side 
(‘pinch test’).
Laboratory analysis and imaging are almost always normal in an ACNES patient if 
performed after history taking and the physical examination (for example on an emergency 
department). If the diagnosis ACNES is deemed likely, the physician may perform a local 
pain point infiltration using lidocain of bupivacaine as a means to confirm the diagnosis. 
A regimen of consecutive local pain point injections is effective in some one-thirds of 
patients with ACNES22, 24. Surgical neurectomy is worthwhile in approximately two-
thirds of the injection regimen-refractory patients. In total, eighty percent of an ACNES 
population reported total or substantial pain relief on after a median 18 months follow-
up following this approach22. These beneficial success rates strongly support this stepwise 
treatment protocol. However, individual treatment steps were hitherto not prospectively 
studied whereas long-term results are largely unknown.
General aim of thesis
To study epidemiology and outcome of treatment strategies in populations who were 
diagnosed with the anterior cutaneous nerve entrapment syndrome (ACNES).
Specific aims
1. To develop a simple tool for the identification of patients with abdominal wall 
pain syndromes such as ACNES among populations who are diagnosed with 
functional abdominal pain.
2. To determine ACNES prevalence in a functional abdominal pain population.
3. To study the incidence of acute ACNES in an emergency department.
4. To describe the socio-economic consequences in a population with ACNES.
5. To validate and to assess long-term results of a surgical neurectomy in an operated 
ACNES population.
6. To assess efficacy of remedial surgery after a failed neurectomy in ACNES patients 
as a means to introduce a next step in the treatment protocol.
Outline of thesis
An irritable bowel syndrome (IBS) population is heterogeneous, harboring a variety 
of abdominal symptoms (and possibly, syndromes). Therefore, IBS is often termed a 
‘diagnosis of exclusion’. Chronic abdominal wall pain (CAWP) is a poorly recognized 
entity and is frequently caused by the anterior cutaneous nerve entrapment syndrome 
(ACNES). Some patients may be misdiagnosed because IBS and CAWP do share 
symptoms. In chapter 2, construction and validation of a novel 18-item questionnaire 
tool designed to distinguish patients with CAWP syndromes (including ACNES) from 
patients with IBS is introduced.
Most IBS patients are treated in a primary care environment. In chapter 3, the 
presence of CAWP syndromes (in particular ACNES) in 4 IBS cohorts in a primary care 
setting around the Netherlands is investigated using the validated diagnostic, 18-item 
abdominal wall pain questionnaire.
Most patients who are ultimately diagnosed with chronic ACNES have suffered from 
this entity for an extensive period of time. However, most patients report visits to an 
emergency department in an earlier phase of the illness. Awareness in an emergency 
1
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department may be suboptimal. In chapter 4, the incidence of ACNES in the emergency 
department of a Dutch teaching hospital is investigated.
Health care consumption in ACNES is believed to be high due to an on-going neglect 
among physicians combined with the severity of the neuropathic pain. In chapter 5, 
direct medical and indirect non-medical cost in the year before the diagnosis ACNES in 
a cohort of 94 patients is described.
In 2011, an effective treatment regimen consisting of injection treatment followed by 
an anterior neurectomy in patients insufficiently responding to an injection regimen was 
reported in 139 patients22. The beneficial effect of a surgical neurectomy was, however, 
not yet demonstrated in a randomized fashion. In chapter 6, results of a double-blind, 
randomized, controlled trial on surgery for abdominal pain due to ACNES are reported. 
Follow up studies on the long-term efficacy of an anterior neurectomy were never 
performed. Chapter 7 describes long-term success rates of surgery in a large ACNES 
population. Although successful in most patients, this treatment regimen is not long-
term beneficial in all. The efficacy of secondary surgery including re-exploration or a 
posterior neurectomy in patients reporting recurrent pain after initially successful 
surgery or following an immediately failed anterior neurectomy is described in chapter 8.
A summarizing discussion and future perspectives are provided in chapter 9. Since 
the beginning of 2014 a valorisation addendum is required according to the doctoral 
regulations. In chapter 10, the valorisation of this thesis is described. In chapter 11, a 
Dutch summary is provided. Acknowledgements, list of publications and a curriculum 
vitae of the author are provided at the end of this thesis.
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Objective
Irritable Bowel Syndrome (IBS) is a syndrome that is characterized by spells of 
abdominal discomfort and pain. According to the Rome III criteria, the diagnosis is based 
on clinical symptoms in the absence of structural or tissue abnormalities. IBS patients 
are defined to report abdominal complaints at least 3 days per month in the previous 3 
months. Moreover, the diagnosis is probable if two or more of the following criteria are 
fulfilled. The onset is associated with a change in frequency and/or appearance of stool 
whereas symptoms are attenuated after defecation1.
Due to the descriptive and general character of these Rome III criteria, a current 
IBS patient population is heterogeneous harbouring a broad variety of abdominal 
symptoms. As a consequence, IBS is often termed a ‘diagnosis of exclusion’2. Estimations 
on prevalence of IBS in The Netherlands may vary from 5–20% in an average community. 
Approximately 1 of 3 IBS patients requests medical help3-6. Consequently, some half a 
million Dutch people are calculated to require treatment for IBS.
Chronic abdominal pain (CAP) is usually thought to arise from a diseased viscus. 
However, CAP may also be caused by an abnormality situated in the wall of the abdomen. 
A common cause of this latter category is the anterior cutaneous nerve entrapment 
syndrome (ACNES). ACNES is caused by entrapment of branches of intercostal nerves 
(Th. 8-12) causing a severe chronic abdominal pain. Myofascial pain and radiculopathy 
are considered less frequent causes of abdominal wall pain7, 8. As a tertiary referral centre, 
our research group is especially interested in CAP due to ACNES. Carnett’s statement 
some 85 years ago that ‘the ACNES problem never received merited recognition in 
medical literature’ still holds true as of today9-15. The diagnosis ACNES is based on the 
finding of a constant site of tenderness that is superficially located with a small area of 
maximal tenderness that can be localized with a fingertip (trigger point). The tenderness 
is invariably increased after abdominal muscle tensing using the Carnett’s test. Moreover, 
a small area of somatosensory alterations surrounding the trigger point is often found 
in ACNES possibly allowing for discrimination between a myofascial cause and 
a radicular cause of the pain9, 11, 16-19. The diagnosis ACNES can be substantiated by a 
subfascial injection of 1% lidocain, typically leading to significant pain reduction after 15 
to 20 minutes20. Abnormalities in blood and organ tissues are practically always absent 
in ACNES patients. Recently, our group evaluated a diagnostic work up protocol and 
treatment regimen in 139 consecutive patients with suspected ACNES. Local trigger 
Abstract
Objective
The irritable bowel syndrome (IBS) population is heterogeneous, harbouring a 
variety of abdominal symptoms. Therefore, IBS is often termed a ‘diagnosis of 
exclusion’. Chronic abdominal wall pain (CAWP) is a poorly recognized entity, 
frequently caused by the anterior cutaneous nerve entrapment syndrome (ACNES). 
Some patients may be misdiagnosed because IBS and CAWP share symptoms. Aim 
of this study was to construct and validate a questionnaire to distinguish patients 
with CAWP (including ACNES) patients with IBS. 
Design
A questionnaire was designed of 17 ACNES characteristic items obtained from 
ACNES patients (n=33) and expert opinion of two specialized surgeons. Eleven IBS-
related items (‘Rome III’ criteria) were added leading to a questionnaire containing 
28 items. This was validated in a ‘gold standard’ ACNES group (successfully 
operated ACNES patients, n=68) and a ‘prospective’ IBS group (n=64) as well as 
in a ‘prospective’ ACNES group (n=47). Distinctive power of individual items was 
analyzed by χ2. Reliability was tested with Crohnbach’s α. ROC curve was used to 
determine cut-off values.
Results
Eighteen of 28 items were significantly distinctive (p<0.01) between ACNES and 
IBS patients leading to an 18-point ACNES score with good internal consistency 
(α=0.85). Cut-off value of 10 points resulted in 94% sensitivity, 92% specificity and 
areas under the curve (AUC) of 0.98. Evaluation of the prospective ACNES group 
led to 85% sensitivity, 92% specificity and AUC 0.95 indicating high discriminative 
properties of the questionnaire. 
Conclusions 
This novel questionnaire may be useful and valid as a simple tool distinguishing 
patients harbouring a CAWP syndrome from those having IBS.
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point injections appeared long term effective in one-third of the patients. Surgical 
neurectomy was effective in about two-thirds of the refractory patients. Some 80% of 
the entire ACNES population reported total or substantial pain relief on the long term20.
As our experience with unravelling the diagnosis in patients with CAWP is growing, 
we were confronted with some patients harbouring ACNES although previously 
diagnosed with IBS. Aim of the present study was to develop and validate a questionnaire 
that may be used to differentiate between IBS and CAWP. We hypothesized that the novel 
questionnaire may allow a discrimination between various patient populations having 
CAP. 
Design
Setting
The study was coordinated by members of the Surgical department and was performed 
in outpatient departments of Gastroenterology and Surgery of Máxima Medical Centre 
(MMC) in Veldhoven, The Netherlands. The MMC is an 865-bed community hospital 
serving a population of approximately 350.000-400.000. It is a tertiary referral centre for 
abdominal wall and groin pain syndromes20-27.  
Development of questionnaire
The preliminary questionnaire was composed in November and December 2010 by input 
from two focus groups and the input from IBS literature. The first focus group consisted 
of 70 ACNES patients that had undergone successful surgery between 2003 and 2008. 
They were randomly selected to contribute to the development of the questionnaire. They 
were requested via an accompanying letter to describe in detail all of the symptoms they 
had experienced in the period prior to surgery. The second focus group consisted of two 
surgeons skilled in diagnosing and treating ACNES. They were invited to report typical 
symptoms from a professional point of view (RR and MS). They both independently 
provided a list containing what they considered typical complaints reflecting the 
syndrome of ACNES. Data obtained from both focus groups were used to identify the 
most ACNES sensitive questions that were subsequently used in the questionnaire. 
This was complemented by inserting typical IBS related questions obtained from three 
different sources (Birmingham IBS questionnaire, Rome III criteria, Dutch IBS interest 
group)28-30. All questions were closed-ended, dichotomous (‘yes’, ‘no’) or 4-point Likert-
scale questions (‘mostly’, ‘regularly’, ‘sometimes’, ‘never’).
Validation of questionnaire
Between February and July 2011 three patient populations were utilized for validation. 
The first population consisted of a group of ACNES patients that had demonstrated a 
favourable response to surgery defined as a >50% reduction in pain (measured by Visual 
Analogue Scale (VAS)) or a >2 point reduction on a 5 point Verbal Rating scale (VRS) 
between 2003 and 2011 (‘gold standard’ ACNES group). This definition was considered 
‘gold standard’ in the absence of an alternative one. To obtain this information, a short 
survey investigating complaints before and after surgery was added to the questionnaire. 
This first validation population partially overlapped with the population used for 
questionnaire development. They completed the questionnaire by paper or by the use 
of the web-based questionnaire from the ThesisTools® system. A reminder was sent after 
four weeks if the participant remained unresponsive. Inclusion ended 3 months after the 
first contact. Responds with more than one missing item were excluded from analysis.
To overcome a possible shortcoming associated with the retrospective character of 
these treated ACNES patients, a second population of newly diagnosed ACNES patients 
that presented to the surgical outpatient department was also included for validation 
purposes (‘prospective’ ACNES group). They were diagnosed between May and July 
2011 and completed the questionnaire prior to visiting the specialist in the outpatient 
department. The diagnosis ACNES was confirmed in all individuals by one of the 2 
expert surgeons.
The third population used for validation consisted of a cohort of consecutive patients 
with a suspected diagnosis of IBS presenting at the gastroenterological outpatient 
department (‘prospective’ IBS group). Patients were prospectively included between 
April and May 2011 and completed the web-based survey. Four weeks after the inclusion 
of these new IBS-patients, diagnosis based on the Rome III criteria was re-checked for 
confirmation.
Calculations
Data analysis was performed using SPSS 18.0 for MacOS X. During the validation phase, 
two different steps were executed. First, Likert-scale questions were dichotomised before 
analysis. ‘Mostly’ and ‘regularly’ were interpreted as a positive answer, where ‘sometimes’ 
Construction and validation of a questionnaire distinguishing a 
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Table 1  Demographic data of validation groups
and ‘never’ were interpreted as a negative answer. Subsequently, the distinctive power of 
each of both ACNES and IBS items of the questionnaire were measured using chi-square 
(chi2) analysis. A <0.01 chi-square cut-off point was used. Non-distinctive questions 
(chi2>0.01) were excluded from the questionnaire. Reliability of the questionnaire was 
determined using Crohnbachs-α. An α >0.9 is considered excellent, α >0.8 is good, α >0.7 
acceptable, α >0.6 is questionable, α >0.5 is poor, and α <0.5 is unacceptable31. 
A second step was to develop a scoring algorithm for the questionnaire. Two 
scenarios were evaluated using results from the gold standard ACNES group and 
from the prospective IBS group. In the first scenario, a simple algorithm was evaluated 
contributing 1 point to each question. In the second scenario, points were given based 
on the distinctive character of a question. Grade of distinctive character was determined 
by the risk rate of a question. One point was given for a risk rate between 1 and 2.5, two 
points for a risk rate between 2.5 and 5, and three points for questions with a risk rate 
>5. Each ACNES related question received point(s) for a positive answer whereas an IBS 
related question scored point(s) for a negative answer. Patients with a high score were 
likely suffering from ACNES, whereas low scores were attained by a typical IBS patient. 
Cut-off values and discriminating values (sensitivity and specificity) were tested in both 
ACNES groups using a ROC-curve. In the end, a final scoring algorithm was constructed.
Results
Development of questionnaire 
The response of 33 ACNES patients (response rate 47%) combined with the opinion 
of both surgeons led to 17 questions that were deemed sensitive and distinctive for 
ACNES. A total of 11 IBS related questions was added resulting in a preliminary 28-item 
questionnaire. ACNES and IBS questions were sequenced in random order. Twenty-two 
of the 28 questions investigated pain (course over time n=3, type n=5, localization n=7, 
provocative factors n=7) whereas six questions were concerned with other symptoms. 
Twelve questions were dichotomous, whereas the remaining 16 were 4-point Likert-scale 
questions.
Validation of questionnaire 
Subjects
In the gold standard ACNES group, a total of 101 responses was obtained from 130 ACNES 
patients (response rate 78%). Of these 101 patients, 73 subjects were successfully treated 
(success rate 72%). As 5 responders were excluded due to missing items, answers of 68 
questionnaires were eligible for analysis (female 81%, age 48±19 yr.). In the prospective 
ACNES group, 83 patients suspected of ACNES and visiting the outdoor department 
of surgery were eligible for validation. As 36 patients were excluded (questionnaire 
completed after rather than before diagnosis (n=21), uncertain moment of questioning 
(n=3), other diagnosis (n=8), missing items n=4), questionnaires of 47 remaining subjects 
with the diagnosis of ACNES were eligible for analysis (female 79%, age 46±17 yr.). In the 
prospective IBS group, a population of 66 subjects was drafted from the IBS-group. As 2 
patients were excluded (haemorrhoids n=1, ACNES n=1), a cohort of 64 IBS subjects was 
eligible for analysis (female 69%, age 50±6 yr., Table 1).
Gold st. ACNES 
(n=101)
Prosp. ACNES 
(n=83)
Prosp. IBS 
(n=66)
p-value 
(ACNES vs. IBS)
Excluded (N) 33 36 2
Eligible for analysis (N) 68 47 64
Male / Female (%) 19 / 81 21 / 79 31 / 69 0.09
Age (SD) 48 (19) 46 (17) 50 (18) 0.38
(gold st. = gold standard, prosp. = prospective)
Definitive form of questionnaire
Some 18 of 28 items showed sufficient discriminative properties between gold standard 
ACNES group and prospective IBS patient group (chi2<0.01). This set of 18 items included 
11 ACNES and 7 IBS questions. In this final set of questions 14 questions investigated pain 
(course over time n=1, type n=3, localization n=5, provocative factors n=7) whereas four 
questions concerned additional complaints. The 18 questions with distinctive character 
had a good internal consistency (α=0.85). These properties allowed for calculation of a 
total score. Table 2 shows discriminating symptoms associated with either ACNES or IBS.
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Table 2 Discriminating items in the questionnaire. Translated from Dutch
Gold St. ACNES
n=68
Prosp. 
IBS
n=64
Chi2
(p-val.)
ACNES-items: Positive
Yes or
Mostly / Regularly (%)
Pain is sharp (cutting) 81 36 <0.001
For me PAIN dominates over DISCOMFORT 83 45 <0.001
Pain is always located on the same spot(s) 94 73 0.001
Pain is located just lateral to the midline of the abdomen 80 45 <0.001
The most intense pain can be localized by the tip of one 
finger
91 48 <0.001
I believe the pain is originated just beneath the skin 57 20 <0.001
Pain is provoked by daily activities (e.g. walking, sitting, 
cycling, bending)
80 33 <0.001
Lying on the affected side aggravates the pain 57 13 <0.001
Pushing on the painful spot aggravates the complaints 85 38 <0.001
Coughing, sneezing of squeezing aggravates the pain 65 11 <0.001
The painful spot feels strange, different or dull 54 16 <0.001
IBS- items: Negative
No or
Sometimes / Never (%)
I believe the complaints originate from my gastrointestinal 
tract
73 16 <0.001
Pain exists on different spots all over the abdomen 86 53 <0.001
Complaints are somehow related to an altered defecation 
pattern
99 36 <0.001
Stress provokes the complaints 88 63 0.001
I experience bloating or a feeling of gas in the intestines 73 23 <0.001
The stool has an abnormal consistency (e.g. hard and 
small, pencil thin, loose, watery)
76 33 <0.001
I feel urgent need for bowel movement without producing 
stool (incomplete defecation)
90 64 <0.001
(gold st. = gold standard, prosp. = prospective)
Scoring algorithm
The first ‘1 point per item’ scenario led to a minimal score of 0 and an 18 points maximum 
score whereas the second scenario had a maximum score of 26 points. Both scenarios were 
tested for sensitivity and specificity at different cut off values. As the more complicated 
scenario 2 conferred no beneficial qualities at the best cut off value (scenario 1: >10 points; 
sensitivity 0.94, specificity 0.92 versus scenario 2: >13 points; sensitivity 0.93, specificity 
0.95), the simple one-point-per-question scenario was chosen. 
Cut off value
Any test cut off point must be chosen on the basis of a hypothesis. As knowledge about 
ACNES is scarce and a minimal prevalence (some %’s) in the IBS-group was expected, 
the questionnaire should have optimal identification properties. Consequently, such an 
identification tool needs high specificity. A 10 points cut off value provides an optimal 
0.94 sensitivity, combined with 0.92 specificity. 
There was a slight reduction in the prospective ACNES group, but the test 
characteristics were still satisfactory (table 3). Sensitivity was 0.85 for a 10 points cut off 
value in this group. Calculated ROC curves of both gold standard ACNES group and the 
prospective ACNES group give outstanding areas under the curve (AUC), representing 
an excellent diagnostic test. The area under the curve (AUC) of the gold standard group 
is 0.98, and the AUC of the prospective ACNES group is 0.95. Scores of all subjects are 
depicted in the combined histogram (figure 1).
Gold Standard ACNES 
(n=68)
Prospective ACNES 
(n=47)
Prospective IBS 
(n=66)
Cut-off value Sensitivity Sensitivity Specificity
7 1.00 0.98 0.61
8 0.99 0.94 0.72
9 0.96 0.89 0.86
10 0.94 0.85 0.92
11 0.90 0.75 0.98
12 0.78 0.64 1.00
Bold type: best cut off value
Table 3 Characteristics of questionnaire with different cut off values in the prospective   
 ACNES-group compared with the gold standard ACNES-group 
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Discussion
The present study describes a stepwise development and validation of a novel 
diagnostic tool for the identification of potential ACNES patients within an IBS 
population. The results indicate that a simple 18-item questionnaire has a 0.94 sensitivity 
combined with 0.92 specificity. How should these test characteristics be interpreted? Test 
performance of nation wide screening programmes used for breast and cervix cancer 
demonstrates sensitivity varying from 0.33-0.91 combined with a 0.81-0.99 specificity32-35. 
The qualifications of the present CAWP/ACNES questionnaire seem substantially better 
whereas its accuracy is excellent (AUC 0.98). Furthermore, a strong internal consistency 
(α=0.85) contributes to the power of the questionnaire as an identification tool. 
A strong point of the present study is the validation in 2 separate populations of 
ACNES patients, a retrospective ‘gold standard’ and a ‘prospective’ ACNES group. 
Answers on 4 of the definitive 18 questions appeared significantly different (chi2<0.01) 
between these two groups. As 3 of these items were IBS-specific questions, it may seem 
that ACNES patients in the prospective group are more convinced of a visceral cause of 
their abdominal symptoms. These findings also suggest that information bias combined 
with recall bias probably played a role in the slight reduction of these test characteristics 
in the gold standard group compared to the prospective one.
Comparing answers of both groups of ACNES with answers derived from the IBS 
patients indicated that the discriminating character of the prospective ACNES group 
was slightly inferior. More specifically, 2 questions appeared less distinctive (chi2>0.01) 
compared to its performance in the retrospective gold standard ACNES group. Both items 
were IBS related items (‘The stool has an abnormal consistency’ and ‘I feel urgent need for 
bowel movement without producing stool (incomplete defecation)’). However, as both 
questions still had significant distinctive properties (<0.05), they were not removed from 
the ultimate 18-item questionnaire. These observations are in line with the presence of 
‘pseudo-visceral symptoms’ that ACNES patients occasionally report36, 37. The patient’s 
conviction of a visceral origin of pain complicates the process of diagnosing ACNES in 
daily clinical practice.
All questions of the Dutch questionnaire were translated into the English language 
as depicted in table 2. Officially, linguistic validation should be performed before this 
questionnaire can be used in a language other than the original language.
Figure 1 Scores of 64 irritable bowel syndrome (IBS) patients (top figure). In the lower figure  
 scores of 68 gold standard (Gold st.) anterior cutaneous nerve entrapment syndrome  
 (ACNES) patients and 47 prospective (Prosp.) ACNES patients. The vertical line is  
 the cut-off value (>10 points).
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The current study harbours flaws. Interpretation is limited by selection bias. Although 
a contemporary IBS population probably includes a broad range of patients presenting to 
various health care providers including general practitioners, the present questionnaire is 
only validated with IBS-patients presenting at the gastroenterology outpatient department. 
It may be possible that general practitioners are confronted with a different subpopulation 
of alleged IBS patients presenting with a slightly different pattern of intestinal symptoms. 
We are currently engaged in a study investigating the test characteristics of the ACNES 
questionnaire in IBS patients presenting to a number of general practices.  
Another flaw of the study is caused by the differential diagnosis of chronic abdominal 
wall pain. When the present study was designed, the authors were convinced that ACNES 
and CAWP were (almost) identical. In other words, it was thought that chronic abdominal 
wall pain was practically always caused by ACNES. The fact that some patients diagnosed 
with ACNES (albeit a minority) did not demonstrate altered skin sensibility urged us 
to assume that the differential diagnosis of CAWP harbours more entities including 
myofascial pain or radiculopathies. To facilitate understanding of the present study, we 
chose to use the terms ACNES and CAWP interchangeably.  
A substantial number of patients with functional gastrointestinal disorders also report 
abdominal wall pain. The present questionnaire will have less discriminating power in 
this subpopulation. On the other hand, if the abdominal wall problems play a prominent 
role in the patients’ pain experience, there is a reasonable chance that this individual is 
identified after completing the questionnaire. This is particularly true as 11 of the 18 
items are obtained from ACNES patients (‘ACNES/CAWP specific items’). In addition, 
most items (14 of 18) investigate issues of pain whereas abdominal wall syndromes are 
mainly characterized by pain and not by functional complains.
Despite explicit guidelines and criteria, clinicians often consider IBS a diagnosis 
of exclusion. Surprisingly, no guideline on IBS reported on findings obtained during a 
standard physical examination. On the other hand, ACNES is preferentially diagnosed 
after a simple but proper physical examination. A significant number of patients may be 
incorrectly burdened with an IBS diagnosis even more so if pseudo-visceral complaints are 
experienced. The present questionnaire may prove a valuable tool for the identification of 
patients with CAWP wrongly assumed as having IBS. The tool may be relevant for several 
groups of specialists including gastroenterologists and general practitioners. Moreover, 
also other specialists may find this questionnaire helpful in the evaluation of patients with 
chronic abdominal discomfort.
Conclusion
A simple 18-item questionnaire may possibly distinguish patients who potentially 
suffer from chronic abdominal wall pain, and in particular anterior cutaneous nerve 
entrapment syndrome, from a population diagnosed with irritable bowel syndrome.
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Abstract
Introduction
The abdominal wall is often neglected as a cause of chronic abdominal pain. Aim of 
this study was to identify chronic abdominal wall pain syndromes, such as anterior 
cutaneous nerve entrapment syndrome (ACNES), in a patient population diagnosed 
with functional abdominal pain, including irritable bowel syndrome. 
Methods
In this cross-sectional analysis, 4 Dutch primary care practices employing physicians 
who were unfamiliar with ACNES were selected. 535 patients ≥18 years old who 
were registered with a functional abdominal pain diagnosis were approached to 
complete a validated 18-item questionnaire (maximum 18 points). Responders 
who scored at least the 10-point cutoff value (sensitivity, 0.94; specificity, 0.92) 
underwent a diagnostic evaluation to establish their final diagnosis. Main outcome 
was the presence and prevalence of ACNES in symptomatic patients diagnosed with 
functional abdominal pain.
Results
Of 535 patients, 304 (57%) responded; 167 subjects (31%) reporting symptoms 
completed the questionnaire. Of 23 patients who scored above the cutoff value, 18 
were available for diagnostic evaluation. In half of these subjects (n=9) functional 
abdominal pain was confirmed. The other 9 patients were suffering from abdominal 
wall pain syndrome, 6 of whom were diagnosed with ACNES (3.6% prevalence 
rate; 95% confidence interval, 1.7–7.6), whereas the remaining 3 harbored a painful 
lipoma, an abdominal herniation, and a painful scar.
Conclusions 
A clinically relevant portion of patients previously diagnosed with functional 
abdominal pain syndrome in a primary care environment suffers from an abdominal 
wall pain syndrome such as ACNES.
Introduction
Diseased organs are frequently identified as the source of chronic abdominal 
discomfort and pain. If history taking, physical examination and diagnostic evaluations 
are not abnormal, a common functional abdominal pain diagnosis such as the Irritable 
Bowel Syndrome (IBS, prevalence of 10-15% in Europe and North America1) may be 
considered2. In contrast, the abdominal wall and the pelvic floor are often neglected as 
a cause of chronic abdominal discomfort and pain. Apart from ignorance and visceral 
preoccupation by physicians, complaints mimicking a problem of visceral origin 
(‘pseudo-visceral’) reported by patients also frustrate a diagnosis of chronic abdominal 
wall pain (CAWP)3-5. 
Myofascial pain and radiculopathy are rare examples of a CAWP syndrome. However, 
CAWP is commonly caused by entrapment of an anterior cutaneous branch of one or 
more thoracic intercostal nerves6. Patients with this anterior cutaneous nerve entrapment 
syndrome (ACNES) have frequently undergone repetitive diagnostic evaluations. 
Unfortunately, these tests are almost always inconclusive leading to a disillusioned patient 
and, even more so, a disappointed doctor3, 6-14. As a consequence, patients with CAWP 
often receive a diagnosis of exclusion such as IBS2, 15.
Primary aim of the present study was to identify patients with CAWP syndromes (in 
particular ACNES) in an IBS cohort using a validated diagnostic 18 item abdominal wall 
pain questionnaire in a primary care setting. We hypothesised that a portion of the IBS 
population was incorrectly diagnosed and actually suffered from an abdominal wall pain 
syndrome. As a consequence of this study, awareness may be increased among primary 
care physicians.
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Methods
This study was a cross-sectional analysis of primary care patients with IBS and 
was coordinated by members of the Surgical Department of the Máxima Medical 
Center (MMC) in Veldhoven/Eindhoven, The Netherlands. The MMC Medical Ethical 
Committee approved its specifics (no. NL36256.015.11). Sample size estimation was 
performed by a power analysis based on a common sense estimated prevalence prediction 
of 5% of CAWP patients within an alleged IBS cohort, resulting in 292 subjects needed to 
screen16. An estimated response rate of 60% would lead to a number needed to approach 
of 487 subjects. 
As our surgical department has a long-standing interest in abdominal wall pain 
syndromes that is frequently communicated to neighbouring primary care physicians, 
it was decided to perform the study with more distant practices. Therefore, 4 Dutch 
primary care practices located beyond twenty kilometres from the MMC were asked to 
participate. Doctors participating in these practices were unaware of the syndrome of 
ACNES. These selection criteria prevented bias and enhanced external validity prior to 
the start of this screening project.
For proper patient selection, participating practices were required to use an electronic 
patient record and to register according to the ‘International Classification of Primary 
Care’-codes (ICPC-codes). This system is internationally accepted as standard for coding 
and classifying complaints, symptoms and diseases in primary care practice. The ICPC 
system consists of numbered chapters and sections. Chapter D focuses on the digestive 
tract. It contains 58 codes ranging from malignant disease to functional disorders18. The 
eight codes associated with functional complaints demonstrate a spectrum of various 
complaints, but only three ICPC-codes focus on complexes of symptoms (‘generalized 
abdominal pain/cramps’ (D01), ‘other localized abdominal pain’ (D06) and ‘irritable 
bowel syndrome’ (D93)). For the purpose of this study and the assumption of IBS as a 
diagnosis of exclusion, these latter three codes were used for patient selection. In absence 
of a specific ICPC-code for CAWP syndromes, we would advise primary care physicians 
to use D06 for this clinical entity.
Figure 1 Typical position of ACNES trigger points. At these points the anterior twigs of the  
 intercostal nerves penetrate the rectus abdominal muscle (T7-T12). The level of the  
 umbilicus corresponds with intercostal nerve T10. The most typical site is T11 on the  
 right side.
Figure 2 The trigger point is localized and palpated by a palpating finger or a swab.  
 The tenderness increases by abdominal muscle tensing using Carnett’s test.
Selection of a population with a high risk on a CAWP syndrome within the IBS 
population was performed using a recently developed and validated 18 item ACNES 
questionnaire (18-pAQ, figure 3)17. This 18-pAQ was found to clearly distinct between 
abdominal wall pain syndromes such as ACNES and IBS. Scores of the 18-pAQ may 
range from 0-18 points. A 10 points cut-off value was found to have an optimal 94% 
sensitivity and 92% specificity.
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Figure 3 The validated questionnaire with its answer key. A 10 point cut off value results in  
 an optimal 94% sensitivity and 92% specificity 
Patients ≥18 years who were registered with ICPC-code D01, D06 and D93 in previous 
years in these 4 selected practices were eligible for study. No limitations were applied 
regarding the moment of registration because of the chronic character of the abdominal 
complaints. Charts of patients with severe comorbidity causing immobility or having 
additional other gastrointestinal disease were identified manually and excluded as were 
patients with a language barrier. Remaining subjects were approached by their respective 
primary care physician via a letter of introduction. Subjects willing to participate were 
requested to complete the attached 18-pAQ. Non-symptomatic subjects and subjects 
reporting other reasons not to participate were requested to return the non-participation 
form. This non-participation form contained two options that could be selected; ‘no 
complaints anymore’ and ‘other, namely…’. Responses were registered and scored after 1 
month. Returned and completed questionnaires with more than one missing item were 
excluded from evaluation.
Due to considerations of logistic nature and feasibility, subjects with a <10 point score 
were not invited for further examination, possibly leading to a slight underestimation of 
the actual prevalence. Subjects with a ≥10 point score in the 18-pAQ were invited for a 
standardized history taking and physical examination by the first author. Currently, no 
golden standard is available for ACNES (and other CAWP syndromes). An abdominal 
wall syndrome is essentially a clinical diagnosis that is suspected on the basis of a triad of 
chronic localized abdominal pain within the lateral boundaries of the rectus abdominis 
muscle (figure 1), a constant site of abdominal tenderness with a small (less than 2 cm2) 
area of maximal intensity (trigger point) and absence of abnormalities in previously taken 
blood analyses and imaging techniques (colonoscopy, US or CT) if available. Carnett’s 
test is a sensitive clinical test discriminating abdominal wall pain from visceral pain 
during a physical examination is the Carnett’s test (figure 2)7. The likelihood of ACNES as 
a typical example of CAWP syndrome is increased when qualitative local somatosensory 
disturbances are present in proximity to the trigger point19, 20. All findings were registered 
on a case report form.
Data analysis was performed using SPSS 18.0 for Mac OS X. Prevalence numbers were 
based on symptomatic responders and presented as percentages with associated standard 
deviations (± SD).
18 item ACNES Questionnaire (18-pAQ)
Question Mark the right 
answer
1 Point if: 0/1
1 I experience bloating or a feeling of gas in 
the intestines
Mostly / Regularly / 
Sometimes / Never
Sometimes / Never
2 Pain exists on different spots all over the 
abdomen
Yes     /     No No
3 For me PAIN dominates over DISCOMFORT Yes     /     No Yes
4 Lying on the affected side aggravates the 
pain
Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
5 The stool has an abnormal consistency (e.g. 
hard and small, pencil thin, loose, watery)
Mostly / Regularly / 
Sometimes / Never
Sometimes / Never
6 I believe the pain is originated just beneath 
the skin
Yes     /     No Yes
7 Pain is sharp (cutting) Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
8 I believe the complaints originate from my 
gastrointestinal tract
Yes     /     No No
9 I feel urgent need for bowel movement wit-
hout producing stool (incomplete defecation)
Mostly / Regularly / 
Sometimes / Never
Sometimes / Never
10 Coughing, sneezing of squeezing aggrava-
tes the pain
Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
11 Pain is always located on the same spot(s) Yes     /     No Yes
12 Pain is located just lateral to the midline of 
the abdomen
Yes     /     No Yes
13 Complaints are somehow related to an alte-
red defecation pattern
Yes     /     No No
14 Pain is provoked by daily activities (e.g. 
walking, sitting, cycling, bending)
Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
15 The painful spot feels strange, different or 
dull
Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
16 Stress provokes the complaints Mostly / Regularly / 
Sometimes / Never
Sometimes / Never
17 The most intense pain can be localized by 
the tip of one finger
Yes     /     No Yes
18 Pushing on the painful spot aggravate the 
complaints
Mostly / Regularly / 
Sometimes / Never
Mostly / Regularly
Total:
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Results
A total of 583 patients were identified as dictated by the 3 ICPC-codes of interest 
in the 4 selected primary care practices. After exclusion based on age <18 years (n=6), 
comorbidity (n=13), other known gastrointestinal disease (n=8), absence of complaints 
(n=2) and personal reasons (n=19), 535 patients were eligible for screening. Some 369 
patients were registered with ICPC code D93 (irritable bowel syndrome). The remaining 
subjects (n=166) were diagnosed with generalized or localized abdominal pain (D01, 
D06).
The response rate was 57% (n=304). Of this responding population, questionnaires of 
167 subjects signing informed consent were analysed (female 68%, age 54±17 years). The 
remaining 137 subjects did not participate in screening (no complaints at present, n=94; 
personal reason, n=37; missing items in the 18-pAQ, n=6). 
Twenty-three of these 167 patients scored 10 points or more on the 18-pAQ. After 
being contacted, 18 individuals were willing to undergo history taking and physical 
examination. Nine subjects were found to have IBS, generalized abdominal pain/cramps, 
or other localized abdominal pain as diagnosed previously. The other half of this group 
(n=9) was diagnosed with a CAWP syndrome. Six of these were having ACNES (D93, 
n=4; D01, n=2). The remaining three patients were diagnosed with a painful lipoma 
(n=1), an abdominal wall herniation (n=1) and scar tissue pain (n=1) on the basis of 
physical examination and ultrasound investigation (figure 4).
Of the six identified ACNES patients, four received a subfascial trigger point injection 
using 1% of lidocain with long lasting satisfactory pain reduction (> 3 months) in three. 
The fourth ACNES patient received additional manual therapy as the pain was refractory 
to injections. A neurectomy is considered if she remains unresponsive14, 20. Pain levels 
of patient five and six were mild. These two individuals were reassured once the origin 
of pain was explained. Despite the somewhat smaller sample size then calculated in the 
power analysis, a prevalence of ACNES was calculated to be 3.6% (95%CI 1.7-7.6) within 
the symptomatic functional abdominal pain population in these 4 selected primary care 
practices.
Figure 4 Flow chart of the study protocol
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Discussion 
The present study demonstrates that ACNES may be diagnosed in some patients 
currently treated for or diagnosed with functional abdominal complaints such as 
IBS. Six subjects harboured characteristics that are typically associated with ACNES, 
corresponding to a 3.6% prevalence (95%CI 1.7-7.6) in the responding ‘alleged’ IBS 
population of 167 individuals. This percentage is based on symptomatic responders. 
Although this may seem a relatively small number, a substantial portion of the Dutch 
population is registered as having functional abdominal complaints. Estimations on the 
prevalence of IBS in the Netherlands may vary from 10–20% (population 16.7 million 
individuals21[Statistiek,  #174][Statistiek,  #174]). Considering that 1 of 3 persons having 
complaints related to IBS seeks medical help, a minimum of half a million individuals 
is calculated to consult a doctor for this problem in the Netherlands22-25. Based on 
these assumptions, some 20 thousand Dutch individuals with ACNES are currently 
misdiagnosed as having functional abdominal pain (95%CI 9.500 – 42.000). Using similar 
assumptions and calculations, some 400.000 US individuals with functional abdominal 
syndromes may suffer from an undiagnosed CAWP such as ACNES26, 27.
During the study’s analysis period, a seventh ACNES patient was identified by one of 
the participating primary care physicians, now familiarized with the typical diagnostic 
triad of ACNES. Remarkably, this patient was registered with an ICPC-code belonging 
to the ‘nervous system’ chapter, probably due to predominant somatosensory alterations 
of the abdominal skin. This newly diagnosed CAWP patient illustrates the diversity 
of interpretations by primary care physicians who are unaware of ACNES. However, 
an important observation of the present study is the immediate effect of heightened 
awareness amongst primary care physicians regarding a CAWP syndrome.
A survey among Dutch surgeons and residents confirmed a hypothesized ignorance 
of ACNES among hospital based specialists. More than 85% of the respondents confessed 
they had never heard of this syndrome (response rate 35%, 507/1450). Moreover, only 
18% of senior surgeons (>10 years of experience) were aware of this clinical entity28. 
It is not surprising that doctors’ delay in diagnosing CAWP syndromes is substantial 
and many patients with ACNES remain undiagnosed. This situation is not typical 
Dutch as CAWP is a globally undervalued medical problem and a diagnostic challenge. 
Therefore, clinicians worldwide require education on abdominal wall pain problems so 
that these clinical entities will be identified in an earlier stage and treated accordingly. 
A complicating factor is the fact that ACNES patients often report ‘pseudo-visceral’ 
complaints (bloating, nausea or pain related to e.g. food intake, altered defecation pattern, 
weight loss) seemingly unrelated to an abdominal wall problem4, 5.
The present diagnostic questionnaire was found to harbour good discriminative 
properties during the validation study17. In a low prevalence population as the current 
one, a 50% positive predicted value is suboptimal but acceptable. As a comparison, 
the positive predictive value of a national screening program for breast cancer in the 
Netherlands is 41%29. However, one can question if this tool is performing appropriately 
in the hands of physicians with little knowledge on CAWP syndromes. Considering the 
suboptimal sensitivity of the used questionnaire, it is likely that some CAWP patients 
remained unidentified in the investigated cohort. However, a subpopulation may be 
identified (approximately 10-15% of the total population) by the questionnaire and 
invited for specific examination.
The present study has shortcomings. A flaw is the relatively low response rate of 
subjects completing the 18-pAQ resulting in a prevalence number with a wide confidence 
interval. One explanation is that approximately a third of all responders (31%) claimed 
to have no complaints at present and therefore did not complete the questionnaire. 
Moreover, the largest group of non-participators did not respond at all (43%). Help-
seeking patients probably are more likely to respond. Furthermore, all patients who were 
ever diagnosed with IBS or localized/generalized abdominal pain were eligible for study. 
This inclusion criterion was deemed important as symptoms intensity of both IBS and 
ACNES may fluctuate over time. A low response rate in patients having few symptoms 
at the time of questionnaire reception is therefore likely. Another point of concern is a 
possible flaw in the ICPC-code registration process. Under-registration and updating of 
patients’ files may be suboptimal in a demanding practice.
What is the clinical relevance of identifying patients with ACNES in a group in which 
the majority of patients have IBS? On the one hand, patients diagnosed with ACNES 
(preferably in an early stage by their physician) are likely to undergo fewer unnecessary 
medical procedures and may benefit from a relatively simple treatment regimen. A 
treatment stratagem including injections or surgery resulted in total or substantial 
long-term pain relief in 80% of patients with ACNES14. On the other hand, even after 
an unsuccessful IBS treatment an alternative diagnosis is not easily considered. This is 
especially due to the low treatment effectiveness of IBS (less then 60% benefits from 
treatment using antispasmodics and antidepressants30). Wrongly diagnosed patients 
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with abdominal wall pain most probably do not have any effect of these IBS treatment 
strategies. Moreover, a proper and effective treatment regimen is not instituted leading to 
prolonged suffering.
Conclusion
A clinically relevant portion of patients wrongfully diagnosed with a functional 
abdominal pain syndrome within the primary care setting is found to suffer from a 
chronic abdominal wall pain (CAWP) syndrome including the anterior cutaneous nerve 
entrapment syndrome (ACNES). Once correctly diagnosed, treatment is simple and 
effective. Increased awareness of CAWP syndromes may have a considerable effect on an 
individual level as well as on the level of the health care system.
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Abstract
Background
Patients with chronic abdominal pain occasionally suffer from the anterior 
cutaneous nerve entrapment syndrome (ACNES). A substantial number of patients 
report previous visits to an emergency department (ED) with acute pain. Aim of this 
study was to obtain the incidence of ACNES in patients presenting with abdominal 
pain in the ED of a Dutch teaching hospital.
Methods
In this observational study, data sets of all patients visiting Máxima Medical 
Center’s (MMC) ED in 2011-2012 were searched for key terms ‘ACNES’, ‘intercostal 
neuralgia’ or ‘abdominal wall pain’. Files of potential patients living within hospital’s 
adherence area were checked using accepted criteria indicating the presence of 
ACNES. Disease incidence was calculated as a ratio to the hospital’s adherence data. 
The ACNES MMC 2013’s incidence in patients evaluated in the surgical outpatient 
department was also calculated.
Results
During the study period, 473 ED patient files met inclusion criteria. A total of 88 
patients belonging to MMC’s adherence area were diagnosed with ACNES leading 
to a mean 22/100.000 ACNES yearly incidence rate. About one of 50 patients with 
abdominal pain visiting the ED suffered from ACNES. A 35/100.000 outpatient 
department ACNES incidence rate was calculated in the year of 2013. Combining 
these two ratios, a 1:1800 ACNES incidence in the general population was obtained.
Conclusions 
In an ED setting of a Dutch teaching hospital, approximately 2% of patients 
presenting with acute abdominal pain suffered from ACNES. ED physicians should 
consider ACNES in abdominal pain patients with normal laboratory or imaging 
tests.
Background
Patients with abdominal pain may suffer from an abdominal wall related entity. A 
typical example is the anterior cutaneous nerve entrapment syndrome (ACNES)1-9. End 
branches of thoracic 8-12 intercostal nerves are caught in abdominal muscles causing 
severe neuropathic pain2, 3, 6, 10, 11. If recognized, injecting anaesthetic agents into the point 
of maximal pain is diagnostic and occasionally therapeutic12, 13. If pain persists, removal 
of nerve end twigs may offer relief 12, 14-17.
A literature survey on incidence of acute abdominal pain in a general emergency 
department (ED) demonstrated that approximately 1% of referrals to general surgeons 
were related to these acute abdominal wall pain syndromes9. Moreover, 20% of patients 
who presented to the ED with a nonspecific acute abdominal pain tested positive for 
abdominal wall tenderness suggesting the presence of an abdominal wall pain syndrome18. 
However, such estimations are biased by author selection and preference. Therefore, a 
reliable estimation of incidence of acute abdominal wall pain syndromes such as acute 
ACNES presenting to an ED is not available. 
Physicians working in the SolviMáx centre for abdominal wall and groin pain 
syndromes are experienced in diagnosing ACNES in adults and adolescents6, 11-17, 19. 
During outpatient department intakes, these ACNES patients frequently reported on 
earlier ED visits with attacks of abdominal pain. Unfortunately, pain was then often 
not recognized as due to nerve entrapment leading to a substantial doctor’s delay2, 7, 20. 
With this finding in mind, awareness in an ED regarding ACNES may seem suboptimal. 
However, if a triad of abdominal pain, a circumscript pain point (in the presence of a 
positive Carnett test and/or local sensory disturbances) and a normal blood analysis 
or ultrasonography/computed tomography are present, a person may suffer from this 
typical ‘clinical syndrome’.
Aim of the present study was to calculate the incidence of ACNES in the ED of a 
Dutch teaching hospital. If substantial, ACNES must attain a more prominent position 
on the list of differential diagnoses of acute abdominal pain in an ED.
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Methods
General information
Data of this retrospective observational study was obtained between 2011 and 2014 in 
Máxima Medical Centre (MMC), a 543-bed community hospital situated in the southern 
part of The Netherlands serving a population of approximately 200.000 inhabitants. MMC 
is considered a typical example of an average Dutch teaching hospital. Approximately 
30 thousand patients present to its ED each year. Comparable to published numbers, 
some 8 percent of visits to MMC’s emergency department is due to abdominal pain21-23. 
Each abdominal pain patient is standardly evaluated by interns of the ED, surgery or 
internal medicine. If deemed necessary, patients are subsequently evaluated by a senior 
emergency physician or by a consultant (emergency medicine, surgery, internal medicine, 
gastroenterology, urology etc.). 
A surgical sub department - separate from the ED - has gained ample experience in 
the evaluation of patients with chronic abdominal wall pain and groin pain syndromes 
(‘SolviMáx’ Center of excellence for Abdominal Wall and Groin Pain)13, 14, 24. MMC 
physicians are regularly updated on new evidence regarding ACNES by these SolviMáx 
specialists. Therefore, awareness on our ED regarding ACNES is likely higher than ED’s 
of other (Dutch) hospitals. 
The MMC Medical Ethical Committee concluded that the rules laid down in Medical 
Research Involving Human Subjects Act did not apply to the present research proposal 
and hereby gave permission to perform the study (N15-004).
Data collection
Electronically stored data using the ChipSoft© health and information system (CS-EHIS, 
version 5.2 HF188, ChipSoft B.V., The Netherlands) served as the source for the present 
study. This software program is used by all MMC health care providers for documentation 
of patient visits25. Two sets of data were extracted from this CS-EHIS system. The first 
set contained data of all patients who visited the MMC’s ED in the year of 2011 and 2012. 
The second dataset consisted of surgical patient records containing one of the following 
keywords: ‘ACNES’, ‘intercostal neuralgia’ or ‘abdominal wall pain’. By electronically 
combining these two data sets, patients of interest were identified and were inserted in 
a separate data file termed ‘potential ACNES-ED patient file (ACNES-EDPF)’ that was 
used as the basis for the present study.
As ACNES is generally considered a typical clinical syndrome, a diagnostic gold 
standard is currently lacking. However, the diagnosis was deemed likely in a patient if the 
following set of signs and symptoms, as registered in CS-EHIS, were met:
1. Presenting with abdominal pain at the ED, and
2. Site of abdominal tenderness with a small (<2 cm2, “finger tip”) area of maximal 
intensity (trigger point) situated within lateral boundaries of the rectus abdominis 
muscle, and
3. Normal laboratory analysis and normal imaging (if performed for this specific 
ED visit), and
4. Pain reduction following infiltration using 5-10 mL of 1% lidocaine, and
5. The diagnosis ACNES was confirmed during a follow up ED visit, or shortly 
thereafter during a visit to one of MMC’s surgical outpatient departments by one 
of the SolviMáx pain specialists as reflected in the surgical patient record.
If the diagnosis in an individual that was present in this ACNES-EDPF file was 
deemed uncertain, history and physical examination, as well as diagnostic and 
therapeutic measures that were tabulated in the patients’ file were again checked for 
additional specifics and clues. If still in doubt, one of the SolviMáx pain specialists (n=4) 
was consulted for advice. Typical findings such as a positive Carnett’s test, a positive pinch 
test and the presence of local sensory disturbances or lateral/paravertebral trigger points 
strongly contributed to confirmation of the diagnosis (figure 1. a-d)2, 3.
Known ACNES patients who visited the ED were excluded. Patients who were 
suspected of having ACNES whereas history and findings at physical examination were 
not consistent with the syndrome were also excluded. These patients were usually referred 
to the ED by family physicians. To correct for spectrum bias, individuals living outside 
MMC’s adherence area were excluded as well.
Accurate figures on MMC adherence were obtained from a market analysis. In the 
year of 2011, a total of 206.000 individuals were assumed to visit the MMC for medical 
assistance. In the year of 2012, this adherence number was officially set at 199.000 
residents (Kiwa Carity B.V., Utrecht, The Netherlands). These numbers are considered to 
be an optimal approximation of MMC’s real adherence. 
An additional calculation of the 2013 incidence of chronic ACNES was based on first 
time patient visits to the SolviMáx outpatient department. Each first SolviMáx outpatient 
department visit of an individual referred as possibly having ACNES is prospectively 
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Table 1 Patients potentially having ACNES visiting the emergency department of a Dutch  
 teaching hospital in 2011-2012
registered from January 1, 2013. Electronic patient files of all individuals diagnosed with 
ACNES via this system were also studied. Patients were excluded if they lived outside of 
MMC’s adherence area, if they were known ACNES patients, or if they had presented to 
MMC’s ED in an earlier stage (2013 MMC adherence, approximately 200.000).
Results
Incidence of ACNES on ED in 2011 and 2012
In the year of 2011, 31.325 patients attended the ED of MMC (2012: 30.023). In the 2-year 
study period, 5.111 patient visits were registered for abdominal pain (8.3%, 5111/61.348). 
A total of 473 ED patient files harboured the preselected keywords ‘ACNES’, ‘intercostal 
neuralgia’ or ‘abdominal wall pain’. A total of 186 patients (39%, table 1) was also 
identified via these keywords. However, they were excluded as they visited the ED for a 
non-abdominal illness (n=186).
In 2011, 41 ED patients with (acute) abdominal pain were diagnosed with ACNES, 
the majority (n=35) belonging to MMC adherence area (table 1, left hand panel). As 
206.000 registered individuals adhered to the MMC area, a 17/100.000 incidence rate 
was calculated. A similar calculation regarding the year of 2012 (56 ACNES, 53 in a 
199.000 MMC adherence) yielded a 27/100.000 incidence rate. As a consequence, a mean 
22/100.000 ACNES ED incidence rate per year was obtained over these two years. If all 
5.111 patient visits with abdominal entities in the ED were considered, approximately 
1:50 was found to have ACNES.
2011 2012 2011/2012
Patient file containing key words ‘ACNES’, ‘intercostal neuralgia’ or 
‘abdominal wall pain’ (n)
250 223 473
Presenting to ED with a non abdominal illness (n)
Trauma
Fever / malaise
Pulmonary 
Cardiac
Neurological
Skin infection and/or abscess
Collapse
Other
114
52
19
10
9
2
7
1
 14
72
27
6
5
11
3
5
3
12
186
79
25
15
20
5
12
4
26
Presenting with abdominal pain (n) 136 151 287
ACNES (n) 41 56 97
Excluding patients outside MMC adherence area (n) -6 -3 -9
Diagnosis ACNES within MMC adherence area (n) 35 53 88
Figure 1 Typical findings during physical examination in an ACNES patient.  
 a. Trigger point is localized using palpating index finger. Tenderness increases when  
 abdominal muscles are tensed as the patient lifts the head (Carnett’s test);  
 b. Skin gnostic sensibility is determined using a swab. The shaded area overlying the  
 trigger point reflects altered sensibility; 
 c. A cold alcohol gauze is utilized to test the vital sensibility;    
 d. By squeezing a fold containing the patient’s skin and subcutaneous fat between  
 thumb and index finger, the area of interest hurts compared to the contralateral side  
 (‘pinch test’).
Data analysis
Data analysis was performed using SPSS 21.0 for Mac OS X (IBM SPSS statistics, IBM 
corporation, New York, United States). Baseline characteristics were presented as 
percentages, mean (SD), or median values (range) as appropriate. Adherence numbers 
of MMC and numbers of ACNES patients diagnosed in 2011 and 2012 were used to 
calculate an ACNES ED incidence and a mean incidence rate using standard calculus.
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Baseline characteristics, history and findings of physical examination in this 
population of 88 ACNES patients are summarized in table 2. The majority was female 
(n=71, 81%), and median age was 37 years (range 12-76). Most (n=62, 70%) patients 
reported that the pain had started in the previous week. A typical right lower abdominal 
preponderance (59%, n=52) was found.
 
Age, m2dian (range) 37 (12-76)
Gender (M:F) 17:71
Duration of symptoms
<1 week
1 week – 1 month
1 month – 6 months
>6 months
62
14
10
2
Physical examination 
Abdominal pain location, n
Right upper quadrant
Left upper
Right lower
Left lower
Bilateral lower
13
5
52
17
1
Trigger point, Yes : No (missing data, n) 88:0 (0)
Carnett-sign, Pos : Neg (missing) 65:5 (18)
Sensory disturbances, Y : N (missing) 60:9 (19)
Pinch, Pos : Neg (missing) 37:5 (46)
2013 outpatient department ACNES incidence
In the year of 2013, a total of 268 new onset patients visiting the SolviMáx outpatient 
department were diagnosed with ACNES. However, just a small portion (85/268, 32%) 
belonged to the adherence area of MMC confirming its status as a referral centre for the 
remaining 68%. As 15 of these 85 newly diagnosed ACNES patients had attended the 
ED of MMC in an earlier phase, a 35/100.000 incidence rate of ACNES in the outpatient 
department was calculated. By combining numbers of ED and outpatient department, a 
total 57/100.000 ACNES incidence rate was obtained. 
Table 2 Characteristics of patients diagnosed with ACNES (n=88) in a Dutch emergency 
 department during a two year period (2011/2012)
Discussion
It is our experience that some patients who are ultimately diagnosed with chronic 
abdominal pain due to the anterior cutaneous nerve entrapment syndrome (ACNES) 
reported that they had previously attended emergency departments (ED) for earlier attacks 
of pain. As blood analysis, ultrasounds or CT-scans were always inconclusive, they were 
frequently sent home without receiving a conclusive diagnosis resulting in a substantial 
doctor’s delay. To this day, ACNES is consistently neglected as a cause of abdominal 
pain2, 5, 7, 8. Awareness regarding ACNES as part of the differential diagnosis of chronic 
abdominal pain in our area is high6, 11-17, 19. It may be assumed that the chances of 
recognizing ACNES in patients with acute abdominal pain visiting our ED are also higher. 
Aim of the present study was to calculate the incidence of ACNES in the ED of a Dutch 
teaching hospital. Based on an analysis of all patients visiting during the 2011/2012 time 
period, a mean 22/100.000 per year incidence rate was obtained. In perspective, about 
one of 50 patients presenting with abdominal pain to the ED was diagnosed to suffer 
from ACNES. In an ED such as MMC’s hosting approximately 30 thousand patients 
yearly, the diagnosis ACNES is made almost once a week. An emergency physician must 
realize that a patient who is referred to the ED for abdominal pain of unknown origin 
may suffer from an abdominal wall pain syndrome such as ACNES.
Most patients with chronic abdominal pain due to ACNES are diagnosed after a 
substantial time period. For instance, mean doctor’s delay was more than a year in one 
study indicating that the pain is per definition chronic13. Interestingly, most patients in the 
current study (70%) presented to the ED within the first week following the onset of pain. 
Although generally considered a chronic entity, a substantial portion of ACNES patients 
apparently experiences pain in an acute setting. This novel finding clearly illustrates our 
limited knowledge on various issues regarding the syndrome. As a consequence, most 
patients with an acute ACNES syndrome probably move on to develop a chronic form 
due to insufficient awareness of consulted doctors.
How can consciousness regarding signs characterizing ACNES be increased? A 
physical examination has a pivotal role in the diagnosis. If serious causes of acute 
abdominal pain are excluded in the ED using a combination of physical examination, 
blood analysis and imaging techniques, results of simple tests may point towards the 
presence of ACNES. A positive Carnett’s test and an area of sensory disturbances covering 
the painful spot are signs reflecting the neuropathic character of this pain syndrome2, 7, 10, 
18, 26, 27. We routinely evaluate skin gnostic sensibility using a simple swab. Hypoesthesia, 
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hyperesthesia/algesia or sometimes even allodynia may be found by comparison to the 
normal contralateral abdominal side. In addition, a gauze soaked with alcohol is utilized 
to test vital (cold) sensibility. A positive pinch test is a sensitive and highly underrated 
sign reflecting the presence of a neuropathic pain syndrome2. By squeezing a patient’s 
skin fold and subcutaneous fat using thumb and index finger, the area of interest will hurt 
when compared to the contralateral side (figure 1). The majority of patients (88%, 37/42) 
in the present study tested positive. A skin pinch test deserves a standard place in the ED 
physician’s toolbox of physical examinational tests for abdominal pain.
When the diagnosis ACNES is likely, ED physicians are advised to start trigger point 
injection therapy. A subfascial injection of 5-10 ml of 1-2 % lidocaine leading to immediate 
pain reduction is diagnostic and occasionally therapeutic. Previous studies in chronic 
ACNES demonstrated permanent pain relief in one-thirds of the patients after injection 
therapy12, 13. Patients with recalcitrant pain after repetitive injections are offered resection 
of entrapped branches of the intercostal nerve leading to long-term pain remission in 
up to three-quarters12, 16. In the remaining population, a renewed surgical exploration is 
found to be effective in an additional two-thirds of the patients. This three-step treatment 
protocol may lead to pain remission in some ninety percent17. Interestingly, the response 
to immediate injection therapy may be more favourable in acute ACNES patients. For 
instance, a conservative strategy sufficed in the majority (64/88, 73%) of the present 
study population. Conversely, just 24 patients (27%) in the study population underwent a 
neurectomy comparing favourably to a 50% surgical rate as reported in another group of 
chronic patients who were still painful after injection therapy12. An optimized response 
to injection therapy in acute ACNES may be related to the short duration of complaints. 
This hypothesis is currently tested in our patient population with ACNES.
How does the present ACNES incidence relate to other known disease entities in 
the Netherlands? The calculated 57/100.000 (1:1800) total ACNES incidence is obtained 
in our area containing approximately 200.000 individuals. If extrapolated to the Dutch 
population (16.800.000 inhabitants), some 9.500 new ACNES patients may be identified 
yearly28. In a survey among alleged irritable bowel syndrome patients in a general practice 
setting in the Netherlands, a prevalence of some 20 thousand ACNES patients (being 
approximately 4% in relative numbers) within this functional abdominal pain population 
was calculated11. The 9.500 ACNES incidence yearly exceeds numbers of Dutch patients 
that are newly diagnosed with for instance inflammatory bowel disease (n=7.200) or 
stomach and duodenum ulcer (n=6.700)29. The incidence number of ACNES patients 
visiting the ED is calculated at 1:4.500 (22:100.000). It is interesting to relate these 
numbers to for instance the well-known incidence of acute appendicitis (approximately 
1:1.000). For every 4-5 acute appendicitis patients, one additional individual with acute 
abdominal pain is diagnosed with ACNES30. From a different perspective, as an average 
Dutch general practice contains about 2500 patients, a Dutch general practitioner will be 
confronted with 1-2 new ACNES patients yearly.
The current study harbours flaws associated with its observational character including 
incomplete data sets. For instance, some specific characteristics of history taking and 
physical examination were not routinely registered possibly indicating bias. Moreover, 
the electronic searching strategy may have been incomplete as the number of used 
key words in the CS-EHIS may have been insufficient or incorrectly registered by ED 
physicians. Although these effects are considered minimal, an incidence underestimation 
rather than an overestimation may have resulted from these flaws. Another disadvantage 
is potentially related to the institution where this study is executed. Although groups 
of physicians working on MMC’s ED are rotating, there is no doubt that awareness 
regarding this neglected syndrome is high compared to other ED’s. Therefore, there may 
be a risk of ‘overdiagnosing’ patients with abdominal wall pain syndromes, also because 
the diagnosis ACNES is a typical clinical diagnosis lacking a gold standard. However, 
we strive to strictly adhere to objective criteria. Moreover, no alternative abdominal 
diagnoses emerged following presentation at the ED or during follow up.
Conclusion
Approximately 2% of all patients presenting with acute abdominal pain were diagnosed 
with anterior cutaneous nerve entrapment syndrome (ACNES) in an emergency 
department setting. If patients with a localized acute abdominal syndrome demonstrate 
normal laboratory or imaging testing, ED physicians should consider ACNES in the 
differential diagnosis.
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Abstract
Background
Doctor’s delay may be substantial in patients with pain due to abdominal wall 
syndromes such as the anterior cutaneous nerve entrapment syndrome (ACNES). As 
a consequence, avoidable health care consumption prior to diagnosis is also deemed 
extensive. Aim of the present study was to calculate avoidable direct diagnostic and 
therapeutic costs and indirect productivity costs in the year preceding the diagnosis 
of ACNES in a patient population of a single hospital (Máxima Medical Center, 
MMC).
Methods
Patients who were referred from outside the hospital’s adherence area and who 
received the new diagnosis ACNES between September 2012 and August 2014 
in MMC were eligible for the study. Study subjects were invited to complete the 
medical consumption questionnaire (iMCQ) and the productivity consumption 
questionnaire (iPCQ). Numbers of health care consumption obtained from 
the iMCQ were multiplied with unit cost prices to attain direct diagnostic and 
therapeutic costs. Productivity losses were calculated by adding up the costs of 
absenteeism, presenteeism and unpaid work loss.
Results
94 Patients fulfilled criteria for the new diagnosis ACNES (female n=74, 79%, mean 
age 41 SD 17). Total direct health care costs in the year preceding the diagnosis was 
estimated to approximate €5,400 per patient. Extrapolation to total number of years 
of doctor’s delay resulted in direct medical costs of €16,600 per patient. A total of 
€13,800 of indirect costs per patient in the year before diagnosis was calculated, 
leading to a total of €19,200 in the year preceding the correct diagnosis.
Conclusions 
Patients with anterior cutaneous nerve entrapment syndrome are avid health care 
consumers in the year preceding their diagnosis. Earlier recognition will reduce 
unnecessary direct and indirect costs associated with the diagnostic and treatment 
approach.
Introducion
The cause of abdominal pain is often obscure. In an acute setting, a definitive diagnosis 
is uncertain in over 40% of patients with sudden onset abdominal pain1. The etiology of 
chronic abdominal pain is also often elusive2. A substantial number of patients treated as 
having chronic visceral abdominal pain may in fact suffer from chronic abdominal wall 
pain (CAWP) syndromes3-9.
A characteristic example of a CAWP syndrome is the anterior cutaneous nerve 
entrapment syndrome (ACNES). Terminal branches of thoracic intercostal nerves are 
somehow entrapped in layers of the abdominal wall9. An ACNES patient experiences 
severe neuropathic pain in a circumscript area of an anterior portion of the abdominal 
area. Physical examination consistently unveils a point of maximal pain. Altered skin 
sensibility (usually hyperesthesia) covering this painful area reflects the neuropathic 
character of this pain syndrome. A positive Carnett test may contribute to the 
diagnosis3,7,9-12.
Although the entity has been recognized for over 80 years, many physicians still are 
unfamiliar with specifics of the syndrome3-9. If unrecognized, a series of unnecessary costly 
diagnostic evaluations may be ordered by general practitioners and hospital specialists9,10. 
For instance, one study reported that 418 diagnostic procedures were executed in 100 
CAWP patients6. Similarly, a 1994 report showed that a workup accounted for 680 
US$ per CAWP patient2. Moreover, a staggering 6727 US$ per patient was invested in 
futile diagnostic testing and hospital charges before arriving at the correct diagnosis 
in a 2001 CAWP study13. However, methodology in these somewhat outdated studies 
was not similar, whereas extrapolation to the Dutch system is difficult due to a different 
organization of health care system.
In the ‘SolviMáx outpatient department for abdominal wall and groin pain syndromes’, 
physicians are consistently confronted with ACNES patients who have also received 
numerous, and often unnecessary, diagnostic as well as invasive procedures before 
the correct diagnosis was established. Moreover, many patients reported difficulties in 
daily life activities and paid work, leading to sick leave and even unemployment. An 
analysis of avoidable costs adopting a societal perspective in an ACNES population may 
demonstrate the relative economic consequences of this frequently overlooked syndrome 
and may show the configuration of health care consumption across different parties.14 An 
investigation may give clues for a potential scope of improved recognition of the disease. 
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Aim of this present study was to assess direct medical and indirect non-medical costs due 
to an unrecognized CAWP syndrome in a population of ACNES patients in the final year 
preceding the appropriate diagnosis.
Methods
General information 
A questionnaire survey was performed between September 2012 and August 2014 at 
the surgical department of the Máxima Medical Center (MMC), a 595-bed community 
hospital situated in the southern part of The Netherlands. Staff members of the surgical 
department of MMC have gained considerable experience in diagnosing syndromes 
of chronic abdominal wall pain and groin pain ever since the beginning of the new 
millennium15-26. As a consequence, a surgical subdepartment termed ‘SolviMáx’ (Center 
of Excellence for Abdominal Wall and Groin Pain) was initiated that evaluates a growing 
number of patients yearly by a team of surgical and medical experts. Most referred 
patients are resided outside of the MMC hospital’s adherence area.
Patient selection
SolviMáx physicians have experienced that potential ACNES patients living close to the 
MMC are possibly presented with a limited delay as a relative high awareness within the 
MMC adherence area is hypothesized. In contrast, a considerable doctor’s delay is present 
in many patients who are referred from outside the adherence area. Associated health 
care costs in patients from these other Dutch areas will more reliably reflect the current 
Dutch daily practice. Moreover, extrapolation to areas other than MMC’s is also more 
realistic as a comparable situation will also prevail in many other countries.
During a two years time period (September 2012 – August 2014), consecutively 
referred patients from outside the MMC adherence area who received the new diagnosis 
ACNES in the MMC were asked to participate in the current study. Our adherence area 
is defined as the total group of general practitioners who would, based on prior contacts 
and geography, refer patients to the MMC. Accurate figures on MMC adherence were 
obtained from a standard market analysis (Kiwa Carity B.V., Utrecht, The Netherlands). 
Study patients were invited to complete the iMTA Medical Consumption Questionnaire 
(iMCQ)27. Exclusion criteria were a prior diagnosis (and treatment) of ACNES, an 
alternative condition associated with abdominal pain or a second opinion for patients 
in whom the diagnosis ACNES was already made or considered previously. Patients that 
were not able to properly read or understand the Dutch language as well as patients not 
willing to participate were not included as well. Symptom duration and age were not 
defined as exclusion criteria.
Diagnostic criteria of ACNES
Diagnosing ACNES occurred during either the first, the second or the third outpatient 
department visit. As a consequence, some patients received the questionnaire after the 
first visit while others after their next visit.
The diagnosis ACNES was confirmed or deemed highly likely if the following set of 
signs and symptoms were met, as previously published16, 17:
1. Abdominal pain, and
2. Site of abdominal tenderness with a small (<2 cm2, “finger tip”) area of maximal 
intensity that is situated within the lateral boundaries of the rectus abdominis 
muscle, and
3. Tenderness increases by abdominal muscle tensing using the Carnett’s test. The 
point of maximal pain is localized using a palpating index finger. Muscles are 
tensed as the patient lifts the head. If tenderness increases, the origin of the pain 
is most likely located in the abdominal wall5, 10, and
4. A positive pinch test reflecting skin sensory disturbances covering the area of 
maximal pain, and
5. Normal laboratory analysis and normal imaging (if previously performed), and
6. Pain reduction following infiltration using 10 mL of 1% lidocaine.
During follow up, no alternative diagnoses possibly explaining the abdominal pain 
emerged in any of the patients. 
Cost measurement
This study adopted a societal perspective including the following costs: (1) first line 
medical costs, (2) medication costs, (3) home care costs, (4) hospital costs including 
cost of outpatient specialist visits, diagnostics, (day care) treatment, surgery and 
hospitalization, and (5) indirect non-medical costs of productivity losses. Medical 
consumption and productivity losses were measured using the Medical Consumption 
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Questionnaire (iMCQ) and the Productivity Cost Questionnaire (iPCQ) as developed by 
the institute for Medical Technology Assessment (www.imta.nl)28-30. These questionnaires 
are recommended in the manual for economic evaluations in health care (CVZ, College 
voor zorgverzekeringen; Health Care Insurance Board). These generic questionnaires are 
developed as patient self-reporting tools.31 For the purpose of this study, questionnaires 
were adjusted in such a way that only medical consumption and production losses as a 
consequence of the abdominal complaints due to ACNES were asked. Each questionnaire 
is preceded by general questions determining sociodemographics of the respondent 
without revealing the patient’s identity. Completing both questionnaires approximately 
requires 30-45 minutes. By completing the questionnaire, patients automatically signed 
for informed consent.
Direct medical costs
The iMCQ includes 31 questions related to medical consumption including numbers 
of first line health care visits, medication use, hospital outpatient department visits, 
diagnostic evaluations, hospital daycare, inpatient care and surgery. In the original 
version of the iMCQ, a 3 months recall period is used as a means to generate reliable 
information32,33. As ACNES patients usually face a longer doctor’s delay and health 
consumption can fluctuate over a longer period, a recall period of 1 year rather than 3 
months was deemed more representative17.
Unit cost prices of first line care were derived from reference lists of the manual for 
economic evaluations in health care from the Health Care Insurance Board (CVZ)31. 
Medication costs were calculated using standard medication prices as described by the 
Health Care Insurance Board (CVZ), online available on www.medicijnkosten.nl34. If 
applicable, the costs were based on the generic name of the product34, 35. The cheapest 
variant was chosen for calculations. Delivery tariff for not freely available drugs was added 
applying a standard fee of €6 per prescribed drug per period of 3 months. Unit prices for 
radiologic and other diagnostic procedures were taken from the NZa (Dutch Healthcare 
Authority) which are assumed to provide a good indication of the actual costs36. Costs 
of most surgical interventions are available within prices of health care products (DBC, 
Diagnosis Treatment Combination, www.opendisdata.nl)37. Outpatient department 
visits, diagnostics, therapies and hospitalization are included into these products. Only 
the portion responsible for the health unit of interest (surgery) was calculated according 
to MMC’s product profiles. All costs were indexed to the year of 2013 using data from 
Statistics Netherlands (CBS). Unit costs prices of hospital health care (diagnostic 
procedures, (surgical) treatment and inpatient care) derived from the different resources 
were re-checked for validity by MMC’s financial department participating in a benchmark 
together with comparable type of hospitals.
Obtained numbers of health care consumption were multiplied by the calculated unit 
cost prices. The portion of patients consuming a health care component was calculated as 
well as total number of units. Subsequently, total costs per health care section and finally 
overall total medical costs were obtained.
Indirect non-medical costs
The iPCQ is used for the measurement of indirect non-medical costs due to productivity 
losses related to the abdominal complaints. The iPCQ consists of 3 modules adding up to 
a total of 12 questions. The modules include productivity of paid work as a consequence 
of absenteeism, productivity loss of paid work without absenteeism (presenteeism) and 
productivity loss of unpaid work. In the questionnaire, standard recall period of 4 weeks 
is handled as longer periods lead to inaccuracy in these self-reports38. Costs were, were 
extrapolated to the total duration of complaints, with a maximum of 52 weeks (1 year). 
Productivity losses at a paid job as a consequence of absenteeism were calculated 
in two situations; short absenteeism (≤ 4 weeks) and long absenteeism (> 4 weeks). For 
patients with long absenteeism, the ‘friction cost method’ was used, according to the 
Dutch guidelines of economic evaluations in healthcare31, 39, 40. This method estimates 
production losses of long-term absence from work only for the period required to replace 
the employee, starting from the beginning of subject’s sick leave (‘friction period’). In 
absence of reliable information about the duration of a vacancy for the year of 2013, a 
2011 friction period of 116 days (17 weeks) was used41. If the friction period expired more 
than a year ago (in the case of a patient who is sick for work at least 69 weeks (52+17)), 
no costs due to productivity losses were calculated. For the calculation of the productivity 
losses, age specific production costs were used.
Productivity loss of paid work without absenteeism (presenteeism) was calculated as 
number of hours of productivity loss (as a product of daily working hours and number of 
days with complaints) multiplied with a factor of efficiency loss (between 0 and 1) during 
these days. The lost productivity hours were multiplied with mean productivity costs 
of different age groups to calculate costs of presenteeism31. Productivity loss of unpaid 
work was calculated by multiplying lost hours of unpaid work with the standard costs of 
domestic help (€12,50). Total costs for all three types of production losses are displayed 
as mean and total cost.
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Data collection and analysis
All analyses were performed with the SPSS 20.0 program for Mac OS X file. Baseline 
characteristics were presented as percentages or mean (SD) as appropriate. Total costs 
for the study population are displayed as rounded costs. Missing items were excluded in 
individual health care units. For total cost calculation, missings were counted as a zero.
Results
Demographics
In the almost two year study period, 1267 unique patients visiting the SolviMáx outpatient 
department were evaluated for a chronic abdominal wall or inguinal pain syndrome. A 
total of 501 patients were diagnosed with ACNES, and two-thirds (n=329) were referred 
from outside the MMC’s adherence area. Some of these patients did not participate 
because of a language barrier or were not interested to participate. From the remaining 
eligible patients, an unknown number was not invited to complete the questionnaire, likely 
due to time restraints associated with an exceedingly busy practice. As a consequence, a 
total of 169 patients were invited to complete the questionnaire. Complete data sets of 94 
patients were returned and analysed (56%). 
Most patients were female (n=74, 79%) as also found in other studies16, 17, 42, 43. Age 
ranged from 13 to 78 years (mean 41 yr., SD 17). The majority (n=74, 79%) suffered from 
ACNES for more than one year. The average duration of symptoms was almost 4.5 years 
(53 months, SD 82, range 2 – 576). Respondents with paid work (n=59) were employed 
for on average of 30 hours a week (SD 12, rage 5-60).
Direct medical costs
Detailed information on type of medical consumption and associated costs are presented 
in table 1. Total health care costs in the year preceding the diagnosis was estimated to on 
average €5,400 per patient.
Most patients visited a general practitioner (GP) in the year preceding diagnosis. 
Some 90% reported at least one GP visit (85/94). These patients had paid an average of 
7 visits. Less than half (41%) of the study population was referred to a physical therapist 
(PT). These patients reported on average 15 PT visits. Total cost of first line care added 
up to €650 per patient. Consumption of almost 90.000 medication pills resulted in some 
€16,300 of additional costs including €1,700 of delivery costs (on average €170 per 
patient). Only 2 patients did not use pain medication. Painkillers, laxatives, tranquilizers 
and antidepressants were frequently used (59 different types of drugs).
Approximately half of the patients reported outpatient hospital visits to 
gastroenterologists and surgeons in the pre-diagnosis year. About thirty percent of the 
respondents also reported visits to other specialists such as pain doctors, internists and 
gynaecologists. Of 10 adolescents who were included in this analysis, 5 were evaluated by 
a paediatrician. Total cost of outpatient visits accounted for €670 per patient.
A substantial number of imaging studies including colonoscopies (n=51), CT scans 
(n=54) and ultrasounds (n=95) indicate the persistent search for a visceral cause of the 
pain. The majority of day-care hospital treatments were associated with pain therapy 
and accounted for €1,010 per patient. More than one-third of the patients (37%) was 
hospitalised (on average 6 days per patient) in the year prior to diagnosis (on average 
€1,130 per patient). A total of 37 invasive surgical procedures were executed because 
of the abdominal pain including diagnostic laparoscopies (n=7), appendectomies (n=6), 
umbilical hernia repair (n=8), cicatricial hernia repair (n=4), scar tissue correction (n=2), 
rib resection (n=1), abscess incision (n=1), uterus extirpation (n=1), ovarian removal 
(n=4) and nerve exploration (n=3). Associated costs with these interventions added up 
to a total of on average €460 per patient.
Twenty of 74 patients suffering from pain for more than one year spontaneously 
stated in the comments section that the majority of health care was consumed prior to 
the study’s one-year recall period justifying an extrapolation of the calculated costs. In 
all patients having ACNES pain for more than one year (n=74, 79%), costs over this year 
were multiplied by the total duration of complaints in years. This extrapolation resulted to 
an estimated total health care costs of €1,500,000, on average €16,600 per patient (range, 
€470 – €98,100).
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Cystoscopy 5 (2) 2 9 102.81 900
CT-colonography 3 (2) 1 4 164.01 700
Blood tests 11 (2) 2 22 22.87 500
Capsule endoscopy 3 (2) 1 3 139.52 400
Other incidental diagnostic tests (n=8) 1-2 (2) 13 1,800
Total (mean per patient): 54,100 (580)
Hospital day care treatment 59 (1)
Nerve blocks 30 (2) 3 83 551.35 45,800
General pain treatment 12 (2) 3 38 551.35 21,000
Transcutaneous Electrical Nerve 
Stimulation (TENS)
9 (2) 4 35 551.35 20,100
Emergency dept. visit 18 (2) 2 33 164.14 5,400
Constipation 2 (2) 6 11 215.87 2,400
Iontoforesis 1 (2) 1 1 551.35 600
Total (mean per patient):  95,300 (1,010)
Out of hospital treatment (days) 4 (1)
Revalidation clinic 4 (1) 18 70 369.58 25,900
Total (mean per patient): 25,900 (280)
Hospitalisation (nights) 37 (1) 6 214 496.76 106,300
Total (mean per patient): 106,300 (1,130)
Surgery 31 (1)
Umbilical hernia repair 7 (2) 1 8 1188.18 9,500
Appendectomies 7 (2) 1 6 1282.28 7,700
Ovariectomy 3 (2) 1 4 1844.59 7,400
Cicatricial hernia rep. 3 (2) 1 4 1759.67 7,000
Diagnostic laparoscopy 8 (2) 1 7 875.40 6,100
Neurectomy 3 (2) 1 3 882.84 2,600
Uterus extirpation 1 (2) 1 1 1844.59 1,800
Rib resection 1 (2) 1 1 1005.47 1,000
Abscess incision 1 (2) 1 1 165.03 200
Scar tissue resection 2 (2) 1 2 56.00 100
Total (mean per patient): 43,500 (460)
Total overall: €503,100
Total per patient: 
(range)
€5.400
(150–29.300)
Table 1 Medical costs in a series of patients in the year prior to the diagnosis anterior  
 cutaneous nerve entrapment syndrome (ACNES)
Component % of n=94 
consuming 
component 
(missing)
Mean no of 
units per 
consuming 
respondent 
Total number 
of units
Unit costs 
(€)
Total costs 
(€)
First line care (visits) 97 (0)
Physiotherapist 41 (0) 15 573 39.13 22,400
General practitioner 90 (0) 7 594 30.44 18,200
Psychology 23 (0) 5 106 86.96 9,200
Company doctor 32 (0) 5 164 30.44 5,000
Social worker 7 (0) 5 37 70.66 2,600
Homeopathy 16 (0) 5 74 39.13 2,900
Dietician 17 (0) 3 40 29.35 1,200
Total (mean per patient): 61,500 (650)
Home care (hours) 6 (0)
Domestic help 5 (4) 142 708 26.09 18,500
Nursing 1 (4) 260 260 70.66 18,400
Total (mean per patient): 36,800 (390)
Medication (tablets/units) 98 (0)
Medication 88.188 14,600
Delivery fee 1,700
Total (mean per patient): 16,300 (170)
Specialist (visits) 95 (0)
Surgeon 55 (2) 4 192 78.26 15,000
Gastroenterologist 50 (2) 4 170 78.26 13,300
Pain specialist 32 (2) 4 134 78.26 10,500
Internal medicine 29 (2) 3 88 78.26 6,900
Gynaecologist 30 (2) 3 79 78.26 6,200
Urologist 13 (2) 4 49 78.26 3,800
Paediatrician 5 (2) 8 39 78.26 3,100
Neurologist 9 (2) 4 28 78.26 2,200
Other specialisms (n=5) 1-3 (2) 27 78.26 2,100
Total (mean per patient): 63,100 (670)
Diagnostic tests (units) 78 (1)
Colonoscopy 29 (2) 2 51 368.41 18,800
MRI-scan 34 (2) 1 46 200.73 9,200
CT-scan 42 (2) 1 54 164.01 8,900
Echography 45 (2) 2 95 52.63 5,000
Gastroscopy 11 (2) 1 13 368.41 4,800
Triple faeces test 7 (2) 2 14 128.00 1,800
X-ray 14 (2) 2 28 46.50 1,300
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Indirect non-medical costs
The different types of productivity losses and their costs are presented in figure 1. A total 
of €13,800 per patient of indirect costs due to productivity losses was calculated in the 
year preceding diagnosis, despite a relatively high number of missings of ‘cost of unpaid 
work loss’ in particular (n=17).
More than half of the respondents with paid work (58%, 34/59) reported sick leave 
prior to receiving the diagnosis ACNES. The majority (68%, 23/34) reported long-
term absence from work (e.g. more than 4 weeks; mean 45 weeks, SD 37, range 4 - 123 
weeks). The other 11 employees reported shorter absence. Cost of absence from work was 
estimated at €7,500 per patient with a paid job in the year before diagnosis.
63% (36/59) of the patients with paid work did not report absence from work during 
the complete recall-period. However, 31 of these 36 (86%) stated to have been at work 
while suffering from abdominal pain (range 1-21 working days in 4 weeks). 28 of 31 
employees reported to have experienced loss of productivity due to the complaints (10-
70%), leading to €5,100 productivity loss per respondent with a paid job in the year 
preceding diagnosis. In the study population, 57 patients reported to have loss of unpaid 
work, on average 17 hours a week per patient. In the year before diagnosis, a mean €9,800 
unpaid work loss per patient who reported this type of work loss was estimated. The total 
of ACNES in the year preceding the diagnosis were estimated at €19,200 per patient of 
which 28% are direct medical costs and 72% are indirect non-medical costs. Most of these 
cost can be assigned as avoidable cost. Discussion
This study demonstrates that the presence of chronic abdominal pain due to anterior 
cutaneous nerve entrapment syndrome (ACNES) is associated with substantial direct 
medical and indirect non-medical costs in the year preceding the diagnosis. Assuming 
that the current study population represents the actual Dutch situation, medical costs 
added up to a mean €5,400 per patient. Adopting a societal perspective including 
productivity losses, an average €19,200 per patient was found. Most of these costs may 
be avoidable.
Some older reports studying health care costs in ACNES patients focused on specific 
portions of the health care process2, 6. For instance, Thompson investigated medical costs 
prior to trigger point injections for abdominal wall pain syndrome in 200113. In that 
study, costs associated with all diagnostics and treatments were similar compared to the 
current study (6.727 US$ ≈ €5,367 versus €5,400 per patient). However, the present study 
Figure 1 Costs associated with loss of productivity due to abdominal pain in ACNES  (€).
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only focused on costs in the final one year before diagnosis. Total medical costs were 
more than three times higher (€16,600) following extrapolation to total years of pain. 
Moreover, we also identified a substantial amount of indirect costs in the year before 
diagnosis as a consequence of the invalidating character of the disease. The most plausible 
explanation of these high costs is twofold. First, the high intensity of neuropathic pain 
in these patients leads to high medical consumption and productivity losses. Second, 
unawareness of ACNES among physicians leads to unnecessary diagnostics and 
treatments resulting in a delay of the appropriate diagnosis and treatment.
Not a single specific health care provider is to blame for the ignorance concerning 
ACNES. Most patients participating in the present study visited a great variety of doctors. 
In the present-day environment of superspecialisation, physicians progressively retire 
into their own back yard44. As a consequence, syndromes including ACNES that are not 
clearly adopted by a certain specialism stand a chance of being ignored by all neighbouring 
specialists. Gastroenterologists, internists, gynaecologists, paediatricians and surgeons 
need to be educated on the clinical significance of the abdominal wall. Moreover, ACNES 
as a differential diagnostic alternative deserves a more prominent place in the curriculum 
of future general practitioners.
It may seem that an improved recognition and understanding of ACNES can prevent 
many unnecessary diagnostics and treatments thus reducing medical costs. Moreover, a 
frustrating patient’s quest of years may be shortened. Once diagnosed, ACNES patients 
in the current study undergo a simple treatment protocol that was recently developed16-18, 
42, 43. In an imaginary population of 100 patients, a regimen of 1 – 3 abdominal wall 
injections is long term effective in one-thirds17, 43. Estimated costs associated with such 
an approach (including visits to GP, surgeon and injection treatment) based on similar 
unit cost prices adds up to approximately €1,400 per patient. For patients not responding 
to this injection regimen, a surgical exploration including transection of the nerve 
endings (neurectomy) was effective in a randomized double blind surgical trial18. Such a 
neurectomy performed in the remaining 67 patients after a conservative treatment cost 
approximately €2,700 per patient. Based on a published 61% long term success rate in 
this population, some 26 patients remain with persistent pain who are offered a second 
surgical exploration (€4,700)42. As a 66% success rate is attained, some 9 of the original 
100 patients possibly do not benefit from this three-step treatment protocol43. Conversely, 
over 90% of a hypothetical ACNES population is diagnosed and successfully treated at 
the expense of approximately €2,800 of medical costs per patient. The alternative is an 
expensive path associated with on-going chronic pain. As demonstrated in this study, 
the average ACNES patient suffered for over 4 years. Direct and indirect costs exceeded 
€19,000 per patient, an amount that is 7 times higher compared to the cost of the proposed 
treatment regimen. Therefore, improved awareness and appropriate treatment of ACNES 
lead to serious savings.
The current study focused on the burden of ACNES in terms of cost to society. 
However, results also demonstrate a substantial inability to fulfill normal daily activities 
in terms of high rates of sick leave and efficiency losses of paid work in ACNES patients. 
Moreover, it may be hypothesized that a delay in diagnosis and inappropriate treatment 
will also seriously affect quality of life. Such studies are recommended to attain a complete 
evaluation of health status in ACNES patients45.
The current study may harbour flaws. All participating physicians (n=5) were instructed 
to check patients for eligibility, but the questionnaire was completed anonymously. As 
a consequence, correctness of data could not be verified whereas reasons for refusal to 
participate were unclear. Furthermore, some potential patients were possibly declined 
participation due to time restraints associated with a busy practice, leading to the 51% 
inclusion rate among eligible patients. A 56% response rate is comparable to other 
rates obtained from mail surveys published in medical journals (approximately 60%)46. 
Characteristics including age and gender of the study population (n=94, female 79%, 
mean age 41 SD 17, range 13 – 78) and the overall eligible population (n=329: female 78%, 
mean age 40 SD 18, range 8 – 81) were identical indicating that a representative group 
participated in the current study. Another potential flaw is a prolonged recall period 
(12 rather than 3 months) that was used for the measurement of medical consumption. 
Therefore, recall bias may have played a role. However, this type of bias usually leads to 
an underestimation of costs33. Furthermore, questions related to medication use were 
difficult to handle for some patients as previously reported30. However, missing items 
also lead to an underestimation of the costs. The number of missing data for calculation 
of indirect non-medical costs due to productivity losses, in particular the module unpaid 
work loss, was substantial. Again however, this omission also leads to underestimated 
costs.
Based on a recently calculated 57:100.000 ACNES incidence rate, costs of illness at 
a given moment may be approximated47. If extrapolated to the Dutch population (2013, 
16.800.000 inhabitants), some 9.500 new ACNES patients may be identified yearly48. 
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On the basis of these assumptions, total yearly costs associated with ACNES in The 
Netherlands are calculated at €182.4 million (€51.3 million direct medical costs and 
€131.1 million indirect non-medical costs). In this calculation, it is also assumed that 
all newly diagnosed ACNES patients experience the same burden of disease, which is 
not necessarily a realistic picture. However, the incidence rate calculation in one other 
study was only based on ACNES patients that consulted an outpatient department or 
the emergency department, indicating a population with severe complaints47. If all these 
patients would undergo a diagnostic and treatment regimen as proposed (€2,800 per 
patient for diagnosis and treatment), direct medical cost is calculated at €26.6 million 
per year. An indirect non-medical cost calculation cannot be determined reliably, but 
a maximum half a year treatment period (including queue time prior to first evaluation 
and the period between treatment steps) is reasonable. According to similar productivity 
losses as calculated in the studied population, an estimated yearly cost reduction of €80-
100 million is reasonable in the Dutch situation. 
Conclusion
ACNES patients are avid health care consumers in the final year preceding their 
diagnosis.  Earlier recognition and treatment of ACNES will result in a substantial 
reduction of direct medical and indirect non-medical costs.
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Abstract
Objective
To clarify the role of a surgical neurectomy on pain in refractory patients following 
conservatively treated ACNES. 
Background
Anterior cutaneous nerve entrapment syndrome (ACNES) is hardly ever considered 
in the differential diagnosis of chronic abdominal pain. Treatment is usually conser-
vative. However, symptoms are often recalcitrant. 
Methods
Patients >18 years diagnosed with ACNES were randomized to receive a neurectomy 
or a sham procedure via an open surgical procedure in day care. Both patient and 
principal investigator were blinded to the nature of surgery. Pain was recorded using 
a Visual Analogue Scale (VAS: 1-100 mm) and a Verbal Rating Scale (VRS 0-5, 0 = 
no pain, 5 = severe pain) prior to surgery and 6 weeks postoperatively. A reduction 
of at least 50% of VAS and/or 2 points of VRS was considered a ‘successful response’.
Results 
Forty-four patients were randomized between August 2008 and December 2010 (39 
females, median age 42 years, both groups n=22). In the neurectomy group, 16 pa-
tients reported a successful pain response. In contrast, significant pain reduction 
was obtained in 4 patients in the sham group (p = 0·001). Complications associated 
with surgery were hematoma (n=5, conservative treatment), infection (antibiotic 
and drainage, n=1) and worsened pain (n=1). 
Conclusion 
Neurectomy of the intercostal nerve endings at the level of the abdominal wall is 
an effective surgical procedure for pain reduction in ACNES patients who failed to 
respond to a conservative regimen.
Introduction
Chronic abdominal pain (CAP) is a diagnostic challenge for both general physicians 
and specialists. It often occurs that a definitive diagnosis is not attained, even after 
extensive evaluation including laboratory tests and multimodal imaging. Interestingly, 
pain is found to originate from the abdominal wall rather than from visceral organs in up 
to 30% of patients with CAP1-4. Although a patient is seldom able to discriminate between 
the two sources of pain, a simple tool such as Carnett’s testing contributes to a distinction 
between the two varieties2, 5, 6.
A positive Carnett’s test result may also be found in the anterior cutaneous nerve 
entrapment syndrome (ACNES), a somewhat mysterious pain syndrome that is said to 
be caused by the trapping of end twigs of intercostal nerves at the level of the rectus 
abdominis muscle. This diagnosis is suggested by a combination of the patient’s history 
(chronic pain), physical examination (circumscript pain localization and abnormal 
sensibility) and the absence of objective abnormalities (laboratory, ultrasound and/
or CT scan). If ACNES is considered, a local subfascial anesthetics injection (trigger 
point infiltration) may prove diagnostic and sometimes therapeutic7, 8. Persistent pain 
relief is reported using sequential trigger point infiltrations combining anesthetics with 
corticosteroids7, 9-13. If pain recurs, an anterior neurectomy can be beneficiary in 
recalcitrant patients. A cohort study recently reported on the results of a tailored regimen 
in 139 patients with suspected ACNES14. Half of these patients (n=69) underwent a 
surgical neurectomy. At a median 18 months follow-up, 71% of the patients were still 
very satisfied with the clinical result of this procedure. However, randomized controlled 
data on surgery for ACNES are unavailable.
The aim of the present study was to evaluate the effect of an anterior neurectomy 
on pain perception in patients with suspected ACNES. Individuals undergoing a sham 
operation served as controls. We hypothesized that pain attenuation following neurectomy 
resulted from resection of the entrapped nerve at the level of the ventral rectus fascia and 
not from a placebo effect.
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Materials and methods
This randomized controlled trial was conducted at a large teaching hospital (Máxima 
Medical Center (MMC), Veldhoven) in the Southeastern part of the Netherlands. The 
MMC is an 865-bed community hospital serving a population of approximately 350,000 
inhabitants. The Department of General Surgery has gained considerable experience 
in the treatment of chronic pain due to abdominal wall or groin nerve entrapment 
syndromes14-17. The hospital serves as a referral center for a substantial number of other 
Dutch hospitals including all 8 Academic Centers. The Medical Ethics Committee of 
MMC approved study design, protocol and informed consent procedures. The study was 
registered in the Dutch Clinical Trial Register (NTR2016). Design and reporting of this 
trial occurs according to the CONSORT guidelines18.
All patients >18 year suffering from locoregional abdominal pain for at least one 
month were eligible for study if the following criteria were met: 
1. Unilateral single tender spot in the abdominal area (trigger point),
2. Constant site of abdominal tenderness with a small (< 2 cm2, ‘finger tip’) area of 
maximal intensity situated within the lateral boundaries of the rectus abdominis 
muscle,
3. Tenderness increases by abdominal muscle tensing using the Carnett’s test. 
During this test, the investigator localizes the point of maximal pain using his 
index finger. While maintaining the finger on this tender spot, the patient is 
asked to lift the upper torso or both legs. When pain intensity is increased by this 
maneuver, the origin of the pain is most likely located in the abdominal wall2, 5, 
6, 19, 20,
4. Temporary pain response (> 50% reduction on VAS) after a trigger point 
infiltration using an anesthetic agent,
5. Normal laboratory findings (C-reactive protein concentration <6 mg/L, serum-
leukocytes 4-109 L, urine sedimentation), and
6. No abnormal abdominal imaging (if previously performed).
7. Failed earlier conservative treatment 
Exclusion criteria were surgical scar related pain syndromes, recent intra abdominal 
pathology, comorbidity or impaired communication. Patients that met these criteria were 
offered a repeat 10 cc 1% Lidocaine injection combined with 40 mg methylprednisolone. 
Only patients insufficiently responding to this injection regimen were considered for the 
present trial. All patients suffered from pain for at least 3 months prior to entering either 
surgical arm. If patients were eligible for study, informed consent was asked.
Study population characteristics were obtained including age, sex, length, weight 
and pain related specifics such as presumed etiology. Disability caused by the pain was 
measured on using a 4-point VRS. Participants were randomly assigned to one of the 
treatment groups following a computer-generated list of random numbers by blocks of 
eight. The allocation sequence was concealed from the researcher enrolling and assessing 
participants in sequentially numbered, opaque and sealed envelopes, prepared by a 
secretary with no involvement in the trial. Enrolment was performed in the outpatient 
department and patients were provided with substantial time to consider participation in 
the two to three weeks before surgery. 
Figure 1 Intra-operative view of a neurovascular bundle (loop) and a nearby branch (loop)  
 perforating the fascial foramina of the anterior sheath of the abdominal rectus muscle
Patients were operated in a day care setting by one surgeon (RR). The area of maximal 
pain was identified using the Carnett’s test and marked. Once general anesthesia was 
administered, a dedicated secretary was asked to open the next sequential envelope and 
to clearly state the allocated procedure (neurectomy or sham procedure). Name and 
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date of birth of the participant were written on the envelope. The anterior sheath of the 
abdominal rectus muscle was exposed after skin and subcutaneous layer were opened 
via a 5-7 cm transverse incision. If a sham procedure was allocated, the procedure was 
terminated at this point and the wound was closed in layers. If a neurectomy was to be 
performed, neurovascular bundles penetrating the subcutaneous fat through pre-existent 
fascial foramina were identified. The fascia was opened and the bundle was ligated and 
removed as well as all its branches within a 5 cm radius (Figure 1). Accompanying 
vascular structures were ligated or coagulated. The sheath as well as the remainder of the 
wound was closed in layers using absorbable suturing material. 
The wound of both study groups was infiltrated with 10 cc of 0·25% bupivacaine. After 
discharge, patients were encouraged to resume daily activities as soon as possible. 
The primary investigator (OB) assessed outcomes in the outpatient department 
six weeks post operatively. Patients were interviewed and a physical examination was 
performed. The investigator and participants were blinded to the characteristics of the 
surgical procedure. Allocation was revealed only after completion of the 6-week study 
period or if an intercurrent event warranted re-intervention. If a sham procedure was 
performed with an unsuccessful outcome, patients were offered a reoperation including a 
real neurectomy within 6 weeks thereafter.
Endpoint was the proportion of patients achieving a minimal 50% improvement 
in pain perception measured using a Visual Analogue Scale [VAS, 0 mm (pain absent) 
to 100 mm (excruciating pain)], and/or an at least 2-point point improvement on a 
Verbal Rating Scale (VRS 0-5, 0 = no pain, 5 = severe pain) at the 6 weeks time point 
postoperatively compared to the preoperative VAS and VRS. 
Based on the experience with a cohort of ACNES patients, the study was powered for 
the endpoint to detect a difference in proportion of successful response (minimal 50% 
improvement in pain perception) of 75% in the neurectomy group versus a successful 
response of 30% in the sham surgery (placebo) group, with a two-sided 5% significance 
level and a power of 80%14. To achieve this, a sample size of 22 patients per group was 
required. A 24-month inclusion period was anticipated for recruitment. Since drop out 
or loss to follow up was not expected, trial sample size was maintained at this number of 
patients.
Statistical analysis
Baseline characteristics were presented as percentages, mean (±SD) or median values 
(range) as appropriate. Differences in baseline characteristics between study groups were 
tested using a Chi square test for categorical variables and a Student’s t-test (normal 
distribution) or Mann-Whitney test (skewed distribution) in case of continuous variables. 
The difference in proportions of success was calculated using the Yeates-corrected Chi 
Square. A p-value < 0.05 was considered statistically significant. Data analysis was 
performed using SPSS 16 for Windows.
Figure 2 Study flow chart
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Results
Patients were recruited from August 1st 2008 through December 31st 2010. A total 
of 126 patients were evaluated for an alleged abdominal wall related pain (Figure 2). 
Based on physical examination and/or laboratory/imaging findings, the origin of the 
abdominal pain was considered less likely related to the abdominal wall in 13 patients. An 
additional group of 58 patients was excluded for reasons listed in figure 2. As 11 patients 
did not consent to participation, 44 patients were randomized after informed consent 
and all received the allocated intervention (neurectomy n=22; sham n=22). Baseline 
demographics, pain levels (VAS, VRS) and disability scores are summarized in table 1. 
Data accrual was complete without dropouts or loss to follow up. Individual patient data 
are presented in table 2. 
The number of patients demonstrating a successful response was significantly higher 
in the group receiving a neurectomy compared to sham surgery (neurectomy, n=16/22 
versus sham, n=4/22, p=0·001, Figure 3). Eighteen of the 22 sham patients reported an 
unsuccessful pain response and were all reoperated within 6 weeks after de-blinding. 
A reoperation resulted in 11 of these 18 (61%) in successful pain reduction as again 
evaluated 6 weeks later. All 4 initially successful sham patients returned with pain within 
6 months after surgery. A second procedure entailing a real neurectomy proved successful 
in 3 of these 4.
Multiple penetrating nerve branches (median 2, range 1-3) were routinely found 
during the neurectomy procedure. Complications associated with surgery were localized 
hematoma (n=5, conservative treatment), infection (n=1, antibiotics and drainage) and 
increased level of local pain (n=1).
Neurectomy (n=22) Sham (n=22)
Age
Sex ratio (M:F)
Height (cm)
Weight (kg)
BMI (kg/m2)
45 (20-73) 
2:20
171 (7) cm
76 (21) kg
26 (7)
40 (19-65)
3:19
168 (5) cm
75 (16) kg
25 (5)
Etiology (n)
Spontaneous
Sport 
Job relateda
Recent abdominal 
surgery
Pregnancya
Unusual activity
15
1
0
4
0
2
17
1
0
3
0
1
Duration pain prior to surgery 
(Months)
19 (5- >120) 12 (3- >60)
Local sensory dysfunction 
around pain point  17 19
VAS (mm) 62 (22-88) 73 (34-98)
Verbal Rating Scale Pain (n)
0 = No pain
1 = Very mild 
2 = Mild 
3 = Moderate 
4 = Severe 
0
0
3
9
10
0
1
2
6
13
Verbal Rating Scale Disability (n)
No pain on daily activities
Mild pain but no disability
Disabled during heavy activity
Disabled during light activity
1
8
8
5
1
5
6
10
Abdominal pain location (n)
Right upper quadrant
Right lower 
Left upper 
Left lower
5
9
3
5
7
9
2
4
BMI = Body Mass Index. 
aAlthough not contributing in the present cohort job related activities and pregnancy are considered etiologic 
factors.14 
Means are presented with (SD) and medians with (Range)
Table 1 Baseline patient demographics, pain characteristics (VAS, VRS) and disability scores
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Table 1 Individual patient data, - indicates no reduction or even increase of pain
Randomization 
number
VAS Pre  
Surgery
VAS Post  
Surgery
Relative  
reduction of 
VAS
VRS reduction Succes by 
definition
Neurectomie      
3 60 18 70% 2 Yes
5 69 9 87% 2 Yes
6 85 0 100% 3 Yes
7 30 0 100% 4 Yes
9 50 0 100% 3 Yes
14 74 14 81% 1 Yes
15 35 44 - 0  
16 34 35 - 0  
17 22 4 82% 2 Yes
19 29 11 62% 2 Yes
22 76 0 100% 3 Yes
23 36 0 100% 2 Yes
25 67 5 93% 3 Yes
26 56 5 91% 2 Yes
27 53 5 91% 3 Yes
29 35 16 54% 0 Yes
30 62 80  - 0  
35 31 38  - 0  
38 45 53  - 0  
40 76 78  - 0  
42 52 15 71% 2 Yes
43 35 9 74% 2 Yes
Sham      
1 12 83  - 0  
2 34 42  - 0  
4 29 27 7% 1  
8 72 45 37% 0  
10 94 83 12% 0  
11 68 4 94% 3 Yes
12 5 73  - 0  
13 65 72  - 0  
18 51 0 100% 3 Yes
20 47 68  - 0  
21 34 52  - 0  
24 32 44  - 0  
28 61 63  - 1  
31 62 55 11% 0  
32 38 10 74% 1 Yes
33 47 42  - 0  
34 52 47 11% 0  
36 24 51  - 0  
37 71 10 86% 2 Yes
39 55 81  - 0  
41 63 68  - 0  
44 58 38 44% 1  
VAS: Visual Analogue Scale, VRS: Verbal Rating Scale
Figure 3 Illustration of successful response (> 50% VAS difference and/or 2 VRS categories)  
 in two groups of patients with suspected ACNES, who either underwent a neurectomy  
 or a sham procedure (p = 0·001); Y-axis shows the number of patients
A double-blind, randomized, controlled trial on surgery for chronic 
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Discussion
The present trial is the first to demonstrate the efficacy of a neurectomy in patients 
with abdominal pain diagnosed with ACNES in a double blind, placebo controlled 
setting. Neurectomized individuals experienced significantly more often pain reduction 
compared to patients just undergoing a sham procedure. Since the number needed 
to treat is very low (treat 3 to cure 2), a reasonably limited surgical procedure such 
as an anterior neurectomy appears a very effective therapeutic option. Hitherto, the 
syndrome of ACNES is associated with skepticism that is fuelled by ‘scientific’ evidence 
provided by opinions of experts. For instance, a long lasting soothing effect after just 
one anesthetic injection is often reported in various abdominal wall pain syndromes 
including ACNES7, 9-13. Since the exact patient composition of reported cohorts frequently 
remained unspecified, a positive or confirmative selection bias process likely influences 
this beneficial outcome. These subjective observations have led critics to suggest that a 
placebo phenomenon might be involved. However, a placebo controlled trial in alleged 
ACNES was considered difficult to ethically justify5. If pain associated with ACNES 
was refractory to all conservative stratagems, surgery was deemed acceptable as a final 
resort and sometimes appeared successful2. The present trial demonstrates that a placebo 
effect can be ignored as the major contributing factor to surgical success in ACNES. A 
neurectomy should therefore be considered as a treatment option in desperate patients 
not responding to conservative strategies.
Although considered the gold standard in contemporary research, one may question 
the ethics of randomized trials including sham surgery. However, a number of studies 
including a sham surgical arm performed under Institutional Review Board approved 
settings have delivered important and sometimes untoward results in the last 60 odd years. 
For instance, ligation of the internal mammary as a means to improve heart blood flow 
appeared completely ineffective as demonstrated in the late 1950’s21. A more recent blind, 
sham-controlled trial showed no benefit of most commonly performed arthroscopic 
procedures for osteoarthritis.22 As uterine nerves contain sensory afferents originating 
in the pelvic area, ablation was a routinely performed and generally accepted treatment 
in women with chronic pelvic pain and dysmenorrhea. However, a surgical trial with 
a sham arm provided evidence of just a limited effect of uterine nerve transection on 
dysmenorrhea in the absence of endometriosis. In contrast, nerve removal was ineffective 
in non-dysmenorrhoeic or endometriotic chronic pelvic pain23, 24. A novel invasive 
procedure requires an ongoing process of monitoring and evaluations prior to a large 
scale implementation. A double blind controlled trial including a sham surgery arm is 
currently the most powerful tool for a safe introduction of such novel procedures in 
surgical practice. 
Findings of the present trial are in line with results of a recent study in ACNES 
patients demonstrating that 2 of 3 neurectomized patients are pain free after a 18 months 
follow up14. However, it is unclear why some patients fulfilling the strict set of 6 inclusion 
criteria did not benefit from surgery. In the present trial, a little over one fourth of the 
patients (6/22) receiving a neurectomy did not experience a significant pain reduction. A 
number of explanations may be forwarded. It is generally thought that nerve entrapment 
in ACNES is usually situated at the level of the superficial fascia of the rectus abdominis 
muscle. The injected anesthetic agent may have diffused towards more deeper located 
nerve portions leading to a successful pain response and subsequent study inclusion. As 
the neurectomy just included nerve end twigs piercing through ventral portions of the 
fascia, it may be that these surgical non responders have a type of ACNES characterized 
by nerve entrapment at dorsal or lateral portions of the muscle as hypothesized by 
others7. This theory is also supported by the observation that some non-responders in 
a retrospective cohort did benefit from a second neurectomy at the dorsolateral side of 
the rectus muscle, at the level of the nerve entering the rectus sheet14. Failure to identify 
neighboring end branches responsible for the abdominal pain may also explain some of 
the non-responders. A median number of 2 nerve branches were found in the present 
trial. Routine exploration of a 5 to 5 cm area of the ventral fascia is advised as a means to 
reduce the percentage of surgical failures. 
A small portion of the study patients (n=4) appeared free of pain although nerve endings 
were not removed during the sham operation. Interestingly, although satisfied with their 
level of pain at the 6 weeks postoperative evaluation, all 4 opted for a reoperation in the 
ensuing months as ‘the pain had recurred’. Three of these 4 reported a successful response 
after a true neurectomy. It is unclear why some patients experience beneficial effects of 
sham surgery. Some of the initial effects may be attributed to a placebo phenomenon. 
However, a plausible explanation may also be a long lasting anesthetic effect following the 
standard perioperative infiltration of the subfascial region and wound. Long-term pain 
reduction after local anesthetics in chronic abdominal pain syndromes is a commonly 
observed phenomenon. A lasting anesthetic effect far beyond the reported agent’s half-
life may be due to a blockade of nerve transmission. Moreover, local anesthetics may also 
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act upon sodium-channel isomers found on the nerve axons involved in chronic pain25. 
These findings support the necessary step of an injection scheme prior to embarking on 
more invasive treatment strategies for ACNES. 
Although the syndrome of ACNES has occasionally received attention in the literature 
on chronic abdominal pain (CAP), a prominent place on the list of possible etiological 
factors of CAP was never attained. ACNES still remains a frequently overlooked entity 
and patients are subjected to prolonged doctor’s delay2, 4, 12, 26, 27. The majority of patients in 
the present trial was referred to our clinic and also demonstrated a substantial median 13 
months diagnostic delay (a few even as much as >120 months). It must be stressed that the 
diagnosis of ACNES is a typical old-fashioned ‘clinical diagnosis’. It may be confidentially 
stated that patients harboring the triad of chronic abdominal pain, a circumscript pain 
point (in the presence of a positive Carnett’s test and/or local sensory disturbances) and 
absence of abnormalities in blood analysis or US/CT suffer from ACNES until proven 
otherwise. The diagnostic algorithm is simple and can be readily employed by an array 
of health providers treating CAP patients. The surgical procedure should be restricted to 
recalcitrant patients but is safe with few complications and it can be executed in a day care 
setting. Such a simple diagnostic and therapeutic approach will indeed cut costs as the 
number of unnecessarily performed specialist consultations and visceral investigations 
will be reduced12, 28. It is hoped that this study will contribute to an accelerated therapeutic 
pathway in patients with suspected ACNES.
We conclude that a ventral neurectomy is effective in a substantial part of patients 
with suspected ACNES failing to respond to a conservative treatment.
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Abstract
Background
Surgery is occasionally proposed in patients with chronic abdominal wall pain due 
to an anterior cutaneous nerve entrapment syndrome (ACNES) who are refractory 
to injection therapy. An anterior neurectomy may seem successful but follow-up is 
usually short and populations are small. Primary aim of this study was to determine 
the long-term success rate of surgery in a large ACNES population.
Methods
In this retrospective observational study, ACNES patients ≥18 years who underwent 
a primary anterior neurectomy between January 2004 and February 2012 in one 
single center were studied. Pain scores were obtained before surgery, after surgery 
and at the moment of questioning using a pain intensity numeric rating scale (PI-
NRS 0-10) and a 6-point verbal category rating scale (VRS). Success was defined as 
a ≥50% PI-NRS reduction or ≥2 point VRS reduction.  
Results 
Data of 181 neurectomies in 154 individuals were available for analysis (females, 
n=127, 82.5%; age 47±17 years, range, 20-83). Pain prior to surgery was severe (mean 
PI-NRS 8.08, SD 1.43). Short-term (1-3 months postoperative) success was 70% 
(127/181 procedures). Three subjects showed spontaneous remission of complaints 
after ≥3 months. After a mean 32 months (range 3–93) follow-up, a success rate of 
61% (109/180) on the long-term was found. 
Conclusion 
A 70% short-term success rate and a 61% long-term success rate following a primary 
anterior neurectomy in patients with chronic abdominal pain due to ACNES 
was attained. Surgery is the method of choice in ACNES patients refractory to a 
conservative regimen.
Introduction
Knowledge on the anterior cutaneous nerve entrapment syndrome (ACNES) as a 
neglected cause of chronic abdominal pain is limited1-13. ACNES patients experience 
severe neuropathic pain in the abdominal area that is caused by entrapped end twigs 
of intercostal nerves at the level of the anterior rectus sheath. Although abdominal pain 
is reported, they in fact suffer from pain originating in the abdominal wall. Patients 
harboring a triad of chronic abdominal pain, a circumscript pain point within the lateral 
boundaries of the rectus abdominis muscle (in the presence of a positive Carnett’s test 
and/or local sensory disturbances), and the absence of abnormalities in blood analysis 
or ultrasonography/computed tomography are likely to suffer from ACNES until proven 
otherwise.
Two recent trials have shed light on diagnostic and therapeutic specifics regarding 
this syndrome. Pain reduction following trigger point infiltration using an anaesthetic 
agent in suspected ACNES patients was based on an anaesthetic mechanism but not on 
a placebo, dry needling, or a mechanical (volume) effect9. In a subsequent double blind 
randomized trial using a sham surgical arm, neurectomy of the intercostal nerve endings 
at the level of the anterior sheath of the abdominal rectus muscle (‘anterior neurectomy’) 
was effective for pain reduction in most patients failing to respond to a conservative 
regimen10.
Once recognized, ACNES patients with unacceptable pain levels are advised to 
undergo a treatment regimen starting with one (or more) local trigger point injections. 
This approach is long-term effective in one-thirds of the population. Surgery such as 
an anterior neurectomy may be discussed with refractory patients. This step-by-step 
treatment protocol leads to total or substantial pain relief in eighty percent of the ACNES 
population8. Surgical success rates were encouraging on the short and median term. For 
instance, a 73% success rate was demonstrated 6 weeks postoperatively in 22 patients in 
a randomised controlled trial10. After 18 months of follow-up, a neurectomy was effective 
in 71% of 69 other individuals8. However, these populations were relatively small whereas 
the long-term efficacy of an anterior neurectomy is still a matter of uncertainty.
Neuroma formation with consequent recurrence of symptoms is a feared long-term 
sequela of any surgical procedure entailing a planned or accidental neurectomy14-17. 
The incidence of neuroma formation in neurectomized ACNES patients is unknown. 
Furthermore, a portion of initially ‘cured’ ACNES patients may experience recurrence of 
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pain once the effects of the local anaesthetic (that is administered as standard procedure 
following the neurectomy) wears off. Aim of the present study is to determine the 
long-term success rate of an anterior neurectomy in a large ACNES population. It is 
hypothesized that the majority of initially successfully neurectomized patient remain free 
of abdominal pain on the long term.
Materials ans methods
General information 
This retrospective observational study was performed between January 2011 and January 
2013, analysing neurectomies performed between 2004 and 2012, in Máxima Medical 
Center (MMC), a 595-bed community hospital situated in the southern part of The 
Netherlands. A separate surgical outpatient department of MMC (‘SolviMáx’ Center of 
Excellence for Abdominal Wall and Groin Pain) has a keen interest in chronic abdominal 
wall pain and groin pain syndromes (such as inguinal neuralgias and Pfannenstiel nerve 
entrapments) ever since the beginning of the new millennium. An increasing number of 
patients are evaluated by a team of experts4, 8-13, 18-23. In the year of 2012, some 250 ACNES 
patients were treated in SolviMáx.
Data collection
Electronically stored data of all abdominal wall pain and groin pain patients receiving 
a neurectomy in MMC over an 8 year time period between January 2004 and February 
2012 were retrospectively entered in a separate database. ACNES patients that were 
linked to registered operation codes were identified from this database. Only adult 
ACNES patients (≥18 year at time of treatment) registered as having undergone a primary 
anterior neurectomy were eligible for study (figure 1). A primary anterior neurectomy 
was defined as the first attempt to remove portions of end twigs of one (or more) of the 
intercostal nerves surfacing at the level of the anterior rectus muscle sheath via an open 
surgical procedure.
Patients meeting inclusion criteria were studied using a standard approach. 
Individuals that were operated between 2004 and March 2011 were invited to respond to 
a questionnaire containing a set of questions that was sent by mail between March-May, 
2011. Non-responders and patients operated between March 2011 and February 2012 
were additionally interviewed by phone by the first author using the same set of questions 
between July 2012 and February 2013. 
Surgical specifics of an anterior neurectomy
Patients are operated in same day surgery as previously reported8, 10. The ‘area of interest’ 
supposedly containing the nerves responsible for the pain is marked preoperatively on 
the basis of a combination of a successful response on previous trigger point infiltration, 
currently reported pain using palpation, Carnett’s test and altered skin sensibility24-26. 
After induction of general anaesthesia, the anterior sheath of the abdominal rectus 
muscle is exposed via a transverse 5-7 cm skin incision. The neurovascular bundle 
penetrating fascial foramina underneath the marked skin area is identified. The foramen 
is widened and the neurovascular bundle is removed over a 1-3 cm length. The proximal 
portion of the bundle is allowed to retract deeply into the rectus muscle. Additional 
nerve branches penetrating the rectus sheath within a 5-cm radius are also removed. 
Accompanying small vessels are ligated or coagulated. Widened fascial foramina are 
Figure 1 Study flowchart. Short and long term success following an anterior neurectomy for  
 ACNES. Numbers between parentheses represent procedures
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closed using a running absorbable suture followed by a standard closing technique of the 
remainder of the incision. The surgical area is infiltrated with 10 ml of 0.25% bupivacaine 
at the end of the procedure. A surgical procedure usually lasts between 30-60 minutes. 
Postoperative wound pain management included the continuation of paracetamol, non-
steroidal anti-inflammatory drugs or opiate analgesic drugs as also administered in the 
preoperative phase, or if deemed necessary. Patients were checked at least twice during a 
6 week postoperative time period, usually via a visit on the outpatient department and via 
a telephone consultation. Specifics and complications were recorded into the hospital’s 
electronic patient file.
Short and long term follow-up 
All study patients were retrospectively asked to report pain in the scar area as experienced 
in the immediate preoperative phase, pain levels at the postoperative 1-3 months time 
point (short term follow-up), and pain at present or at the moment of recurrent abdominal 
pain ≥3 months postoperative (long term follow-up). Both a 0-10 pain intensity numeric 
rating scale (PI-NRS) and a 6-point verbal categorical rating scale (VRS) (Table 1) were 
used27-30. 
Pain Intensity Numeric Rating Scale (PI-NRS)
0  –  1  –  2  –  3  –  4  –  5  –  6  –  7  –  8  –  9  –  10
No pain Excruciating pain
Verbal categorical Rating Scale (VRS) 
1  –  None
2  –  Mild
3  –  Discomforting
4  –  Distressing
5  –  Horrible
6  –  Excruciating
Short-term surgical success was defined as a ≥50% pain reduction using PI-NRS and/
or a minimal 2-point reduction using VRS at the postoperative 1-3 months time point, as 
suggested in previous studies8-10. All other scores were considered failures. For short-term 
failures who did not demonstrate pain reduction on the long-term, this time point was 
considered the endpoint of the study.
Long-term success was attained if present pain scores were ≤50% of preoperative pain 
levels using PI-NRS or if the present VRS was at least 2-point lower8. Conversely, data of 
short-term successful patients with recurrent pain (scores >50% of preoperative PI-NRS 
and <2-point lower VRS) that developed in proximity to the surgical scar at any moment 
between the primary anterior neurectomy and the long-term follow-up evaluation were 
studied in detail by three authors separately (TvA, RR, MS). If disagreement was initially 
present between these three, the decision on cause for long-term pain was eventually 
based on consensus.
Four types of abdominal pain on the long-term after an initial pain free period were 
distinguished:
1. ‘Recurrent disease’ was defined as the situation that an ACNES patient developed 
recurrent neuropathic pain in/underneath the scar area after a pain free period 
of ≥3 months following the primary anterior neurectomy. The surgical result was 
interpreted as long-term failure.
2. ‘Residual disease’ was defined as recurrence of (for the patient recognizable) 
neuropathic pain <3 months after the primary anterior neurectomy. The initial 
postoperative pain reduction was considered due the effect of the local anaesthetic 
being a standard element of the surgical procedure. These cases were interpreted 
as short-term surgical failures.
3. ‘De novo ACNES’: symptoms and signs of ACNES in an area at least 5 cm distant to 
the neurectomy scar, suggesting entrapment of a neighbouring intercostal nerve 
or a new ACNES on the contralateral side. However, pain was not experienced 
in the area of the primary anterior neurectomy. Therefore, the surgical result was 
interpreted as long-term successful.
4. ‘Abdominal pain other than ACNES’. Although subjects experience pain, this 
pain was not related to ACNES. The surgical result was interpreted as long-term 
successful.
Calculation of short and long-term success rates was made after patients with pain on 
the long-term after an initial pain free period were categorised.
Table 1 Pain scales 
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Table 2 Characteristics of surgical procedureRecall bias
As a form of recall bias was feared in this retrospective study design, pre and postoperative 
values as recorded in the electronic patient files (if available) were compared with recalled 
values as reported in the questionnaire. As pain scores were not registered routinely in 
all electronic patient files, prospectively registered pain scores were exclusively used to 
investigate the presence of recall bias. Conversely, only retrospectively obtained pain 
scores were used for the analysis of treatment success.
Data analysis
Data analysis was performed using SPSS 20.0 for Mac OS X. Changes in PI-NRS and VRS 
over time were compared individually to determine the operative success. Descriptive 
PI-NRS and VRS measures were presented as percentages, mean values (± SD) or median 
values (range) as appropriate. Differences in PI-NRS and VRS on various moments were 
calculated using a paired sample T-test (normal distribution) or Wilcoxon signed rank 
test (skewed distribution). Pearson correlation coefficients were calculated to determine 
the strength of linear dependence between the two variables.
Results
Study population
Between January 2004 and February 2012, 626 subjects with abdominal wall or groin 
pain underwent 806 neurectomies. Of these, a total of 214 primary anterior neurectomies 
were performed in 186 subjects with ACNES. As patients <18 year (n=16) were excluded 
and 3 patients had deceased, 195 procedures in 167 subjects were eligible for analysis. 
Questionnaire data from 93% procedures in 154 subjects were analysed (181/195, non-
responding n=7, no contact address n=7).
Most patients were female (n=127, 82.5%). The median age was 47±17 years 
(range, 20-83). Some 23 patients were operated twice for ACNES that was present in 
two different abdominal areas, whereas two subjects received surgery three times for 
ACNES originating in three different abdominal areas. Fifteen patients reported minor 
complications after the procedure (8%). A hematoma was conservatively managed in 10. 
One hematoma, one seroma and three wound abscesses needed surgical drainage in the 
remaining five patients (table 2).
Primary anterior neurectomies, n 181
Location of surgery, quadrant, n (%)
Right upper 
Left upper
Right lower
Left lower
Bilateral
22 (12)
18 (10)
93 (51)
40 (22)
8 (5)
Immediate postoperative complications, n (%)
Hematoma (conservative treatment)
Hematoma (surgical treatment)
Seroma (surgical)
Abscess (surgical)
15 (8)
10
1
1
3
Short-term and long term results
At the 1-3 months postoperative evaluation, some 132 procedures were by definition 
successful. Interestingly, 3 initially unsuccessful subjects became pain free in the ≥3 
months postoperative period. After a mean 32 months follow-up (range, 3–93; loss to 
follow-up, n=1), success was attained in 101 procedures, indicating (some degree of) pain 
had recurred after an initial pain free period in 33 primary anterior neurectomies. These 
33 primary anterior neurectomies were performed in 33 individuals.
Fate of patients (n=33) with long-term pain after an initial pain  
free period
Recurrent disease was diagnosed in 20 of these 33 patients following a mean 10-month 
period of success (range 3-48). A re-exploration in 15 of these 20 patients revealed a 
(histologically proven) traumatic neuroma in three. A wait and see policy was followed 
in the remaining 5 subjects. 
‘Residual disease’ was diagnosed in 5 patients, whereas ‘de novo ACNES’ was diagnosed 
in 6 additional patients (3 lower level, 1 higher level, 2 contralateral). Abdominal pain 
other than ACNES was diagnosed in two remaining patients.
Calculation of short-term and long-term success 
Short-term success of the primary anterior neurectomy was 70% (n=127/181). The long-
term success of the operation was 61% (n=109/181). Long-term failures (n=71) included 
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51 short-term failures and 20 recurrences. A 16% (n=20/127, figure 1) recurrence rate 
was thus calculated.
Levels of pain are depicted in figure 2. Interestingly, the short-term failure group 
(n=51) demonstrated postoperative scores that were significantly lower compared to 
preoperative level (postoperative 6.55 SD 2.10 vs. preoperative 7.67, SD 1.41; p=0.001). 
In the subgroup with recurrent disease (n=20), long-term pain levels were not different 
compared to preoperative levels (postoperative 8.15, SD 1.56 vs. preoperative 8.60, SD 
1.35; p=0.10).
pain (prospective: mean 2.45, SD 2.97, range 0-10 vs. retrospective: 3.26, SD 3.00 range 
0-9; p<0.001). These results indicate the presence of a structural but relative discrete recall 
bias effect, although it is appreciated that data were available in just half of the population. 
A high Pearson correlation coefficient was found between the two variables (ρ=0.91). 
No difference was found regarding this effect when subgroup analysis was performed on 
either the successful or the failure group (data not shown). 
Discussion
The present study in a large group of ACNES patients confirms a 70% short-
term surgical success rate of a primary anterior neurectomy as also found in smaller 
populations8, 10. The 61% long-term success rate with a mean 32 months follow-up period 
is acceptable. The 16% recurrence rate is a more reliable estimation compared to a 4% rate 
as reported previously in a smaller group with a shorter follow-up8. Patients should both 
be counselled on the 70% success rate on the short-term as on the substantial recurrence 
rate associated with the primary anterior neurectomy procedure on the long-term.
One study recently proposed a standard step-by-step treatment strategy for ACNES.8 
An anterior neurectomy is the alternative invasive option once injection therapy fails to 
confer success. This situation is real in 2 of 3 ACNES patients as approximately 30% remains 
permanently pain free after injection therapy only8. How should a 61% long-term success 
rate of a primary anterior neurectomy be judged? Such data should be viewed in the light 
of published 30-40% short-term success rates of pharmacological treatment strategies for 
chronic peripheral neuropathic pain31, 32. Unfortunately, most pharmacological treatments 
harbour unfavourable side effects whereas long-term efficacy is frequently not reported 
in these studies but is likely lower31-33. Evidence regarding alternative treatment options 
such as peripheral stimulation or deep brain stimulation for these pain syndromes is 
scarce34. On the contrary, an anterior neurectomy is a simple procedure with few minor 
complications (table 2). Confirming the conclusion of two relative small other reports, 
data of the here presented largest study to date (n=181) strongly supports the contention 
that a primary anterior neurectomy currently is the treatment of choice in ACNES 
patients that are refractory to the first step injection regimen8, 10. 
Sole aim of the present investigation was to study the outcome of the primary anterior 
neurectomy. In our SolviMáx Center of Excellence, knowledge on alternative treatment 
Figure 2 Pain reduction in 3 ACNES populations. In the short-term failure group,  
 the short-term postoperative measurement was the end-point of the study.  
 (*statistically significant; ns not significant, compared to pre-operative)
Recall bias
Pain scores (PI-NRS) that were prospectively obtained in the preoperative situation were 
obtained in half of the procedures (49%, 88/181). These values were consistently lower 
compared to retrospectively obtained values (prospective: mean 7.69, SD 1.22, range 5-10 
vs. retrospective: 8.28 SD 1.34, range 2-10; p<0.001). In addition, prospectively obtained 
postoperative values (43%, 77/181) were also lower compared to retrospectively obtained 
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options after recurrent or residual pain following an anterior neurectomy is building. 
Although high-level evidence is currently lacking, some of our patients benefitted from 
additional surgical explorations. Fifteen of the 20 recurrent pain patients underwent 
a second operation. In 3 of these, a histologically proven neuroma was found. Other 
patients with persistent pain were referred to alternative pain specialists. We are currently 
involved in studying the fate of these patients. However, it is essential that a number 
of recalcitrant patients require a multidisciplinary specialist team capable of offering 
multimodal treatment options.
An interesting observation is a significantly lower postoperative pain score in the 
‘failure group’. Although the neurectomy was a failure according to our strict definition 
(failure: current pain scores >50% by PI-NRS or <2-points attenuation by VRS compared 
to preoperatively), these patients experienced an attenuated pain level after the operation. 
This phenomenon may be related to mechanisms of recognition and confirmation. 
Merited attention for their problem may contribute to coping leading to acceptance and 
subsequently a lower pain perception.
This study potentially harbours flaws associated with its retrospective character. Due 
to recall bias, pain perception may change over time. As a result, retrospectively obtained 
PI-NRS and VRS scores possibly do not correctly reflect pain levels as experienced in 
the past. However, our results comparing retrospectively and prospectively collected data 
demonstrated a minimal difference in pain intensity over time (preoperative difference 
0.59 on a 0-10 point scale, postoperative 0.81). For the purpose of this study, the influence 
of recall bias was therefore neglected since just considerable pain reduction (≥50% PI-
NRS reduction and/or ≥ 2 point reduction on VRS) was relevant for the primary study 
aim. It was initially thought that, depending on the treatment result (success or failure), 
perception of pain would differ over time. However, results of the present study do not 
support this contention. 
We strongly feel that ACNES is still an overlooked entity although its existence is 
nowadays undisputed8-10, 12. In current practice with nearly unlimited diagnostic options, 
the need for proper physical examination in chronic pain patients may seem of minor 
importance. However, abdominal wall pain syndromes including ACNES are typical 
clinical entities that are diagnosed with the doctor’s ears and fingers. Patients reporting 
chronic abdominal pain with a circumscript pain point (trigger point) within the lateral 
boundaries of the rectus abdominis muscle (in the presence of a positive Carnett’s test and/
or local somatosensory disturbances surrounding the pain point) having normal blood 
results and no imaging abnormalities likely suffer from an abdominal wall syndrome 
such as ACNES. With Carnett’s test, the trigger point is localized and palpated using a 
finger. While the finger remains positioned onto the painful spot, tenderness increases 
when abdominal muscles are tensed as the patient lifts his/her head. Skin sensibility is 
tested by the use of a simple swab. Either a normal skin, hypoesthesia, hyperesthesia and 
sometimes even allodynia may be diagnosed. A cold alcohol gauze can also be used to 
test the vital sensibility. These simple tests greatly aid in arriving at a proper diagnosis of 
a neuropathic pain syndrome such as ACNES.
Pain specialists have long thought that ‘cutting nerves is just not done’. It is said that 
this type of surgery invariably leads to either post-dissection pain, de-afferentation 
pain or phantom pain. These pain syndromes are only amenable to medication with 
centrally working mechanisms. However, these concepts are challenged35. Also neuroma 
formation with consequent pain recurrence (occasionally more severe than ever) is a 
feared long-term result of any surgical procedure entailing a neurectomy14-17. The present 
analysis shows that these fears may not be true as levels of pain in these recurrences 
were comparable (and not worse) to preoperative values. On the other hand, short and 
long-term pain relief after a primary anterior neurectomy is far superior compared to 
any other treatment strategy for this type of severe neuropathic pain. Therefore, we 
propose to adhere to the current step-by-step treatment protocol (injections followed by 
surgery in non-responding patients) in future ACNES patients. This complete regimen 
of consecutive local trigger point injections followed by a primary anterior neurectomy 
in recalcitrant ACNES patients is long-term effective in about three-quarters of the cases. 
However, some patients stand a small chance of developing a new ACNES pain syndrome 
in another abdominal area as was demonstrated in this study.
Conclusion
A 70% short-term success rate and a 61% long-term success rate following a primary 
anterior neurectomy is reported in a large population of patients with anterior cutaneous 
nerve entrapment syndrome. Surgery is the method of choice in ACNES patients who are 
refractory to conservative pain treatment strategies.
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Abstract
Background
Injection treatment followed by an anterior neurectomy in patients insufficiently 
responding to an injection regimen is successful long term in three-quarters of 
patients with anterior cutaneous nerve entrapment syndrome (ACNES). The 
efficacy of secondary surgery, including re-exploration or a posterior neurectomy 
in patients reporting recurrent pain after initially successful surgery or following an 
immediately failed anterior neurectomy is unknown.
Methods
A database of ACNES patients receiving surgery between 2004 and 2012 in the 
SolviMáx institution was analysed. Adult patients with residual pain after an anterior 
neurectomy (failures) or with recurrent pain after initially successful surgery 
(recurrences) were selected. Following a re-exploration or a posterior neurectomy, 
pain was scored using a pain intensity numeric rating scale (PI-NRS 0–10) and a 
six-point verbal category rating scale (VRS). Success was defined as a ≥50 % PI-NRS 
reduction and/or ≥2 point VRS reduction. 
Results 
ACNES patients undergoing an anterior neurectomy (n=181) were analysed during 
the 8-year study period. At follow up, 51 patients reported unacceptable pain levels 
following an anterior neurectomy, whereas 20 developed recurrent abdominal wall 
pain. Of these 71 unsuccessful patients, 41 underwent secondary surgery including a 
re-exploration (n=10) or a posterior neurectomy (n=31). After a 25 months median 
follow-up, secondary surgical treatment regimens proved successful in 66% (27/41). 
Patients with recurrent pain did better (14/15) than patients who were immediate 
failures after the anterior neurectomy (13/26, p=0.01).
Conclusion 
Secondary surgery including re-explorations and posterior neurectomies are 
successful in two-thirds of ACNES patients with persistent pain or recurrence of 
pain after an anterior neurectomy.
Introduction
The anterior cutaneous nerve entrapment syndrome (ACNES) is a condition that is 
caused by entrapped intercostal nerves leading to local abdominal pain that is located 
within the lateral boundaries of the abdominal rectus muscle. ACNES is an universally 
neglected cause of chronic neuropathic abdominal pain. Several treatment options have 
been forwarded in recent years1-6. A regimen of consecutive local trigger point injections 
is long-term effective in one third of patients with ACNES1. In patients failing such a 
conservative regimen, an anterior neurectomy appeared successful in approximately 70% 
of operated patients1-3. After a >2.5 years median follow up, a 61% long-term efficacy rate 
was recently demonstrated in this population3. In all, some three-quarters of ACNES 
patients are reasonably pain free if a stepwise regimen including injections followed by 
anterior neurectomy is followed. Such a treatment protocol may presently be considered 
standard treatment1-3, 5, 7.
Despite superior results compared to other treatment options for peripheral 
neuropathic pain treatment, approximately one-quarter of the eventually neurectomized 
patients do not respond to surgery or do experience recurrent abdominal wall pain 
over time1-4. These unsuccessful patients reported a substantial 7-8 pain score on a 
0-10 pain intensity numeric rating scale3. No alternative treatment options apart from 
pharmacological pain strategies have been proposed for these populations8-10. In the 
SolviMáx center for abdominal wall and groin pain syndromes, alternative surgical 
treatment steps have been explored. If pain is still (or again) localized at the level of the 
abdominal wall, one may decide to inject anaesthetic agents in the painful area. If pain is 
temporarily relieved but recurs, a reexploration of the operated area may possibly allow for 
the identification and removal of persistent end twigs (secondary anterior neurectomy). 
Alternatively, removal of neurovascular bundles at the level of the posterior abdominal 
rectus fascia may theoretically offer relief (posterior neurectomy).
Aim of this retrospective study was to assess success rates of secondary surgical 
procedures in ACNES patients after a failed anterior neurectomy or who report recurrent 
pain after an initially successful anterior neurectomy. It is hypothesized that a substantial 
portion of these re-operated patients would benefit from secondary surgical procedures.
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Materials and methods
General study information
This retrospective observational study was conducted between July 2012 and January 
2013 in Máxima Medical Center (MMC), a 543-bed teaching hospital situated in The 
Netherlands. Staff members of the surgical department of MMC (‘SolviMáx’ Center of 
Excellence for Abdominal Wall and Groin Pain) have since long expressed an interest in 
the diagnosis and treatment of chronic abdominal wall pain and groin pain syndromes 
including inguinal neuralgias and post caesarean section nerve entrapments. Increasing 
numbers of patients are evaluated and treated by a team of experts in this center1-5, 11-19. 
It was judged that results of the present study were obtained as part of an evaluating and 
auditing process (patient response outcome measurement, PROM). Thus, approval by 
our local ethics committee was deemed not necessary.
Patient selection
All patients were evaluated on the basis of a standard history and physical examination. 
Selected patients were all previously diagnosed with ACNES using a set of common signs 
and symptoms1, 20-23. ACNES is characterized by (1) a constant site of anterior abdominal 
tenderness that is superficially located with a small (<2 cm2) area of maximal intensity, 
(2) this point of maximal pain can be localized by the tip of 1 finger (trigger point), and 
(3) tenderness increases by abdominal muscle tensing using the Carnett’s test. During 
this test, the trigger point is localized and palpated using a finger or a swab. Tenderness 
increases when the patient is asked to lift the head and abdominal muscles are tensed, 
suggesting its origin is probably located in the abdominal wall1, 21, 22. Typical findings such 
as a positive pinch test and the presence of local sensory disturbances in proximity to the 
trigger point strongly contributes to confirmation of the diagnosis1, 4, 19, 20. Once ACNES 
is considered as a cause of chronic abdominal pain, the diagnosis is confirmed by local 
infiltration using a short-acting anesthetic agent. A simple treatment regimen including 
injections and a neurectomy in injection regimen refractive patients is subsequently 
offered1.
Electronically stored data of all ACNES patients receiving an anterior neurectomy 
in the SolviMáx between January 2004 and February 2012 were entered in a database. 
An anterior neurectomy is defined as the first attempt to remove end twigs of intercostal 
nerves penetrating at the level of the anterior rectus muscle sheath via an open surgical 
procedure1-3. Pain levels using a 0-10 pain intensity numeric rating scale (PI-NRS) and 
a 6-point verbal categorical rating scale (VRS) were collected at various time points as 
previously reported (table 1)1-4. A total of 214 anterior neurectomies were performed 
during the 8 year time period. Data of 33 patients were not obtained (<18 year n=16, loss 
to follow up n=14, deceased n=3)3.Therefore, 181 primary anterior neurectomies were 
eligible for long term efficacy analysis.
From this database, two groups of ACNES patients were eligible for the present study. 
The first group consisted of patients who experienced persistent pain within the 3 months 
postoperative time period following the anterior neurectomy (‘failures’). Persistent pain 
was defined as a less than 50% pain reduction (using PI-NRS) and a less than 2-point pain 
reduction (using VRS) compared to preoperative pain levels. The second group consisted 
of patients who were initially successfully treated (by definition a ≥50% reduction using 
PI-NRS, and/or ≥2-point reduction using VRS) during the postoperative 3 months 
time period. However, pain recurred during follow up thereafter (‘recurrent disease’). 
Recurrent pain was defined as a less than 50% reduction (using PI-NRS) and a less than 
2-point reduction (using VRS) compared to the level prior to the anterior neurectomy3. 
Data of these two groups of patients (failures and recurrences) were studied in 
detail. Patients who decided to start again with conservative treatment regimens were 
excluded from analysis, mainly because these conservative treatment steps were received 
in facilities other than our center. As such, supervision on patient compliance and quality 
of care was deemed impossible. Moreover, the great variety of conservative treatment 
options including neurostimulation therapy, paravertebral blocks, and pharmacotherapy 
precludes a simple comparison with surgical therapy.
Subjects that did undergo additional surgery were interviewed by telephone by a 
researcher that was not involved in the surgical care (TvA). Perioperative pain levels (PI-
NRS and VRS) and current status of pain after the secondary surgery were obtained as 
previously reported3. Type of surgical technique (reexploration or posterior neurectomy) 
and complications were extracted from the electronic patient file.
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Table 1 Used pain measuring scales 
Pain Intensity Numeric Rating Scale (PI-NRS)
0  –  1  –  2  –  3  –  4  –  5  –  6  –  7  –  8  –  9  –  10
No pain Excruciating pain
6-point Verbal categorical Rating Scale (VRS) for pain characteristics 
1  –  None
2  –  Mild
3  –  Discomforting
4  –  Distressing
5  –  Horrible
6  –  Excruciating
Secondary surgical treatment strategies
Two surgical options were explored in persistently painful patients. If patient history 
and physical examination including local blocks suggested that the pain was due to the 
presence of previously unresected end twigs, the scar of the anterior neurectomy was 
reopened. Persistent neurovascular branches that were indeed found at the level of the 
anterior sheath of the abdominal rectus muscle were removed. This type of surgery is 
termed ‘secondary anterior neurectomy’. In essence, this technique is similar to a primary 
anterior neurectomy1-3.
An alternative procedure termed ‘posterior neurectomy’ was executed in the very 
same procedure if the secondary anterior neurectomy revealed no residual end twigs, 
or in a third procedure if a secondary anterior neurectomy again was not successful. 
During a posterior neurectomy, the intercostal nerve is identified at the level of the 
posterior sheath of the abdominal rectus muscle (figure 1). Characteristics of this surgical 
technique were not previously found in the surgical literature. 
Similar to an anterior neurectomy, patients are operated in day care or are hospitalized 
for one night. The pain trigger point is preoperatively marked onto the skin. After 
induction of general anaesthesia, the scar is reopened and the anterior rectus aponeurosis 
(consisting of the external oblique sheath and the anterior part of the internal oblique 
sheath) is incised. The rectus muscle is retracted medially allowing inspection of the 
posterior rectus sheath. At this level, the posterior rectus sheath usually consists of 
the posterior part of the oblique muscle sheath and the transverse fascia. At the lateral 
border, the neurovascular bundle enters the space quite obliquely, running over the 
posterior fascia and entering the rectus muscle more medially. A 2-4 cm portion of the 
intercostal nerve is removed while the remaining proximal nerve ending is allowed to 
retract. Accompanying vessels are coagulated or ligated. Following the procedure, the 
wound is closed in layers as appropriate and the wound is infiltrated with a long acting 
local anaesthetic (i.e. 10 cc of 0.25% bupivacaine). A posterior neurectomy usually lasts 
between 30-60 minutes.
This two-step surgical protocol in unsuccessfully operated or recurrent ACNES 
patients was not followed in two patients due to complicating factors as judged by the 
attending surgeon. As a consequence, these individuals were excluded from analysis.
Figure 1 Schematic (upper) and intraoperative (lower) impression of a secondary posterior  
 neurectomy of the intercostal nerve penetrating at the level of the posterior rectus  
 sheath in an ACNES patient (BMI 40, 125 kg) after a previous unsuccessful anterior  
 neurectomy at the level of Th10 (umbilicus) at the right side
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Data analysis
Data analysis was performed using SPSS 21.0 for Mac OS X. Changes in PI-NRS and 
VRS over time determined the success of operation. Fisher exact test was used to 
analyse the differences between surgical techniques or outcome. Differences in baseline 
characteristics between groups were tested using a χ2 test for categorical variables and a 
Student t test (normal distribution) or Mann-Whitney test (skewed distribution) in case 
of continuous variables. A p-value <0.05 was considered statistical significant.
Results
Patient selection
As reported in the materials and methods, 181 primary anterior neurectomies performed 
in SolviMáx between January 2004 and February 2012 were analysed for long term 
efficacy3. A total of 71 patients thereof met inclusion criteria of the present study (figure 
2). There was no loss to follow up. 
This group of 71 individuals contained 51 immediate failures after an anterior 
neurectomy and 20 patients with recurrent disease after an initially successful anterior 
neurectomy. 28 patients (24 failures and 4 recurrences) opted for a conservative treatment 
consisting of a wait-and-see policy supported by medication. The two-step secondary 
surgical protocol was not followed in 2 (1 failure, 1 recurrent pain). Consequently, the 
present study reports on data obtained from 41 patients (26 failures and 15 recurrences).
Surgical results
The majority of these 41 subjects was female (n=29, 71%; male n=12). Median age was 
43±16 years (range 20-77). Patient characteristics were not different compared to the 
conservatively treated group (n=28, female 89%, p=0.08; age 52±17 years; range 20-77, 
p=0.10).
A re-exploration (secondary anterior neurectomy) was executed in 10 patients leading 
to success in 3. A posterior neurectomy (as a third operation) after a failed secondary 
exploration in 2 additional patients proved successful in both. The re-exploration was 
not successful in the other half (n=5) of these patients. No additional explorations were 
performed in these 5 individuals. Of these, 4 decided to undergo treatment regimens 
provided by alternative health care facilities (pain clinic n=2, orthomanual therapy n=1, 
third opinion n=1). The fifth patient accepted the current pain level (PI-NRS = 5) as it was 
better compared to preoperatively (PI-NRS = 8). 
A posterior neurectomy was executed in the remaining 31 patients leading to success 
in 22 (22/31, 71% success rate). Therefore, the secondary surgical treatment protocol was 
overall successful in two thirds of the operated patient group (66%, 27/41; median 25 
months (range, 3–49) follow-up). PI-NRS scores of successful and unsuccessful subjects 
before secondary surgery protocol were comparable (successful 8.07, SD 1.33, range 5-10 
vs. unsuccessful 8.00, SD 1.18, range 5-10; p=0.82).
Figure 2 Flowchart of additional surgical treatment strategy in patients with either failure or  
 recurrent disease after a primary anterior neurectomy
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When focusing on the group of immediate failures after the anterior neurectomy, 
26 underwent secondary surgery. Surgical treatment was successful in 50% (13/26). 
In contrast, additional surgery appeared successful in 14 of 15 (93%) patients with a 
recurrence. Therefore, secondary surgery was more effective for recurrent pain than for 
residual pain (14/15 vs. 13/26, p=0.01).
Complications included one wound abscess requiring a surgical drainage procedure 
and one wound infection that was effectively treated with a seven-day course of 
antibiotics. 
Discussion
The present study in ACNES patients demonstrating severe pain after a failed anterior 
neurectomy or who experienced recurrent pain after an initially successful neurectomy, 
indicates that additional surgical procedures may be beneficial in two-thirds of the 
population. Furthermore, secondary surgery for recurrent ACNES pain is more effective 
compared to surgery for patients with residual pain. This difference may possibly be 
explained by disinhibition of central neural pathways in ACNES patients with residual 
pain24. Conversely, one third does not respond favourably. Medication may be of benefit 
in these individuals8, 9. Alternatively, neurostimulation therapy or paravertebral blocks 
may be explored as suggested by a number of case report studies10, 25-28. Pain physicians 
who are specialized in treating these chronic peripheral neuropathic pain populations 
should also explore these treatment options prior to deciding on secondary surgery. 
Data of the present study allow for a rough calculation of the overall ACNES treatment 
success rate in a dedicated institution. Recently, treatment efficacy of a combined 
stepwise approach including injections followed by surgery (if required) was reported1-4. 
Interestingly, a regimen of just consecutive local trigger point injections was long-term 
effective in 33% of investigated patients1. Surgical neurectomy was median term beneficial 
in 70% of injection-recalcitrant patients1, 2. Despite occasional recurrences, 61% of a large 
ACNES population remained satisfied on the long-term3. Although data were generated 
in different study populations, these results seem to confirm the great potential of a 
standard treatment protocol. The treatment protocol that is currently proposed consisting 
of injection therapy (step I) followed by an anterior neurectomy (step II) supplemented 
with secondary surgical options (step III) may lead to a 90% success rate (figure 3).
Figure 3 Flowchart of the total treatment protocol developed in recent years based on an 
 imaginary 100 patient cohort.
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Initially, scepticism was present regarding the potential salutary effect of secondary 
surgery including additional neurectomies in persistently painful patients. Despite our 
reservation however, secondary surgical attempts appeared successful in the majority of 
patients. An important issue during the surgical procedure such as the surgeon’s role 
requires addressing. For instance, nerve ends may have been missed during the anterior 
neurectomy. It should be appreciated that removing end twigs is a matter of balance. It 
makes sense that only nerves causing the pain are resected favouring a limited exploration. 
Based on the premise that a one-trigger-point-ACNES is a pain syndrome caused by 
entrapment of twigs of just one intercostal nerve branch, the surgeon should identify 
all branches of this specific nerve. However, these structures may look perfectly normal. 
Therefore, visual inspection does not help the surgeon to distinguish normal from 
entrapped branches. On the other hand, a policy of ‘not missing the causal nerve at any 
rate’ may lead to a more extensive nerve resection including (portions of) neighbouring 
intercostal branches. This approach potentially enhances the chance of post dissection 
pain and neuroma formation. Residual pain is thus possibly explained by a too limited 
resection during the anterior neurectomy.
Secondly, which surgical technique can be utilized once the plane superficial to the 
anterior rectus sheath is judged devoid of penetrating nerve endings and a re-exploration 
is on the verge of failing? One option is to explore the alleged entrapped intercostal nerves 
at a more proximal level. Interruption of the intercostal nerve at the level of the posterior 
rectus sheath entrance was found effective in a substantial portion of persistently painful 
patients. In fact, in the present paper we have described a novel surgical procedure that 
is not reported previously. However, the value of a posterior neurectomy as a surgical 
alternative equal to an anterior neurectomy in patients refractory to injections is 
questionable and is therefore currently under investigation.
The present study harbours flaws including retrospectively accumulated pain scores. 
Interestingly, a recent study evaluating differences in prospectively versus retrospectively 
generated pain data found only a negligible and clinically irrelevant influence on recall 
bias in this setting 3. Another flaw is the lack of specifics and follow up data of patients 
that opted for conservative treatment. The number of patients may also seem limited. 
However, this study is probably the only one as other studies on secondary surgery for 
ACNES were not identified in the literature.  
Conclusion
In the search for a sensible and logical stepwise approach in the treatment of ACNES, 
additional surgical strategies are beneficial in two-thirds of patients reporting pain after 
an anterior neurectomy. Patients with recurrence of pain do better than patients with 
residual abdominal wall pain. 
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Summarizing discussion
Abdominal wall pain syndromes such as the anterior cutaneous nerve entrapment 
syndrome (ACNES) have never received the attention that is deserved. Physicians from 
different specialties and countries have reported on this syndrome in the preceding 
century1-8. Unfortunately, these few studies have just resulted in a basic level of knowledge 
on abdominal wall pain syndromes. For instance, a 2006 survey in Dutch surgeons 
(n=425) and surgical interns (n=82, 35% response rate) revealed that 85% of respondents 
did not even know the syndrome at all. Of senior surgeons with >10 years of experience, 
just 18% was ever confronted with abdominal wall pain such as ACNES. Moreover, less 
than 9% of surgical interns was up-to-date with symptoms of the syndrome7. These 
numbers are unacceptably low, considering that exposure to this patient category in a 
surgical department may be high. Knowledge among non-surgical specialties may even 
be more limited.
ACNES is a typical neuropathic entrapment syndrome that is generally associated with 
high pain levels. As a consequence, each patient will consult a doctor. If not recognized 
(not unlikely considering the marginal awareness), a series of unnecessary costly 
diagnostic evaluations may be ordered by general practitioners and hospital specialists6,9. 
In one study, 418 diagnostic procedures were executed in 100 CAWP patients10. A 1994 
report demonstrated that an average workup amounted to a 680 US$ per CAWP patient5. 
Moreover, an astonishing 6727 US$ per patient was invested in futile diagnostic testing 
and hospital charges before arriving at the correct diagnosis in a 2001 CAWP study11. 
These data indicate that the economic burden of these entities is substantial.
In current practice with nearly unlimited diagnostic options, the need for a proper 
physical examination in chronic pain patients may seem of minor importance. However, 
abdominal wall pain syndromes including ACNES are characteristic ‘clinical entities’ 
that may be diagnosed with the doctor’s ears, eyes and fingers. In patients suffering from 
ACNES, a continuous sharp or burning pain with exacerbations dominates the picture12, 
13. Maximal tenderness is usually located on a ‘patient-characteristic’ spot within lateral 
boundaries of the rectus abdominis muscle. Onset of pain is often acute and is occasionally 
caused by previous surgery, pregnancy, sports or an abrupt movement. However, a clear 
cause is not found in about half of the patients12. Provoking factors are certain body poses 
and activity. Symptoms that mimic gastrointestinal organ dysfunction (‘pseudo-visceral’) 
can also be experienced in some individuals.
As ACNES is generally considered a typical ‘clinical syndrome’, physical examination 
is a most crucial step in the diagnosis. A constant site of abdominal tenderness with a 
small (<2 cm2, ‘finger tip’) area of maximal intensity situated is located at the level of the 
rectus abdominis muscle. Tenderness increases when these abdominal muscles are tensed 
while the patient lifts the head (Carnett’s test). Local sensory disturbances of the skin are 
frequently present. A so-called ‘pinch’ test (squeezing an overlying skin fold containing 
the patient’s skin and subcutaneous fat between thumb and index finger) will often unveil 
a very sensitive skin covering the area of interest compared to the contralateral side. If 
the diagnosis ACNES is deemed likely, the physician may perform a local pain point 
infiltration using lidocain or bupivacaine as a means to confirm the diagnosis. A regimen 
of consecutive abdominal wall injections is effective in some one-thirds of patients with 
ACNES12, 13. Surgical neurectomy is worthwhile in approximately two-thirds of the 
injection regimen-refractory patients. In total, eighty percent of an ACNES population 
reported total or substantial pain relief on after a median 18 months follow-up following 
this approach12. Chapter 1 provides a more detailed description of the background, 
diagnosis and treatment of ACNES.
The first main subject of this thesis focused on epidemiology and economic impact
of the syndrome. Patients who are labeled with a ‘diagnosis of exclusion’ such as the 
irritable bowel syndrome (IBS) may possibly suffer from a neglected abdominal wall 
syndrome such as ACNES. An IBS population is heterogeneous and harbors a variety 
of abdominal symptoms. According to the Rome III criteria, the diagnosis IBS is based 
on clinical symptoms in the absence of structural or tissue abnormalities. It is surprising 
that no criteria about physical examination are included. IBS patients by definition report 
abdominal complaints at least 3 days per month in the preceding 3 months. Moreover, 
the diagnosis is probable if two or more of the following criteria are fulfilled. The onset is 
associated with a change in frequency and/or appearance of stool, whereas symptoms are 
attenuated after defecation.14 It was hypothesized in the present thesis that some ACNES 
patients may be misdiagnosed as IBS and ACNES share symptoms. Chapter 2 reports 
on the construction and validation of a questionnaire that is able to distinguish patients 
with ACNES from IBS. A simple 18-item (0 - 18 points) questionnaire showed a 0.94 
sensitivity combined with a 0.92 specificity at a 10 points cut-off level.
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The study reported in chapter 3 demonstrates that ACNES may be diagnosed in some 
patients currently being treated for functional abdominal complaints such as IBS. In a 
cross-sectional analysis, 4 Dutch primary care practices employing physicians who were 
unaware of the existence of ACNES were selected. A total of 535 patients >18 years old 
who were registered with a functional abdominal pain diagnosis were approached when 
they were symptomatic to complete an 18-item questionnaire. From the 167 symptomatic 
responders, 18 individuals scoring above the earlier identified 10-point cutoff point 
underwent a diagnostic evaluation to establish their final diagnosis. Half of them were 
found to have a CAWP syndrome. Six subjects harbored characteristics that are typically 
associated with ACNES, corresponding to a 3.6% prevalence (95% CI, 1.7–7.6) in this 
responding population with alleged IBS (n = 167). Based on a Dutch prevalence of IBS 
and estimations on percentage of IBS patients consulting a doctor, a minimum half a 
million Dutch individuals were found to seek medical help15-18. On the basis of these 
assumptions, some 20 thousand Dutch individuals diagnosed as having functional 
abdominal pain in fact suffer from ACNES (95% CI, 9.500 – 42.000). Numbers of ACNES 
patients in primary care practices may even be higher as the present survey only focused 
on a small portion of the patient population. Findings in this study may be an eye-opener 
for general practitioners. 
The aim of the observational study that is reported in chapter 4 was to calculate 
the incidence of ACNES in patients presenting with abdominal pain in the emergency 
department (ED) of a Dutch teaching hospital. Together with obtained incidence 
numbers of patients evaluated in the surgical outpatient department a general incidence 
rate could be determined. Data sets of all patients visiting Máxima Medical Center’s 
(MMC) ED in 2011–2012 were searched for key terms ‘ACNES’, ‘intercostal neuralgia’ 
or ‘abdominal wall pain’. Files of potential patients living within hospital’s adherence 
area were checked using accepted criteria indicating the presence of ACNES. Disease 
incidence was calculated as a ratio to the hospital’s adherence data. The ACNES MMC 
2013’s incidence in patients living within the adherence area and evaluated in the surgical 
outpatient department was also calculated. During the 2-year study period, a total of 
88 patients belonging to MMC’s adherence area were diagnosed with ACNES leading 
to a mean 22/100.000 ACNES yearly incidence rate on the ED. This finding indicates 
that approximately 1 to 50 patients presenting with acute abdominal pain on an ED is 
found to suffer from ACNES. Furthermore, a 35/100.000 outpatient department ACNES 
incidence rate was calculated in the year of 2013. Combining these two ratios, a 1:1.800 
total ACNES incidence in the general population was obtained.
Some studies have attracted attention to an exceedingly high health care consumption 
in ACNES populations. However, these investigations were performed several decades 
ago in countries that differ from the Dutch health care system. An analysis of direct 
medical and indirect productivity costs in the year preceding the diagnosis in an ACNES 
patient population in a single hospital (MMC) was reported in chapter 5. Patients who 
were referred from outside the hospital’s adherence area and who received the new 
diagnosis ACNES between September 2012 and August 2014 in MMC were eligible for 
inclusion. Study subjects were invited to complete a medical consumption questionnaire 
(iMCQ) and a productivity consumption questionnaire (iPCQ). Numbers of health care 
consumption obtained from the iMCQ were multiplied with unit cost prices to attain 
direct diagnostic and therapeutic costs. Productivity losses were calculated by adding 
up the costs of absenteeism, presenteeism and unpaid work loss. Ninety-four patients 
fulfilled study criteria (female n=74, 79%, mean age 41 SD 17). Total direct health care 
costs in the year preceding the diagnosis was estimated to approximate €5,400 per patient. 
Extrapolation to total number of years of doctor’s delay resulted in direct medical costs 
of €16,600 per patient. A total of €13,800 of indirect costs per patient in the year before 
diagnosis was calculated, leading to a total of €19,200 in the year preceding the correct 
diagnosis. It is concluded that patients with ACNES are avid health care consumers in the 
year preceding their diagnosis. Earlier recognition will likely reduce unnecessary direct 
and indirect costs associated with the diagnostic and treatment approach.
The second main subject of this thesis is studying surgical treatment options in 
ACNES. Although approximately one third of ACNES patients is long-term successfully 
treated with an injection regimen, most patients experience recurrent complaints after 
such a conservative regimen. A surgical neurectomy was effective in about two thirds 
of the injection regimen refractory patients.19 Favorable results of a surgical neurectomy 
were, however, not yet demonstrated in a randomized controlled fashion. In chapter 6, 
adult patients diagnosed with ACNES were randomized to receive an anterior neurectomy 
or a sham (placebo) procedure via an open surgical procedure in day care. Both patients 
and principal investigator were blinded to the nature of surgery. Pain was recorded prior 
to surgery and 6 weeks postoperatively. A ≥50% reduction on a visual analogue (VAS) 
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scale and/or 2 points drop on a verbal rating scale (VRS) were considered ‘successful 
responses’. Forty-four patients participated between August 2008 and December 2010. 
In the neurectomy group, 16 of 22 patients reported a successful response. In contrast, 
significant pain reduction was obtained in just 4 patients in the sham group (p = 0.001). 
This study demonstrates that pain in most ACNES patients is caused by terminal branches 
of intercostal nerves.
An anterior neurectomy may seem successful but follow-up was short and 
populations were small. The primary aim of a cross sectional report (chapter 7) was to 
determine the long-term success rate of surgery in a large ACNES population. Patients 
who underwent a primary anterior neurectomy between January 2004 and February 2012 
were investigated. Pain scores were obtained before and after surgery, and at the moment 
of follow up using a pain-intensity numeric rating scale (PI-NRS 0-10) and a 6-point 
VRS scale. Success was defined as a ≥50% PI-NRS reduction or ≥2 point VRS reduction. 
Data of 181 neurectomies in 154 individuals were available for analysis. Short-term (1-3 
months postoperative) success was 70%. After a mean 32 months (range 3–93) follow-
up, a success rate of 61% was found. Consequently, a 16% (n=20) recurrence rate was 
observed. It was concluded that surgery is long-term successful in roughly two of three 
operated ACNES patients. 
Although the currently proposed treatment protocol (injections supplemented with 
an anterior neurectomy) is long-term successful in most ACNES patients, alternative 
treatment options for the remaining unresponsive quarter were never investigated. In 
chapter 8, the efficacy of secondary surgery including a re-exploration or a posterior 
neurectomy in patients reporting recurrent pain after initially successful surgery 
or following an immediately failed anterior neurectomy is studied. Adult patients 
with residual pain after an anterior neurectomy (failures) or with recurrent pain after 
initially successful surgery (recurrences) were selected from a database of 181 surgical 
neurectomies that were performed in MMC between 2004 and 2012. Following a re-
exploration or a posterior neurectomy, pain was scored using a pain intensity numeric 
rating scale (PI-NRS 0–10) and a six-point verbal category rating scale (VRS). Success was 
defined as a ≥50% PI-NRS reduction and/or ≥2 point VRS reduction. At follow-up, 51 
patients reported unacceptable pain levels following an anterior neurectomy, whereas 20 
developed recurrent abdominal wall pain. Of these 71 unsuccessful patients, 41 underwent 
secondary surgery including a re-exploration (n=10) or a posterior neurectomy (n=31). 
After a median 25-month follow-up, these secondary surgical treatment regimens proved 
successful in 66%. Patients with recurrent pain did better (14/15) than patients who were 
immediate failures after the anterior neurectomy (13/26, p=0.01). It was concluded that 
secondary surgery is worthwhile in ACNES patients who did not respond to a treatment 
protocol including injections supplemented with an anterior neurectomy. 
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Conclusions of this thesis
1. An 18-item questionnaire is a useful tool to prospectively identify patients with 
abdominal wall pain who were earlier diagnosed as having functional abdominal 
pain (sensitivity 0.92, specificity 0.94).
2. A clinically relevant portion of patients diagnosed with a functional abdominal 
pain diagnosis in a general practitioner’s setting actually suffers from ACNES 
(prevalence 3.6%, CI 1.7 – 7.6%).
3. The incidence of acute ACNES patients in an emergency department (ED) of a 
regional teaching hospital is 22/100.000 per year indicating that approximately 
2% of patients presenting on an ED with acute abdominal pain suffers from 
ACNES. The general incidence of ACNES is estimated at 1:1.800 suggesting that, 
in the Netherlands alone, some 9.500 unique patients may be diagnosed with 
ACNES yearly.
4. Patients with ACNES are avid health care consumers in the year preceding their 
diagnosis (€5,400 per patient). Extrapolation on the basis of years of doctor’s 
delay resulted in direct medical costs of €16,600 per patient. As a total of €13,800 
of indirect costs per patient in the year before diagnosis was calculated, a total of 
€19,200 in the year preceding the correct diagnosis was spent per ACNES patient. 
5. Neurectomy of intercostal nerve endings at the level of the abdominal wall 
effectively reduces pain in ACNES patients failing a conservative regimen. A 70% 
short-term success rate and a 61% long-term success rate after a primary anterior 
neurectomy are attained.
6. Secondary surgery including re-explorations and posterior neurectomies are 
successful in two-thirds of ACNES patients failing a combined injection-anterior 
neurectomy regimen.
Future perspectives
Basic information regarding incidence, prevalence, diagnosis and treatment for 
ACNES is sketchy. Efforts initiated in our SolviMáx expertise center are aimed at closing 
basic gaps in this knowledge. A growing number of referred patients provides us with 
a unique possibility to answer important future research questions. A ‘no nonsense’ 
practical approach in SolviMáx gave way to the development of a standard treatment 
protocol in ACNES that appeared to suit most patients suffering from this abdominal 
wall pain syndrome. However, a small minority of patients did not benefit, no matter 
what was done. 
One future research interest is related to studying this group of non-responders. 
Important questions such as ‘how did they respond on injection therapy?’, ‘what was their 
duration of complaints?’, ‘which signs during physical examination were present?’ must 
be answered. By possibly recognizing patterns in responders versus non-responders, 
prognostic factors may be identified. Potential subtypes of ACNES may exist. Children 
with ACNES potentially form a subgroup that may behave differently8. Etiology of 
adolescent ACNES is possibly more mechanical leading to just symptoms at the level of 
the anterior branch of the intercostal nerve, compared to an adult population. In an ideal 
situation, prognostic factors are determined on an individual level leading to a patient-
specific approach. Furthermore, as many patients report (pseudo) visceral complaints 
that recover after a successful ACNES treatment, the role of segmental relations (viscero-
afferent and vice versa) should be investigated and elucidated.
The current thesis also focused on the burden of ACNES in terms of societal cost. 
However, studies also demonstrated a substantial inability to fulfill normal daily activities 
as reflected by high rates of sick leave and efficiency losses of paid work.  Moreover, it 
is likely that a delay in diagnosis and inappropriate treatment will also seriously affect 
quality of life. The role of psychological factors in ACNES should be studied more 
intensively. Future studies are required to attain a complete evaluation of altered health 
status in ACNES patients.
A specific quality of a non-academic center such as MMC is a somewhat down-to-
earth and pragmatic approach of most medical issues. As such, a frequently overlooked 
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abdominal pain syndrome lacking a structured diagnostic approach and treatment 
protocol was identified. Subsequently, a scientific program focused on improving 
recognition, diagnosis and treatment was developed. Several contributions in leading 
journals enabled physicians to follow a proposed step-by-step treatment protocol. 
Surgical treatment results were superior compared to treatment strategies in other 
chronic peripheral neuropathic pain populations20, 21. All these efforts were established 
in a relatively short time frame. However, it must be appreciated that a number of basic 
fundamental questions require answering. Future basic research, together with an 
academic partner, should focus on nerve anatomy and pathophysiology of the syndrome. 
According to a logical stepwise research approach, reverting to basal research may seem 
as ‘one-step-back’. However, results from these basic studies may allow for new ideas 
expanding knowledge on classification and treatment of this intriguing syndrome. 
An improved understanding of nerve anatomy may give clues for the development of 
alternative surgical techniques. As showed in this thesis, some patients benefitted from 
a novel surgical technique termed a ‘posterior neurectomy’. The intercostal nerve is 
identified at the level of the posterior sheath of the abdominal rectus muscle. A successful 
response in a portion of these patients suggests that the posterior rectus sheath may also 
serve as a possible site for entrapment. Consequently, it is hypothesized that a posterior 
neurectomy may be a better choice as initial surgical step in injection regimen refractory 
patients. With expanding knowledge regarding anatomy of the intercostal nerve, more 
proximal neurectomies using a laparoscopic approach may be worthwhile in some 
patients. These alternative options should be studied in the near future.
It is appreciated that the present future perspectives are exclusively presented 
from a surgical point of view. Additional treatment options lie outside of the surgical 
spectrum. Medication may be of benefit in some ACNES patients but structured studies 
are currently lacking20, 21. Neurostimulation therapy or paravertebral blocks may also be 
explored as suggested by a number of case report studies, as well as manual therapy22-26. 
In our practice, these treatment steps are currently investigated once an unsuccessful 
surgical treatment is at hand. But it may be worthwhile to initiate these strategies as a first 
step in the treatment process.
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Introduction
The anterior cutaneous nerve entrapment syndrome is a frequently overlooked, and 
to many physicians, a largely unknown entity1-3. Over the last century, just a handful of 
physicians have reported on a limited number of aspects of this painful syndrome3-11. 
Most contributions focused on clinical presentation, diagnosis and basic treatment 
options. Although these papers undoubtedly had educational value, they did not lead 
to a permanently increased awareness among physicians. The present work highlights 
the ACNES incidence and prevalence in certain populations, and the socio-economic 
impact of a disease that causes pain. The cost due to medical consumption and loss of 
productivity as a consequence of having an unrecognised disease are investigated. The 
most important aspect of it all is to ‘increase awareness’ among general practitioners 
as well as a wide variety of medical specialists such as internists, gastroenterologists, 
emergency physicians, gynaecologists, urologists and paediatricians. We therefore 
chose to not only publish our work in surgical journals but also in journals for general 
practitioners, gastroenterologists and emergency medicine physicians. Our work was 
also presented on several national and international meetings of different specialties. 
Furthermore, information appeared in national newspapers and TV media over the last 
years whereas a website was launched containing information for both patient and doctor 
(www.buikpijn.nl).
Socio-economic relevance
As concluded in chapter 5, in the year preceding the diagnosis ACNES patients consume 
on average €5,400 on health care costs and have an average productivity loss of €13,800. 
Based on a calculated 57:100.000 ACNES incidence rate (chapter 4), costs of illness 
can be approximated12. When extrapolated to the Dutch population (2015, 16.900.000 
inhabitants), some 9.500 new ACNES patients may be identified yearly13. On the basis of 
these assumptions, total yearly costs associated with ACNES in The Netherlands can be 
estimated at €182.4 million (€51.3 million direct medical costs and €131.1 million indirect 
non-medical costs), assuming that all newly diagnosed ACNES patients experience a 
similar burden of disease, which is not necessarily true. However, the calculated incidence 
rate (chapter 4) was also based on ACNES patients with severe complaints, since they all 
consulted an outpatient department or an emergency department for unacceptable pain12. 
If all these patients would undergo a diagnostic and treatment regimen as proposed 
in the present thesis (± €2,800 on average per patient for diagnosis and treatment), 
direct medical costs are calculated at €26.6 million per year. An indirect non-medical 
cost calculation cannot reliably be determined, but a maximum half a year treatment 
period (including waiting time prior to first evaluation as well as time periods between 
treatment steps) is reasonable. Assuming similar productivity losses as calculated in this 
thesis, early detection and treatment would lead to an estimated yearly €80-100 million 
cost reduction. Thus, it can safely be concluded that earlier recognition will substantially 
reduce both the suffering amongst individuals as well as reduce unnecessary direct and 
indirect societal costs. Indeed, ‘Carnett cuts costs’14.
Relevance in the medical field
The studies in this thesis are just based on incidence and prevalence in The Netherlands. 
It is reasonable to assume that ACNES is also common and underdiagnosed in the rest of 
the world. Over the last few years we have received requests for help (e-mail consultations 
or personal visits) from patients and physicians from other parts of the world (USA, 
United Kingdom, Sweden, Greece, South Africa, Germany, Belgium, Denmark). The vast 
majority of patients had learned about us through the internet or through physicians 
who had read our publications. In these patients a provisional diagnosis of ACNES was 
established. A common question was whether we knew a physician or pain specialist in 
their respective country who was knowledgeable and willing to treat this pain entity. We 
discovered that the number of physicians who treat ACNES worldwide is exceedingly 
limited. As a result, a handful of foreign patients (i.e. US and UK) came to the SolviMáx 
center for treatment.
The first few chapters focused on epidemiological aspects of the syndrome and 
provided more solid data compared to previous reports that were mostly based on 
personal experiences of individual physicians4, 15-17. The results of the present thesis will 
aid in recognising the syndrome and allow for a standard inclusion of ACNES in the 
differential diagnosis of abdominal pain. In a hypothetical ideal situation, each physician 
is aware of the existence of the syndrome and recognises its characteristic symptoms ‘at 
first sight’. If so, a long and frustrating (for both doctors and patients) diagnostic process 
is prevented whereas patients do get a tailored approach in an early phase of the illness. 
Apart from the enormous societal cost reduction as earlier discussed, a serious reduction 
in disease burden (both duration and severity of complaints) amongst ACNES patients 
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can be achieved. Currently, some patients are labelled with psychosomatic disorders 
when the pain is not recognised as due to ACNES. As a consequence, these patients feel 
frustrated and ignored leading to uncertainty and depression.
A regimen of consecutive abdominal wall injections followed by surgery in resistant 
cases is the method of choice as demonstrated in a cohort of 139 ACNES patients18. In 
the present thesis, the efficacy of the anterior neurectomy is unequivocally demonstrated 
by a randomised controlled trial and by studying the long-term results of the technique. 
A novel second invasive treatment step (‘posterior neurectomy’) is added to the existing 
surgical protocol leading to improved overall results. As a consequence, some 90% of 
ACNES patients can now be treated successfully. Most of these patients are able to return 
to normal daily activities instead of living the life of a chronic pain patient.
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Samenvatting
Het onderwerp ‘buikwandpijnsyndromen’, waaronder het ‘anterior cutaneous nerve 
entrapment syndrome’ (ACNES) heeft nooit de aandacht gekregen die het eigenlijk 
verdient. In de afgelopen eeuw is er toch af en toe vanuit verschillende disciplines en 
landen gepubliceerd over dit syndroom1-8. Helaas heeft dit beperkt aantal studies niet 
geleid tot een voldoende kennisniveau omtrent buikwandpijnsyndromen. Een enquête 
onder Nederlandse chirurgen (n=425) en chirurgen in opleiding (n=82, 35% respons 
ratio) in 2006 toonde bijvoorbeeld aan dat 85% van de ondervraagden niet bekend was 
met dit pijnsyndroom. Van de chirurgen met >10 jaar ervaring gaf slechts 18% aan ooit 
geconfronteerd te zijn geweest met een buikwandpijnsyndroom zoals ACNES. Ook 
was slechts 9% van de chirurgen-in-opleiding bekend met de symptomen hiervan7. 
Deze percentages zijn onacceptabel laag, ook al omdat patiënten met deze klachten 
vaak worden verwezen naar een chirurg. Het vermoeden is dat kennis bij andere, niet 
chirurgische, specialismen mogelijk nog beperkter is.
ACNES is een typisch neuropatisch pijnsyndroom dat is geassocieerd met een 
hoog pijnniveau, waardoor de meeste patiënten medische hulp zullen zoeken. Als de 
geconsulteerde arts het syndroom niet herkend (gezien het bovenstaande niet ondenkbaar), 
worden vaak onnodige en kostbare diagnostische onderzoeken verricht op verzoek van 
huisartsen en medisch specialisten6, 9. Eén studie toonde aan dat er niet minder dan 418 
diagnostische procedures waren uitgevoerd bij 100 buikwandpijnpatienten10. Een ander 
onderzoek uit 1994 liet zien dat de work-up van een buikwandpijn-patiënt gemiddeld 
US$ 680 kostte5. Een derde onderzoek uit 2001 toonde aan dat een bedrag van maar liefst 
US$ 6727 per patiënt werd uitgegeven aan (uiteindelijk) niet bijdragend diagnostisch 
onderzoek en ziekenhuiskosten vóórdat de juiste buikwandpijn gerelateerde diagnose 
werd gesteld11. Deze onderzoeken tonen onafhankelijk van elkaar aan dat de economische 
belasting van diagnostische entiteiten, zoals uitgevoerd voor ACNES, substantieel is.
In de huidige medische praktijk met een bijna ongelimiteerde toegang tot diagnostische 
middelen, lijkt de rol van een gedegen lichamelijk onderzoek minder belangrijk te zijn 
geworden. Een buikwandpijnsyndroom zoals ACNES is echter juist een typisch voorbeeld 
van een klinisch syndroom, dat moet worden vastgesteld op basis van de bevindingen 
uit een gedegen anamnese en lichamelijk onderzoek. ACNES-patiënten hebben een 
karakteristiek verhaal van een continu scherpe of brandende pijn, die in bepaalde situaties 
of houdingen toeneemt12, 13. Het gebied van de maximale pijn is normaliter zeer plaatselijk 
en bevindt zich binnen laterale grenzen van de musculus rectus abdominis. De pijn is 
vaak op een acuut moment ontstaan, na bijvoorbeeld een operatie, een zwangerschap, 
sportbeoefening of een onverwachte beweging. Echter, in ongeveer de helft van de 
patiënten kan de oorzaak niet goed achterhaald worden12. Specifieke houdingen en 
lichamelijke activiteit kunnen de klachten verder uitlokken. Ook kunnen symptomen 
die een orgaan-gerelateerd probleem doen vermoeden (misselijkheid, opgeblazen gevoel, 
obstipatie, etc.), voorkomen.
ACNES is dus bij uitstek een typisch klinisch syndroom, waarbij het lichamelijk 
onderzoek cruciaal is voor de diagnose. Er is sprake van een pijnlijk gebiedje in de buik 
met een klein maximaal pijnpunt (<2 cm2, ‘top van een vinger’) binnen de grenzen van 
de rectus abdominis spier. De pijn neemt toe op het moment dat de onderzoeker het 
maximale pijnpunt palpeert terwijl de patiënt de buikspieren aanspant (Carnett’s test). 
Sensibiliteitsstoornissen rondom het pijnpunt zijn vaak aanwezig. De zogeheten ‘pinch 
test’, waarbij een kleine huidplooi ter hoogte van het pijnpunt tussen duim en wijsvinger 
wordt vastgepakt, veroorzaakt vaak een vervelende pijnsensatie vergeleken met de niet 
aangedane zijde. Als de diagnose ACNES waarschijnlijk wordt geacht, kan infiltratie 
van de buikwand met lidocaïne of bupivacaïne worden overwogen om de diagnose te 
bevestigen. Een serie van 2 of 3 injecties (vaak met 1-2 weken tussenpozen) is blijvend 
effectief bij ongeveer 1/3e van de ACNES-patienten12, 13. De tweede behandelstap bij 
patiënten die niet blijvend gunstig reageren op injecties is een chirurgische neurectomie, 
die bij ongeveer 2/3e van de overgebleven patiënten effectief is. Dit behandelprotocol 
heeft geleid tot een totaal succespercentage van ongeveer 80% bij 139 ACNES patiënten 
met een mediane follow up van 18 maanden12. Hoofdstuk 1 (chapter 1) geeft een meer 
gedetailleerde omschrijving van achtergrond, diagnose en behandeling van ACNES.
Het eerste hoofdthema van dit proefschrift is gericht op het bestuderen van de 
epidemiologie en de economische impact van ACNES. Patiënten waarbij een ‘diagnose 
per exclusionem’ zoals het prikkelbare darmsyndroom (PDS) werd vastgesteld of 
vermoed, lijden mogelijk aan een buikwandsyndroom zoals ACNES, hetgeen tot dan toe 
over het hoofd is gezien. Een PDS populatie is heterogeen en bevat een grote variëteit 
aan symptomen en klachten. Volgens de Rome III criteria is de diagnose PDS gebaseerd 
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op een combinatie van klachten, zonder de aanwezigheid van structurele anatomische 
afwijkingen. Verrassend genoeg zijn er geen bevindingen uit het lichamelijk onderzoek 
opgenomen in de Rome III criteria. Volgens de definitie moeten PDS patiënten ten 
minste 3 dagen per maand in de afgelopen 3 maanden buikpijnklachten rapporteren. 
De diagnose PDS kan worden gesteld als er aan 2 of meer van de volgende criteria 
wordt voldaan. De buikpijnklachten ontstaan met een verandering in frequentie en/
of consistentie van de ontlasting, waarbij de klachten verminderen na stoelgang14. De 
hypothese in het huidige proefschrift is dat sommige ACNES patiënten mogelijk onjuist 
als PDS zijn gediagnosticeerd, aangezien PDS en ACNES overeenkomstige symptomen 
kunnen hebben. In hoofdstuk 2 (chapter 2) worden ontwikkeling en validatie van een 
vragenlijst beschreven, die in potentie onderscheid kan maken tussen patiënten met 
ACNES en PDS. Een simpele lijst van 18 vragen (0 – 18 punten) blijkt een sensitiviteit 
van 0.94 te hebben, gecombineerd met een specificiteit van 0.92 bij een afkapwaarde van 
10 punten. Deze vragenlijst kan dus effectief beide patiëntengroepen onderscheiden. 
De studie die wordt beschreven in hoofdstuk 3 (chapter 3) laat zien dat ACNES-
patiënten inderdaad onterecht gediagnosticeerd kunnen worden met een functionele 
buikpijndiagnose zoals PDS. Vier Nederlandse huisartsen die niet van het bestaan van 
ACNES afwisten werden geselecteerd in deze cross-sectionele analyse. 535 patiënten 
ouder dan 18 jaar die in deze praktijken waren geregistreerd met een functionele 
buikpijndiagnose werden benaderd om de ontwikkelde 18 item vragenlijst in te vullen. 
Van de 167 symptomatische respondenten scoorden 18 individuen boven de vastgestelde 
afkapwaarde van 10 punten, en hadden dus mogelijk een buikwandpijnsyndroom. 
Zij ondergingen een diagnostische evaluatie bestaande uit anamnese en lichamelijk 
onderzoek om tot een definitieve diagnose te komen. De helft van deze patiënten (n=9) 
bleek inderdaad een buikwandpijnsyndroom te hebben, en 6 hiervan voldeden aan de 
kenmerken van ACNES, hetgeen overeenkomt met een prevalentie van 3.6% (95% CI, 
1.7–7.6) binnen de onderzochte prikkelbare–darm-populatie. Gebaseerd op de geschatte 
prevalentie van PDS (Nederlands Huisartsen Genootschap), zoekt in Nederland ongeveer 
een half miljoen mensen met PDS medische hulp voor hun buikpijnklachten. Op basis 
van deze aanname is het mogelijk dat zo’n 20 duizend individuen, bij wie eigenlijk de 
diagnose PDS is gesteld, in werkelijkheid lijden aan ACNES (95% CI, 9.500 – 42.000). 
De totale aantallen ACNES-patiënten in huisartsenpraktijken in het algemeen zijn 
mogelijkerwijs nog hoger, aangezien bij deze studie alleen is gekeken binnen de PDS 
populatie en niet bij andere (buik)pijn-patiënten. Resultaten in deze studie kunnen een 
eyeopener voor huisartsen zijn.
Het doel van de observationele studie van hoofdstuk 4 (chapter 4) is om een indruk te 
krijgen van de incidentie van ACNES op de spoedeisende hulp (SEH) van een Nederlands 
opleidingsziekenhuis. Samen met de verkregen incidentiecijfers van patiënten die werden 
geëvalueerd op de chirurgische polikliniek kan zo een algemene incidentie worden bepaald. 
Eerst werden patiënten die de SEH van Máxima Medisch Centrum (MMC) in 2011 of 
2012 bezochten met de zoektermen ‘ACNES’ ‘intercostaalneuralgie’ en ‘buikwandpijn’ 
geïdentificeerd. Dossiers van potentiële patiënten die binnen het adherentiegebied 
van het ziekenhuis woonden, werden beoordeeld op de aanwezigheid van ACNES 
aan de hand van bestaande en geaccepteerde criteria van anamnese en lichamelijk 
onderzoek. De ziekte-incidentie kon vervolgens worden bepaald aan de hand van het 
eigen MMC-adherentiegebied met de daarbij behorende patiëntaantallen. De incidentie 
van ACNES-patiënten die in het daaropvolgende jaar (2013) via de polikliniek werden 
gediagnosticeerd, werd op een gelijke wijze berekend. Gedurende de studieperiode van 
2 jaar, werd bij 88 patiënten binnen het adherentiegebied van MMC na een SEH-bezoek 
de diagnose ACNES gesteld, hetgeen neerkomt op een jaarincidentie van 22/100.000. Dit 
betekent dat ongeveer 1 ACNES diagnose wordt gesteld per 50 patiënten die zich met 
acute buikpijn melden op de SEH. Hiernaast kon over 2013 een 35/100.000 jaarincidentie 
worden bepaald van ACNES patiënten die via de polikliniek werden geëvalueerd. Het 
combineren van deze twee incidentiematen leidt tot een totale ACNES incidentie van 
1:1.800 per jaar in de algemene populatie.
Eerdere studies hebben de hoge diagnostische kosten bij ACNES-patiënten al onder 
de aandacht gebracht. Deze onderzoeken dateren echter van decennia geleden en zijn 
uitgevoerd in buitenlandse gezondheidssystemen. Een analyse van directe medische en 
indirecte productiviteitskosten in het jaar voorafgaande aan de diagnose in een ACNES-
populatie wordt beschreven in hoofdstuk 5 (chapter 5). Patiënten die van buiten het 
adherentiegebied van MMC kwamen en waarbij de diagnose ACNES in MMC werd 
gesteld tussen september 2012 en augustus 2014 waren geschikt voor studiedeelname. 
De onderzoekspersonen werden verzocht een medische consumptie vragenlijst (iMCQ) 
en een productiviteitsvragenlijst (iPCQ) in te vullen. De aantallen uit de zorgconsumptie 
vragenlijst werden vermenigvuldigd met de kostprijs per eenheid, om zo de diagnostische 
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en therapeutische kosten te kunnen berekenen. Productiviteitsverliezen werden 
gecalculeerd door kosten van absentie, productiviteitsverlies zonder absentie en verlies 
van onbetaalde arbeid bij elkaar op te tellen. 94 patiënten voldeden aan de studiecriteria 
(vrouw n=74, 79%; gemiddelde leeftijd 41 jaar, SD 17). Totaal berekende kosten van 
zorgconsumptie kwamen neer op gemiddeld €5,400 per patiënt. Extrapolatie naar de totale 
klachtenduur voordat de diagnose werd gesteld (mediaan ongeveer 4 jaar), leidde tot een 
gemiddelde van €16,600 aan directe zorgkosten per patiënt. De productiviteitsverliezen 
werden berekend op €13,800 per patiënt in het jaar vóórdat de diagnose werd gesteld. 
Deze calculaties leiden tot een totaal van €19,200 aan kosten in het jaar vóór de diagnose 
ACNES per patiënt. Concluderend kan gesteld worden dat ACNES-patiënten een hoge 
zorgconsumptie en veel productiviteitsverliezen vertonen in het jaar voorafgaand aan 
de diagnose. Eerdere herkenning van dit syndroom zal deze kosten waarschijnlijk sterk 
verminderen.
Het tweede hoofdonderwerp van dit proefschrift betreft de chirurgische behandeling 
van ACNES. Hoewel ongeveer 1/3e van de ACNES-patiënten op de lange termijn succesvol 
met behulp van lokale injecties kan worden behandeld, ervaren de meeste andere 
patiënten geen blijvend resultaat van deze initiële behandelstap. Deze restgroep wordt 
een anterieure neurectomie aangeboden, hetgeen in een eerdere retrospectieve analyse 
succesvol is gebleken bij ongeveer 2 van de 3 geopereerde patiënten19. De goede resultaten 
van een dergelijke chirurgische interventie bij deze patiëntenpopulatie was echter nog niet 
aangetoond in een gerandomiseerd gecontroleerd onderzoek. In hoofdstuk 6 (chapter 6) 
wordt een onderzoek beschreven waarin volwassen ACNES-patiënten, die onvoldoende 
pijnvrij zijn na injecties, worden gerandomiseerd voor een anterieure neurectomie dan 
wel een ‘schijnoperatie’. Uiteraard was deze studie door de lokale Medisch Ethische 
Commissie goedgekeurd. Zowel de patiënt als de hoofdonderzoeker waren tot 6 weken na 
de operatie niet op de hoogte van de aard van de ingreep. Het pijnniveau werd genoteerd 
vóór de ingreep, direct na de ingreep en 6 weken postoperatief. Een >50% pijnreductie 
(VAS, visuele analoge schaal) en/of een reductie van minimaal 2 punten (VRS, verbale 
pijnschaal) werd beschouwd als ‘succes’. 44 patiënten participeerden in de periode tussen 
augustus 2008 en december 2010. In de neurectomiegroep reageerden 16 van de 22 
patiënten succesvol op de ingreep. In de schijnoperatiegroep daarentegen reageerden 
slechts 4 patiënten met succes (p = 0.001). Deze studie toont aan dat de pijn bij de meeste 
ACNES patiënten wordt veroorzaakt door de eindtakken van de intercostaal zenuwen en 
dat een neurectomie hierbij veelal goed kan helpen.
Een anterieure neurectomie lijkt een redelijk succesvolle behandeling bij ACNES-
patiënten, maar de studies die dit aantonen zijn relatief klein met een korte follow-up. Het 
doel van hoofdstuk 7 (chapter 7) is om de lange-termijn-succespercentages te bepalen van 
chirurgie in een grote ACNES-populatie. Alle patiënten die een anterieure neurectomie 
ondergingen tussen januari 2004 en februari 2012 werden onderzocht. Pijnscores vóór en 
na de operatie en op het moment van ondervragen werden verkregen middels een 10-punts 
pijnscore (PI-NRS) en een 6-punts verbale pijnscore (VRS). Succes werd gedefinieerd als 
≥50% pijnreductie op de PI-NRS en/of minstens 2 punten reductie op de VRS. Bij 154 
individuen werden 181 neurectomieën uitgevoerd en derhalve geanalyseerd. Op de korte 
termijn (1-3 maanden postoperatief) werd bij 70% een succesvolle respons vastgesteld. 
Na een mediane follow up van 32 maanden (3-93 maanden) kon een succesvolle respons 
bij 61% worden vastgesteld. Bij 16% (n=20) werd een recidief ACNES (klachten op exact 
dezelfde plaats) waargenomen. Concluderend kan worden gesteld dat een operatie bij 
ACNES-patiënten die onvoldoende reageren op injecties ook op de lange termijn bij 
ongeveer 2 van de 3 patiënten succesvol blijft.
Hoewel het behandelprotocol, bestaande uit lokale infiltraties gevolgd door een 
anterieure neurectomie, op de lange termijn succesvol is bij de meeste patiënten, zijn 
de opties voor het resterende kwart van de ACNES patiënten, die uiteindelijk niet 
goed reageren, nooit onderzocht. In hoofdstuk 8 (chapter 8) wordt de effectiviteit van 
alternatieve chirurgische opties na een niet succesvolle eerste operatie onderzocht. 
Dit zijn enerzijds patiënten die überhaupt nog nooit succes van behandeling hebben 
ervaren, en anderzijds patiënten die aanvankelijk wel een succesvolle respons op operatie 
hadden, maar bij wie de ACNES recidiveerde. Bij een tweede operatie zijn er twee opties, 
een secundaire anterieure neurectomie (re-exploratie) of een niet nog nooit eerder 
beschreven techniek, de zogenaamde ‘posterieure neurectomie’. Volwassen patiënten 
met recidiverende klachten of een initieel niet succesvolle respons, werden voor deze 
studie geselecteerd uit een database van 181 chirurgische procedures die tussen 2004 
en 2012 in het Máxima Medisch Centrum zijn uitgevoerd. De pijnniveaus rondom de 
re-exploratie of posterieure neurectomie werden opnieuw middels de PI-NRS en VRS 
bepaald, waarbij postoperatief succes werd gedefinieerd als minstens 50% pijnreductie 
op de PI-NRS en/of minimaal 2 punten reductie op de VRS. 51 patiënten die na een 
eerdere neurectomie onacceptabele pijnniveaus rapporteerden, en 20 patiënten die 
recidief klachten ontwikkelden, konden voor deze studie worden geselecteerd. Van 
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deze 71 patiënten ondergingen 41 uiteindelijk opnieuw een chirurgische ingreep (re-
exploratie, n=10; posterieure neurectomie, n=31). Na een mediane follow up van 25 
maanden, bleek een tweede operatie bij 66% van de patiënten succesvol. Hierbij toonden 
patiënten met recidief ACNES betere resultaten (14/15) dan de patiënten bij wie al direct 
na de eerste operatie pijnklachten onverminderd aanwezig bleven (13/26, p=0.01). Op 
basis van deze studie kan worden vastgesteld dat een tweede operatie (re-exploratie of 
posterieure neurectomie) de moeite waard kan zijn bij ACNES-patiënten, die recidief of 
persisterende pijnklachten ervaren na een eerste operatie.
Conclusies van dit proefschrift
1. Een in dit onderzoek ontwikkelde 18-item vragenlijst kan een 
‘buikwandpijnsyndroom’ identificeren bij mensen waarbij in een eerder stadium 
onterecht de diagnose ‘functionele buikpijn’ is gesteld (sensitiviteit 0.92, 
specificiteit 0.94).
2. In huisartsenpraktijken blijkt een klinisch relevant deel van patiënten met 
‘functionele buikpijn’ in werkelijkheid aan ACNES te lijden (prevalentie 3.6%, 
CI 1.7 – 7.6%).
3. De incidentie van acute ACNES-patiënten op een spoedeisende hulp (SEH) 
van een regionaal opleidingsziekenhuis is 22/100.000 per jaar. Dit betekent dat 
ongeveer 2% van de acute SEH buikpijnpatiënten ACNES heeft. De algemene 
jaarincidentie van ACNES is vastgesteld op 1:1.800, hetgeen aangeeft dat er in 
Nederland jaarlijks ongeveer 9.500 nieuwe ACNES-patiënten bijkomen.
4. Patiënten met ACNES hebben een forse zorgconsumptie in het jaar voorafgaand 
aan hun diagnose (€5,400 per patiënt). Extrapolatie van deze kosten op basis 
van het aantal jaren dat patiënten gemiddeld klachten hebben vóórdat de juiste 
diagnose wordt gesteld, leidt tot een bedrag van €16,600 aan directe medische 
kosten. Daarnaast blijken in het jaar voorafgaand aan de diagnose de indirecte 
kosten gemiddeld €13,800 te zijn. Derhalve wordt per patiënt in totaal €19,200 
aan direct en indirecte kosten gemaakt in het jaar voorafgaand aan de diagnose.
 
5. Een neurectomie van anterieure eindtakken van de intercostaalzenuw leidt tot 
een significante pijnreductie bij ACNES-patiënten die niet succesvol konden 
worden behandeld met injectietherapie. Met deze ingreep kan een korte termijn 
behandelsucces van 70%, en een lange termijn succes van 61% worden bereikt. 
6. Een secundaire chirurgische ingreep zoals een re-exploratie of een posterieure 
neurectomie is succesvol bij ongeveer 2/3e van de ACNES–patiënten bij wie de 
pijn na een eerdere anterieure neurectomie persisteerde of recidiveerde.
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Toekomstperspectief
Algemene informatie rondom incidentie, prevalentie, diagnose en behandeling van 
ACNES is schaars. De inspanningen die tot nu toe in het SolviMáx Expertise Centrum 
zijn geleverd, hebben mede als doel om hiaten in deze basiskennis op te vullen. Een 
toenemend aantal verwezen patiënten voorziet ons van een unieke mogelijkheid om 
nieuwe onderzoeksvragen te kunnen beantwoorden. Een praktische aanpak binnen 
SolviMáx heeft ertoe geleid dat een simpel uitvoerbaar behandelprotocol is ontwikkeld, 
dat voor de meeste ACNES-patiënten een goede uitkomst biedt. Echter, er is nog 
steeds een kleine minderheid binnen deze buikwandpijnpopulatie, die ondanks alle 
behandelingsopties die tot nu toe ontwikkeld zijn, nog steeds onvoldoende baat hebben.
Eén belangrijk gebied van toekomstig onderzoek betreft dus de groep patiënten die niet 
goed reageert op het bestaande behandelprotocol. Belangrijke vragen als: ‘hoe reageerden 
deze patiënten op de initiële injectietherapie?’, ‘hoe lang hadden zij al klachten?’, ‘welke 
klinische kenmerken bij lichamelijk onderzoek waren aanwezig?’ moeten nog worden 
beantwoord. Door het inzichtelijk maken van verschillen in patronen tussen hen die goed 
reageren en patiënten die niet succesvol zijn behandeld, kunnen mogelijk prognostische 
factoren worden blootgelegd. Misschien kunnen op basis hiervan verschillende ACNES 
subtypes worden gedefinieerd. Kinderen vormen mogelijk al zo’n subtype8. De etiologie 
bij kinderen lijkt veelal mechanisch van aard, wat leidt tot symptomen die enkel tot de 
anterieure tak van de intercostaalzenuw herleid kunnen worden. In de ideale situatie zullen 
deze prognostische factoren leiden tot een individueel patiënt-specifiek behandelplan. 
Ook zal, gezien het feit dat veel patiënten ook (pseudo) viscerale klachten aangeven die 
na behandeling verdwijnen, de rol van segmentale relaties moeten worden onderzocht en 
nader verduidelijkt.
Deze thesis heeft zich ook gericht op de last die ACNES met zich meebrengt 
in maatschappelijke en economische zin. Onze studies toonden het onvermogen 
van patiënten aan om gewone, dagelijkse activiteiten te volbrengen, gezien de hoge 
absentiecijfers en productiviteitsverlies in de arbeidssituatie.  Het is zeer aannemelijk dat 
de vaak langdurige zoektocht om tot de juiste diagnose te komen een serieuze impact 
heeft op de kwaliteit van leven. Voor een beter inzicht en begrip zou de rol van deze 
psychosociale factoren bij ACNES-patiënten intensiever bestudeerd moeten worden. 
Toekomstig onderzoek zou zich moeten toeleggen op een complete evaluatie van de 
gewijzigde gezondheidsstatus van deze patiëntenpopulatie.
Een kwaliteit van een niet-academisch centrum zoals MMC is het pragmatisch 
aanpakken van medische vraagstukken. Zo is een nagenoeg vergeten buikwand-
pijnsyndroom zonder een gestructureerde diagnostische aanpak en behandelprotocol 
‘(her)ontdekt’, waarvoor een wetenschappelijk programma werd opgezet, dat zich heeft 
gefocust op snelle en betere herkenning, diagnostiek en behandeling. Verschillende 
bijdragen in toonaangevende medische tijdschriften hebben geleid tot een stapsgewijs 
behandelprotocol. Dit protocol blijkt bovendien te leiden tot betere resultaten 
dan gerapporteerd in vergelijkbare andere chronische perifere neuropathische 
pijnpopulaties20, 21. Al deze inspanningen hebben in een relatief kort tijdbestek 
plaatsgevonden. De keerzijde van deze praktische aanpak is echter wel dat een aantal 
fundamentele vraagstukken nog niet opgehelderd zijn. Toekomstig onderzoek zou zich, 
bij voorkeur met een academische partner, meer moeten richten op de anatomie van de 
aangedane zenuwstructuren en pathofysiologie van dit syndroom. Deze oproep lijkt in 
te druisen tegen een logische, stapsgewijze onderzoeksaanpak, maar het kan wel nieuwe 
inzichten geven die bijvoorbeeld een duidelijke classificatie mogelijk maken met een 
daarbij behorende specifieke behandeling. Een beter begrip van de neuroanatomie kan 
bovendien bijdragen aan alternatieve (chirurgische) behandeltechnieken. Zoals ook in dit 
proefschrift duidelijk werd, hadden sommige patiënten baat bij een nieuwe chirurgische 
techniek, de zogeheten ‘posterieure neurectomie’. Bij deze benadering worden de 
intercostaal-zenuwtakjes geïdentificeerd ter hoogte van de achterste rectusfascie. Een 
succesvolle respons in sommige patiënten suggereert dat de zenuwbeknelling ook ter 
hoogte van de achterste rectusfascie kan vóórkomen. Deze redenering volgend zou een 
posterieure neurectomie, als eerste chirurgische stap, een betere behandeloptie kunnen 
zijn dan de anterieure neurectomie, aangezien de zenuw op een proximaler traject wordt 
doorgenomen. Weer een stap verder zou een neurectomie op een nog proximaler niveau 
zijn, bijvoorbeeld via een laparoscopische benadering. Ook andere, niet chirurgische 
therapeutische handelingen op een proximaler niveau zouden een optie kunnen zijn. 
Deze alternatieve behandelopties zouden in de nabije toekomst verder onderzocht 
kunnen worden.
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Vanuit onze heelkundige visie is het begrijpelijk dat de hierboven beschreven 
toekomstperspectieven veelal vanuit een chirurgisch oogpunt worden beschreven. Er 
liggen echter ook behandelopties buiten het chirurgische spectrum. Medicatie kan bij 
een deel van de ACNES-patiënten een positief effect hebben, maar goed opgezette studies 
ontbreken op dit moment20, 21. Andere therapeutische interventies zoals ruggenmerg 
of dorsale ganglion neurostimulatie-therapie, paravertebrale blokkades en manuele 
therapie hebben mogelijk ook toegevoegde waarde22-26. In onze praktijk worden deze 
behandelopties vaak pas benut als de chirurgische opties falen, doch het lijkt zinvol om 
de waarde van deze behandelingen als eerste behandelstap nader te onderzoeken.
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Dankwoord
De weg naar de totstandkoming van dit proefschrift is niet beperkt tot de jaren dat 
ik me actief heb ingezet voor de studies die dit boek bevatten. Enkele basisnormen en 
waarden zijn mij letterlijk met de paplepel ingegoten en deze hebben ertoe bijgedragen 
dat ik deze promotie in de huidige vorm heb kunnen afronden. Discipline, eerlijkheid en 
bescheidenheid zijn enkele eigenschappen die snel bij mij komen bovendrijven. Ik ben 
hier mijn ouders, Henk en Betsy van Assen, enorm dankbaar voor. Mijn broers Jan en 
Anton hebben hier sterk ook aan bijgedragen, waarvoor dank! 
Ik had 4 jaar geleden niet kunnen bedenken dat ik auteur zou zijn van het boek dat nu 
voor u open ligt. Zonder de vele patiënten die het vertrouwen in mij hebben gesteld door 
te participeren in de onderzoeken die dit proefschrift bevat, had dit nooit gerealiseerd 
kunnen worden. Alleen met jullie deelname is het voor mij mogelijk geweest om kleine 
stukjes van die puzzel die ACNES heet op te lossen. Opnieuw is mij duidelijk geworden 
dat jullie de bron zijn van nieuwe informatie en de toegang zijn tot oplossingen.
Prof. dr. G.L. Beets en prof. dr. M. van Kleef, promotores, beste heren, bedankt 
voor het enthousiasme, de open houding en de goede samenwerking die het mogelijk 
hebben gemaakt om de afronding van dit proefschrift uiteindelijk in zo’n kort tijdsbestek 
te kunnen realiseren. Ik besef me dat mijn strakke tijdlijn en uw drukke agenda’s soms 
hebben kunnen conflicteren, maar dit heb ik zelf gelukkig nooit zo ervaren. Altijd kon ik 
rekenen op scherpe analyses en terechte vragen die hebben bijgedragen aan de kwaliteit 
van dit proefschrift.
Dr. R.M.H. Roumen, copromotor, beste Rudi, jij hebt mij 4 jaar geleden meegezogen 
in de wereld die ACNES heet. Jij zag iemand die je in staat achtte een bijdrage te kunnen 
leveren in het ACNES onderzoek. Ik zag en zie iemand die bevlogen is alles wat hij 
doet, gecombineerd met een flinke dosis overtuigingskracht. Dit geldt voor zowel de 
patiëntenzorg als het onderzoekswerk. Vanaf het eerste moment heb jij mij gegrepen met 
je enthousiasme en zie waar het toe geleid heeft! Je bent echt een ‘wandelende ideeënbus’ 
en hebt de capaciteit om in 5 minuten een heel proefschrift bij elkaar te filosoferen. Toch 
zal dit niet zijn wat me het meest is bijgebleven in de afgelopen jaren. Je volledige begrip 
en grenzeloze steun die jij, en ook Marc, hebt gegeven toen ik had besloten niet verder 
te gaan binnen de chirurgie, heeft diepe indruk op mij gemaakt. Je hebt het vermogen 
getoond om over je eigen schaduw heen te kijken en je bent je altijd vol voor mijn 
carrière blijven inzetten. Mijn persoonlijke keuzes heb je hierin boven de belangen van 
dit proefschrift gesteld. Als mens en als professional waardeer ik je daarom enorm. We 
zullen beiden meer en meer onze eigen weg inslaan, maar ik weet dat je deur altijd voor 
mij openstaat en dat is andersom niet anders. 
Dr. M.R.M. Scheltinga, copromotor. Beste Marc, alias ‘koning manuscriptrevisie’, ik 
ken niemand die zo snel teksten reviseert als jij. Het blijft een raadsel hoe je dit voor 
elkaar krijgt en dit is daarom ook een terugkerend onderwerp van gesprek onder de 
onderzoekers van de afdeling chirurgie in het Máxima Medisch Centrum. Je snelle 
werkwijze, doortastende kritieken en nooit aflatende goede zin hebben mij ontzettend 
geholpen met het afronden van de verschillende studies. Daarnaast is onze gezamenlijke 
liefde voor het wielrennen en aangename afwisseling geweest op de ACNES problematiek. 
Bedankt voor het zijn van de katalysator van mijn proefschrift, ‘I hope I kept you busy 
enough...’
Alle co-auteurs, dr. O.B. Boelens, dr. P.V. van Eerten, dr. C. Perquin, drs. J.Th. 
Kamphuis, drs. C.A.M. Bouwmans, drs. J.W. de Jager-Kievit, drs. J.A. Brouns, bedankt 
voor de samenwerking tijdens de verschillende onderzoeksprojecten. In het bijzonder 
Oliver, bedankt dat ik het stokje van je heb kunnen overnemen.
Prof. dr. Prof. dr. N.D. Bouvy, Prof. dr. F.J.P.M. Huygen, Prof. dr. J.F.M. Metsemakers, 
Prof. dr. J.J. van Overbeeke en Prof. dr. A.J.P.M. Smout, leden van de manuscript-
commissie. Dank voor het beoordelen van mijn proefschrift.
Collega’s van de afdelingen waar ik in de afgelopen jaren werkzaam ben geweest in 
het Máxima Medisch Centrum. Jullie interesse, begrip, ideeën en opbeurende woorden 
zijn van onschatbare waarde geweest. Binnen de afdeling chirurgie heb ik me altijd 
welkom en gewaardeerd gevoeld, ondanks dat ik niet in de kliniek werkzaam was. Op 
de spoedeisende hulp heb ik de kans gekregen om mijn klinische vaardigheden verder te 
ontwikkelen, maar ook heb ik hier de vrijheid gekregen om het onderzoek prioriteit te 
geven op momenten dat dit nodig was. Binnen het escalatieteam kon ik altijd wel terecht 
een luisterend oor of een goed advies. Maar ook vond ik hier welkome ontspanning 
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tussen de onderzoeks-werkzaamheden door. Op de afdeling sportgeneeskunde is de 
afronding van dit proefschrift met veel interesse en belangstelling gevolgd. Ook hier heb 
ik de vrijheid gekregen om ‘tussen de bedrijven door’ de nodige zaken af te handelen.
Medewerkers van het secretariaat, polikliniek en drukkerij, dank voor jullie 
engelengeduld, ondersteuning en nooit aflatende inzet. Els en Mijke van de SolviMáx 
polikliniek, dank voor jullie hulp bij het verspreiden en verzamelen van het vele 
onderzoeksgerelateerde papierwerk. Tommy van de drukkerij, geen deadline was jou te 
veel, altijd stonden jij en je team klaar om op tijd een opdracht af te krijgen.
Familie, bedankt voor jullie interesse in mijn ‘proza’. Deze betrokkenheid doet een 
mens goed, vooral op momenten dat dingen niet lopen zoals je ze gepland hebt. Van 
mijn 95-jarige opa tot ‘de melkboer’ op familiedagen, allemaal hebben jullie op een eigen 
manier jullie bijdrage geleverd die mij de motivatie hebben gegeven om dit project af te 
ronden.  
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